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Porcine reproductive and respiratory syndrome virus (PRRSV) causes late-term
abortion in sows and pneumonia in growing piglets. PRRSV evades the host immune
response by several mechanisms, including the modulation of cytokine secretions in
infected pigs, which is the subject of this dissertation. Particularly, PRRSV reduces the
secretion of the pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α) but
increases the secretion of the anti-inflammatory cytokine interleukin-10 (IL-10). The
latter effect, however, is PRRSV strain-specific. In this dissertation, we have examined
mechanisms by which PRRSV regulates TNF-α and IL-10 expressions. The pathogenic
strain FL12, derived from a PRRSV infectious clone, consistently suppressed TNF-α but
failed to induce IL-10 in infected swine cells. In addition, no significant IL-10 production
takes place in pig tissues following infection with vFL12. Using a TNF-α promoterreporter gene construct, we demonstrated that the viral non-structural proteins, Nsp1α and
Nsp1β reduce the TNF-α promoter activity in transiently transfected cells, mainly by
inhibiting the cellular transcription factors Nuclear Factor-κB (NF-κB) and Specificity
Protein 1 (Sp1) respectively. Furthermore, screening of Nsp1α mutant constructs revealed

that five amino acid residues (Gly90, Asn91, Arg97, Arg100, and Arg124) are important
for inhibiting the TNF-α promoter activity. Nsp1α also reduced TNF-α protein levels in
an in vitro translation assay, and Gly90 was important for this activity. Screening of
Nsp1β mutant constructs showed that multiple amino acid stretches in all domains are
important for inhibiting the TNF-α promoter activity. We obtained two mutant vFL12
strains with substitutions at Nsp1αGly90 and Nsp1β70SMVRE74 positions. Both mutant
viruses increased TNF-α mRNA levels at early times after infection when compared to
parental vFL12 strain in infected macrophages. However, only Nsp1α mutant virus
induced higher TNF-α protein levels when compared to vFL12 in infected macrophage
cultures. Moreover, Nsp1β mutant virus was attenuated in infected pigs. In summary, we
have identified proteins that regulate the expression of TNF-α. These results may be
useful for designing novel prophylactics and therapeutics for PRRSV.
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CHAPTER I
Literature Review
1. Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a disease affecting
swine, which is characterized by reproductive failure in pregnant sows and pneumonia in
growing pigs. The causative agent, porcine reproductive and respiratory syndrome virus
(PRRSV) belongs to the family Arteriviridae classified under the order Nidovirales (193).
The virus is classified into two genotypes, European (genotype I) and North American
(Genotype II) based on genetic relatedness (111). Within each genotype, several
genetically distinct strains are circulating in the swine populations temporally and
geographically (153, 162).
Since its identification in the late 1980s (77), the control of PRRS in the field was
unsuccessful due to the lack of effective vaccines. At present, the virus is endemic
throughout the world and is an economically important pathogen of swine. Current live
attenuated vaccine strains do not provide complete protection against heterologous strains
and may revert back to virulence (91, 128). Even with the availability of reverse genetics
systems for PRRSV (113, 114, 126, 178), the knowledge about the basis of attenuation,
means to increase heterologous protection, means to avoid immune evasion mechanisms
are needed to develop safe, effective, live attenuated PRRSV vaccines. In this dissertation,
we aimed to understand and explore means to attenuate PRRSV by knocking down
cytokine evasion mechanisms, which could lead to better vaccine development in the
future.
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2. Pathogenesis of PRRS
2.1. Clinical signs
PRRS is characterized by two groups of clinical syndromes, reproductive and
respiratory. The reproductive syndrome is mainly characterized by reproductive failure in
pregnant gilts and sows during the third trimester of pregnancy (29, 69). The reproductive
clinical signs include pre-mature farrowing with mummified fetuses and still born piglets
(69). The respiratory clinical signs are more prominent in infected neonatal piglets and
nursery pigs (143). They include dyspnea and tachypnea (69, 142). Type I genotype
strains predominantly causes reproductive disease in pregnant sows. Type II genotype
strains generally cause both reproductive as well as respiratory diseases in pregnant sows
and young piglets respectively (122). Other atypical clinical signs of PRRS include fever,
lethargy, inappetence, rough hair coat, cutaneous erythema, blue discoloration of ears,
conjunctivitis, periorbital edema, and subcutaneous edema (141).
2.2. Mortality and morbidity
The mortality and morbidity rate of infected pigs is inversely correlated with age
but directly correlated with the severity of disease complication by secondary infections.
The mortality rate in neonatal pre-weaning pigs infected with PRRSV in utero or
perinatally may reach 100% (69, 143). The mortality rate in weaned pigs infected with
PRRSV usually ranges from 1-2% and increases up to 15% if concurrent bacterial
infections occur (143). However, the mortality rate is usually low (1-4%) in infected
sows (69).
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2.3. Transmission and sites of replication
Direct contact between PRRSV-infected pigs and uninfected pigs is a major route
of transmission (141). Upon exposure to infectious body fluids (141), virus may initially
replicate in resident macrophages present in mucosal surfaces. The virus then spreads
systemically to lungs, several secondary lymphoid tissues, endometrium, fetal
implantation tissues and fetus (49, 75, 137). In infected young pigs, virus replicates
primarily in a subpopulation of alveolar macrophages in lungs (49), however, in fetuses,
thymus has become a primary site of replication (144).
Viral replication in various tissues establishes a viremic period that starts as early
as 24 h (h) after infection, peaks at 7-14 days, and lasts up to one month, especially in
young pigs (49, 142, 143). After this viremic period, virus establishes a persistent phase
lasting at least 150 days post-infection due to continued low-level replication in lymphoid
tissues such as tonsils and lymph nodes (3, 196). Persistently infected pigs also remain an
important source of transmission within a herd for at least 86 days post-infection (11).
They ultimately clear virus from infected tissues after several months of infection (3).
2.4. Lesions
Gross lesions include inconsistent diffuse tan consolidated lesions in affected
lobes of lungs and prominent enlargement of affected lymph nodes especially in growing
pigs (32, 46). Microscopically, interstitial pneumonia in lungs is common due to
inflammation caused by PRRS virus (32, 142). Lung microscopic lesions include necrotic
cell debris in alveoli, thickening of alveolar wall due to infiltration of macrophages and
lymphocytes (142). In lymph nodes, germinal center necrosis, germinal center
hyperplasia and hypertrophy, polycystic appearance are major lesions observed during
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field and experimental PRRSV infections (142). Apoptosis of infected macrophages
including bystander non-infected macrophages, and infiltration of inflammatory cells into
infected tissues are major causes of lesions observed during PRRS pathogenesis (142,
156).
3. Molecular biology of PRRSV
3.1. Structure of virion
PRRSV virion is composed of a nucleocapsid core surrounded by an envelope.
The nucleocapsid core is a double layered hollow core (161) comprised of a RNA
genome encapsidated with dimeric forms of the nucleocapsid (N) protein (161). The
genome is a single-stranded, positive-sense, capped and poly-adenylated RNA of
approximately 15Kb. The N protein interacts with the RNA genome through a N-terminal
domain that is rich in positively charged amino acids, and dimerizes through a C-terminal
domain (161). The envelope is a bi-layered lipid membrane containing six membrane
proteins that interact with host receptors, nucleocapsid proteins, and is involved with
virus uncoating.
The envelope has six structural proteins, GP2, E, GP3, GP4, GP5, and M. GP2,
GP3, and GP4 that together form a hetero-trimeric complex that appear as a protruding
structure on the surface of PRRSV virion (161, 197). GP5 and M together form a heterodimeric complex that contribute to the smooth structure of the virion surface (109). These
two proteins have relatively small ectodomains covalently linked by a disulfide bond
(161). GP5 and M also have large endodomains that weakly interact with the
nucleocapsid (161, 197). The GP2-GP3-GP4 heterotrimer also interacts with the E
protein (197). GP5-M and GP2-GP3-GP4-E complexes form major and minor
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components of the envelope respectively. All GP2-5 proteins are N-glycosylated proteins
with at least two complex N-glycans that usually contain terminal sialic acid residues (37,
38).
3.2. Viral entry and uncoating
PRRSV virion initially attaches to heparin sulfate molecules on the cell
surface through interactions with the M protein (41). Following this attachment, the virus
interacts with another receptor, sialoadhesin through terminal sialic acid residues present
in its glycoproteins (39, 40). This interaction leads to clathrin-mediated endocytosis
which puts the PRRSV virion in acidified late endosome (86). Further, the interaction of
PRRSV with CD163 receptor through both GP2 and GP4 is essential for virus uncoating
in endosomes (36, 182). The virus uncoating also requires the E protein which may form
an H+ ion channel to help in disrupting the nucleocapsid interactions with the envelope
(98). Upon virus uncoating, the free nucleocapsid is released into the cytoplasm.
3.3. Viral replication, transcription, and assembly
When naked or encapsidated RNA genome reaches the cytoplasm, it is considered
to be infectious and primary translation starts. The RNA genome contains nine open
reading frames, ORF1a, ORF1b, ORF2-7, and ORF5a (73). During primary translation,
ORF1a and ORF1b are translated through ribosomal scanning and ribosomal frame shift
mechanisms respectively. ORF1a and ORF1b produce two polyproteins, pp1a and pp1b
of approximately 2397 and 3854 amino acids respectively. The pp1a and pp1b are
proteolytically processed into 14 non-structural proteins, Nsps 1α, 1β, 2-6, 7α-7β, 8-12
(87, 112, 180). Nsp1α, Nsp1β, Nsp2, and Nsp4 are cysteine/serine proteases that autocleave themselves from the poly-protein (87, 112). However, other ORF1 proteins are
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processed by Nsp4, a serine protease (112, 180). The viral replication complex assembles
on a endomembrane scaffold created by Nsp2 and other ORF1a proteins (181). The main
component of the replication complex is Nsp9 which is a RNA dependent RNA
polymerase (112). The replication complex also contains Nsp11 and Nsp12 (112). The
replicase complex amplifies genomes/anti-genomes in double membrane vesicles (135).
The replicase complex also produces six sub-genomic mRNAs using six antigenome templates synthesized from 20% of the genome located at the 3’ end (43). Each
of these sub-genomic mRNAs produces one or two structural proteins that become part of
virion (73, 199) .
Virion assembly occurs in the endoplasmic reticulum and/or Golgi complex
through budding of nucleocapsids into their lumen. During budding, the envelope
formation around the nucleocapsid is primarily determined by GP5-M heterodimers that
reside in intracellular membranes (197). GP5-M complexes weakly interact with
nucleocapsid that leave a significant gap between the envelope and nucleocapsid (161).
GP2-GP3-GP4-E complexes are recruited to virion envelope through interactions
between GP4 and GP5 (36). After budding, packaged virions are loaded in intracellular
vesicles and transported to the cell surface for progeny virus release.
4. Cell tropism of PRRSV
4.4.1. Macrophages
PRRSV has a restricted cell tropism, infecting cells of myeloid lineage that
include differentiating monocytes, fully differentiated macrophages, immature and
mature dendritic cells (48, 55, 190). In pigs, PRRSV-infected cells are found in clusters
and are not always located in close proximity to microscopic lesions (97). They are found
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in lungs, tonsils, spleens, testes, ovaries, and lymph nodes such as retropharyngeal,
bronchial, sternal, thoracic, aortic, inguinal, and mesenteric lymph nodes, (49, 119, 168,
169). In lungs, alveolar macrophages become predominant target for replication although
PRRSV replicates in septal macrophages, intravascular macrophages (49, 61, 174). Only
2% of alveolar macrophages are infected during acute infection of lungs (49).
Macrophages present in endometrium and fetal placental tissues are also highly
permissive for PRRSV, which may contribute to virus spread to the fetus (75). However,
peritoneal macrophages are resistant to PRRSV replication because they lack a cellular
receptor for PRRSV (48). Monocytes that are cultivated in vitro become permissive after
one day of culture which correlates with increase in CD163 expression (134).
4.4.2. Dendritic cells
Dendritic cell populations have differential susceptibility to PRRSV infection.
Lung dendritic cells are not permissive for PRRSV replication (106). However, the
dendritic cells grown in vitro such as monocyte-derived dendritic cells and bone marrowderived dendritic cells are highly susceptible to PRRSV infection (22, 55, 190). The level
of infection is independent of the maturation status of dendritic cells (55, 190). In
addition to macrophages and dendritic cells, PRRSV can infect testicular germ cells (168).
4.4.3. Host factors required for PRRSV infection
In addition to cellular receptors for PRRSV, other host factors determine tropism
for PRRSV. For instance, in permissive MARC-145 cells, vimentin binds to the
nucleocapsid protein of PRRSV which may be required for the subsequent nucleocapsid
transport within cytosol through cytoskeletal filaments (81). Similarly, CD151, a
tetraspanin, is required for permissivity in MARC-145 cells (152). In MARC-145 cells,
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direct cell-to-cell transmission of PRRSV is also observed in a cytoskeleton-dependent
manner (18).
5. Innate immune responses during PRRSV infection
PRRSV suppresses innate immune responses in infected alveolar macrophages,
pulmonary intravascular macrophages and plasmacytoid dendritic cells (1, 20, 102).
PRRSV inhibits several innate signaling pathways such as type I interferon (10), tumor
necrosis factor-α (164), and bactericidal pathways (174). In natural killer cells (NK cells)
of infected swine, PRRSV also inhibits cell-mediated cytotoxicity (74).
5.1. Type I Interferon responses against PRRSV infection
Exogenous IFN-α in the supernatant of infected alveolar macrophages inhibits
PRRSV replication (17). To efficiently replicate in vivo, PRRSV actively suppresses type
I interferons such as interferon-β and interferon-α in infected macrophages (1, 10).
Furthermore, PRRSV interferes with type I interferon production in non-permissive
plasmacytoid dendritic cells (19, 20). Reduced IFN levels in PRRSV-infected lungs
exacerbate pneumonia caused by porcine respiratory coronavirus (PRCV) super-infection
(74). When PRCV infected pigs were super-infected with PRRSV, PRCV induced IFN-α
could reduce PRRSV viral titers in the lungs (17). Detailed studies revealed that PRRSV
non-structural proteins inhibit type I interferon induction and interferon signaling in
infected macrophages (10). However, PRRSV structural proteins may contribute to the
suppression of type I interferon induction in non-permissive plasmacytoid dendritic cells
(20).
PRRSV non-structural proteins, Nsp1α, Nsp1β, and Nsp11, prevent interferon
regulatory factor-3 (IRF-3) activation that is essential for type I interferon induction (10).
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Moreover, another non-structural protein, Nsp2 inhibits IFN-β synthesis through its
ovarian tumor (OTU) domain that deubiquitinates IκB thereby preventing NF-κB
activation (167). Interestingly, PRRSV also suppresses expression of toll-like receptors
(TLR7, TLR3), which trigger IRF-3 and NF-κB activation (24). Additionally, PRRSV
blocks the downstream IFN signaling pathway to inhibit the amplification of IFN
responses (133). For example, Nsp1β blocks the nuclear translocation of signal
transducer and activator of transcription 1/2 (STAT1/2) thus inhibiting the expression of
interferon-stimulated genes such as ISG15 and ISG56 (133).
Structural proteins on the surface of PRRSV virion particles also interact with an
unknown molecule on the surface of plasmacytoid dendritic cells to inhibit type I
interferon induction (20). Furthermore, structural proteins down modulate the constitutive
interferon regulatory factor-7 (IRF-7) expression in plasmacytoid dendritic cells by
inhibiting the STAT1 transcription factor (20).
5.2. TNF-α response against PRRSV infection
PRRSV suppresses the inflammatory cytokine, tumor necrosis factor-alpha (TNFα) in infected macrophages and plasmacytoid dendritic cells (19, 102). PRRSV Nsp1α
and Nsp1β inhibit TNF-α expression at its promoter level by suppressing NF-κB
activation and Sp1 trans-activation, respectively (164). In addition, PRRSV may also
inhibit downstream TNF-α signaling because over-expressed Nsp1α suppresses NF-κB
nuclear translocation in response to exogenous TNF-α (159). Exogenous addition of
TNF-α was found to decrease viral titers of infected alveolar macrophages (102)
suggesting TNF-α has anti-viral effects directed against PRRSV.
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5.3. Modulation of macrophages survival and innate function by PRRSV
PRRSV establishes an anti-apoptotic state in infected alveolar macrophages
during early stages of infection (33, 58, 200). However, it induces apoptosis in infected
alveolar macrophages during later stages of infection (33). During in vivo infection, the
virus induces apoptosis predominantly in by-stander non-infected macrophages/
monocytes and infiltrated T cells (75, 92).
Besides its effect on the survival of alveolar macrophages, PRRSV also decreases
their ability to kill and remove opportunistic secondary bacterial infections during in vivo
infections (158, 174). The virus significantly decreases the levels of superoxide anion and
myeloperoxidase-H2O2-halide product in infected alveolar and intravascular macrophages
(174). In addition to impaired bactericidal activity, macrophages also showed decreased
phagocytosis of bacteria such as Hemophilus parasuis during later stages of PRRSV
infection (158). In summary, PRRSV may compromise the innate immune functions of
alveolar macrophages during secondary bacterial co-infections.
PRRSV induces IFN-γ serum levels from day 1 up to 22 days post-infection in
infected pigs (194). The cellular source of this early IFN-γ production is believed to be
from activated NK cells (194). Because exogenous IFN-γ has consistently shown antiviral effects in PRRSV-infected macrophage cultures (8), it is logical to suggest that
increases in IFN-γ serum levels during early phases of an in vivo infection (194) may
have anti-viral effects on PRRSV replication in macrophages. Even though there is an
influx of NK cells into PRRSV-infected tissues (148), their effector functions including
cytotoxicity, are severely impaired in infected pigs (74). Suppression of NK cell
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functions is active rather than passive because PRCV super-infection could not activate
NK cells in the presence of PRRSV in lungs (74).
In conclusion, PRRSV interferes with innate immune responses during in vivo
infection which might affect the induction of adaptive immune responses: in particular
cell-mediated immune (CMI) responses.
6. Adaptive immune responses during PRRSV infection
6.1. Humoral immune responses against PRRSV
PRRSV can induce specific B cell effector and memory responses during in vivo
infection (119). Consequently, PRRSV induces a robust antibody response as early as 7
days post-infection (205). The PRRSV-specific antibody responses were detected for at
least 604 days post-infection (93). But, the antibody responses are heavily skewed
towards non-neutralizing antibodies during 7-21 days post-infection (205). In contrast,
the neutralizing antibody responses generally appear late after resolving viremia (205)
and, are variable depending on the viral strain (188). Fewer reports have suggested that
PRRSV may induce polyclonal activation of B cells non-specifically in tonsils from three
days post-infection (95).
The non-neutralizing antibody responses are postulated to enhance PRRSV
infection during viremic period (104). In spite of their late appearance post-infection and
their lack of participation with respect to viral clearance, neutralizing antibodies may play
a significant role in preventing an infection (105). This concept was confirmed by passive
transfer of neutralizing antibodies prior to infection, thus providing sterilizing immunity
in pregnant sows and young pigs if the titer is at least 1: 8 to 1:16 (104, 105). However,
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the presence of neutralizing antibodies in serum does not prevent virus replication in
infected tissues and also does not prevent virus spread to exposed animals (104).
The recall anamnestic responses against homologous PRRSV challenge are due to
the induction of memory B cell responses in secondary lymphoid organs but not in
Peyer’s patches of small intestine or bone marrow (119). Memory B cell responses are
predominantly directed against proteins that induce non-neutralizing antibodies such as
Nsp2 and N rather than those that induce neutralizing antibodies such as GP5 (119). As
expected, plasma cell responses are primarily directed towards Nsp2 and N proteins
during secondary antigen exposure (119). Nevertheless, the anamnestic responses against
a heterologous PRRSV challenge have been described as shorter and provide incomplete
protection (94). Interestingly, antibody-dependent depletion of MHC II+ cells and CD4+
cells from infected peripheral blood mononuclear cells (PBMCs) were sufficient to
decrease the PRRSV-specific T cell proliferative responses by about 80% (7).
Neutralizing antibodies are induced by GP2, GP3, GP4, GP5, and M proteins (116,
129, 186, 187, 202). GP3 and GP5 neutralizing epitopes are shielded from induction of
neutralization antibodies by N-glycans (5, 187).

GP5 possess a major neutralizing

epitope in its ectodomain whose immunogenicity is masked by an adjacent nonneutralizing decoy epitope (129, 136).
Overall, PRRSV induces robust humoral immune responses: but effector and
memory B cell responses are skewed toward non-neutralizing antibodies. Infection averts
the development of neutralizing antibodies beyond the viremic phase, which is relatively
weak and protective only against challenges with homologous or closely related strains.
But challenges with heterologous strains only protects well to fraction of the animals.
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6.2. Cell-mediated immune responses against PRRSV
PRRSV interferes with CMI responses, which allow a long-lived persistent
infection (96). In addition to serum neutralizing antibodies, IFN-γ-specific T cell
responses play a significant role in PRRSV clearance (6). The IFN-γ-specific T cell
responses can be detected as early as 14 days post-infection (dpi) (6). After 8-10 weeks
after infection, IFN-γ-specific T cell responses increases until 48 weeks, remains stable
until 690 days post-infection (110). This gradual development of IFN-γ-specific T cell
responses is sub-optimal when compared to pseudorabies viral infections (110).
Nevertheless, the IFN-γ-specific T cell responses are partly responsible for viral
clearance from acutely infected lungs including viremia but are ineffective in clearing
virus from persistently infected tissues (96, 148).
In PBMCs from infected pigs, T cell proliferative responses are mainly
contributed by CD4-CD8+ (high) and CD4+CD8+ cells (62, 96). CD-CD8+ (high) cells
and CD4+CD8+ cells represent the effector cytotoxic T cells and memory T cells in
swine respectively (123, 208). Specifically, the drop in viremia after 3-4 weeks of
PRRSV infection is correlated with enhanced CD4-CD8+ (high) cells in PBMCs (62, 96).
In contrast, in acutely infected lungs, CD4-CD8+ cells but not CD4+CD8+ cells are
predominantly infiltrating after 7 days post-infection (148).
The CD4-CD8+ T cell infiltration into lungs may be due to selective chemotactic
signals and their kinetics are correlated with decreases in cell-associated PRRSV in lungs
(148). CD8+ cytotoxic T lymphocytes are juxta-positioned next to PRRSV-infected cells
in lungs as judged by immunohistochemical staining (176). However, the impaired CD2+
CD8+ (high) T cell responses in mediastinal lymph nodes and tonsils during PRRSV
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persistent infection may favor viral persistence in those tissues (96). This is consistent
with the finding that CD3+CD8+(high) cells from PRRSV-infected pigs do not exhibit
cytotoxicity towards PRRSV-infected alveolar macrophages as detected by in vitro CTL
assay (34).
T cell responses to mitogens such as Concavalin A, and Phytohemagglutinin
(PHA) were transiently impaired in blood and lymphoid organs during PRRSV
persistence (96). This non-specific T cell suppression may be due to the induction of Th3
regulatory cells in response to PRRSV-infected dendritic cells (155). These PRRSVinduced Th3 regulatory cells are phenotypically characterized as Foxp3+CD25+ T cells
that can suppress PHA-stimulated PBMCs (155). Overall, these studies suggest that
functional impairment of CD8+ (high) T cells may be the explanation for ineffective
PRRSV clearance in infected pigs.
Apart from αβ TCR+ T-lymphocytes, pigs also contain a high percentage of γδ
TCR+ T-lymphocytes in blood that contributes to specific adaptive responses against
various pathogens (127). Another report suggests that γδ TCR+ T-lymphocytes cells
possess constitutive natural killer activity in pigs (103). Interestingly, γδ TCR+ Tlymphocytes also expand in response to PRRSV in the peripheral blood during 14 to 70
days post-infection and are capable of inducing IFN-γ in response to antigen stimulation
(127). Most of the responding γδ TCR+ T-lymphocytes are positive for the CD8 marker
(103). The role of γδ TCR+ T-lymphocytes in clearing virus from blood is not fully
understood (127).
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Functionally, the expanded CD8+ cells from PRRSV-infected pigs that comprise
CD8(high), CD4+CD8+, γδ TCR+CD8+ cells have moderately increased cytotoxic
activity from 15% to 35% towards a tumor cell line in an in vitro cytotoxicity assay (103).
7. Cytokine responses during PRRSV infection
PRRSV generally suppress induction of many pro-inflammatory, anti-viral and T
cell immunomodulatory cytokines in infected macrophages and dendritic cells. It also up
regulates immunosuppressive cytokines such as TGF-β and IL-10: but this is dependent
on the viral genotype and strains. The presence of several exogenous anti-viral cytokines
in the supernatant of infected macrophages or MARC-145 cells can inhibit PRRSV
replication.
7.1. Modulation of pro-inflammatory cytokines by PRRSV
PRRSV weakly induces pro-inflammatory cytokines both in vitro and in vivo. In
infected pigs, IL-1β and IL-8 levels are increased during acute replication but not viral
persistence (107). Interestingly, PRRSV increases IL-8 protein, but not its mRNA levels
(173). In the majority of infected pigs, PRRSV consistently induces IL-1β with a similar
kinetics following viremia (92, 184). However, infection increases TNF-α slightly at 14
days post-infection (dpi) in some infected pigs (92, 184). In contrast, significant IL-6
induction was observed in PRRSV-infected pigs in vivo (173, 184). In infected fetuses,
there were marked up regulation of TNF-α and IFN-γ in lungs and serum both at mRNA
and protein levels (144). Two-weeks old in utero infected piglets exhibited increased IL12 and IFN-γ mRNAs (72). However, four-weeks old in utero infected piglets have
increased TNF-α and IL-8 mRNA levels (72). PRRSV-infected pigs consistently up
regulate IL-12p40 mRNA levels in PBMCs and PAMs during acute and persistent phases
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of infection (173). There is a correlation between IL-12p40 levels and IFN-γ levels in
infected pigs (61).
PRRSV also augments the production of all pro-inflammatory cytokines such as
TNF-α, IL-1, IL-6, IL-8 in pigs co-infected with Mycoplasma hyopneumoniae or treated
with bacterial endotoxin (173, 184). These pro-inflammatory responses are due to CD14
and LPS receptor up regulation on monocytes infiltrating into the lungs (183). PRRSV
also stimulates pro-inflammatory chemokine: Regulated upon Activation Normal T-cell
Expressed and Secreted (RANTES) in TLR-MyD88-dependent manner (191). In contrast,
PRRSV suppresses the inflammatory chemokine: macrophage inflammatory protein-1β
(MIP-1β) during infection of alveolar macrophages (102).
In cultured cells, PRRSV modulates pro-inflammatory cytokine levels in a cell
type dependent fashion. PRRSV suppresses IL-1α, IL-1β, TNF-α and IL-12p40 following
infection of PAMs (102, 173). Similarly, PRRSV does not induce IL-6, IL-8, IL-12, and
TNF-α from plasmacytoid dendritic cells (20). However, in bone marrow-derived
immature dendritic cells, PRRSV up regulates IL-1, IL-6, IL-8, but not IL-12 and TNF-α
(22). In immature monocyte-derived dendritic cells, PRRSV does not induce IL-12, but
induce weak TNF-α at 24 h and 48 h post-infection (190). However, a particular strain of
PRRSV up regulates IL-12 and TNF-α in monocyte-derived dendritic cells (132).
PRRSV Nsp2 protein down modulates IL-1β and TNF-α (27).
7.2. Anti-viral cytokines that inhibit PRRSV replication
Treatment of pigs with recombinant porcine IL-12 reduced PRRSV viral
replication in PAMs by inducing IFN-γ (21). Similarly, another IFN-γ-inducing cytokine,
IL-18 inhibits PRRSV replication in permissive cells (25). IFN-γ has anti-viral effects on
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PRRSV replication by a dsRNA-inducible protein kinase (PKR) dependent fashion (145).
This effect is dose-dependent and dependent on the length of exposure prior to infection
(8). TNF-α and IFN-α also have anti-viral effects on PRRSV replication (100, 102).
Treatment of PAMs with TNF-α before or during infection reduces PRRSV titers in the
supernatant (102). Interestingly, most IFN-α subtypes contribute to anti-viral effects on
PRRSV replication (150). Viral isolates have different sensitivity to anti-viral effects of
IFN-α and have different abilities to induce IFN-α (100). Recently, recombinant porcine
IL-29 was shown to have an anti-viral effect on PRRSV replication (189).
7.3. Modulation of anti-inflammatory cytokines during PRRSV infection
Certain PRRSV strains stimulate anti-inflammatory cytokines such as IL-10 and
TGF-β. Piglets infected in utero have increased levels of IL-10 mRNA after four weeks
of age (72). Similarly, several experiments with different PRRSV strains showed up
regulated IL-10 expression that reached maximum levels at 7-9 days post-infection (45,
92). Leukocytes and monocytes may up regulate IL-10 levels in PRRSV-infected
broncho-alveolar lavage cells (BALC) and PBMCs respectively (23, 170). In vitro studies
in dendritic cells revealed PRRSV induces IL-10 in mature monocyte-derived and bone
marrow-derived dendritic cells but not in immature monocyte-derived dendritic cells (22,
55, 190). Independent studies also demonstrated that IL-10 responses during PRRSV
infection are strain-specific (55, 165, 171). The levels of IL-10 during PRRSV
anamnestic responses are inversely correlated with the number of IFN-γ secreting T cells
during experimental infection and vaccination with different European genotype strains
(44, 45). However, in Foxp3+CD25+T regulatory cells detected after PRRSV infection,
transforming growth factor-β (TGF-β) but not IL-10 is induced (155).
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7.4. Modulation of T cell cytokines by PRRSV
In response to PRRS virus stimulation, T cells induce IL-2 and IFN-γ but not IL-4
and IL-10 during T cell proliferation (123). PRRSV-infected monocytes suppress IFN-γ
and TNF-α secretion from PMA/ionomycin activated T cells, which is dependent on IL10 induction from infected monocytes (23) .
8. TNF-α and its modulation by viruses
8.1. Biological functions of TNF-α
TNF-α is an immediate-early cytokine secreted mainly by macrophages, dendritic
cells, and T cells. TNF-α binds two cellular receptors, TNFR1 (p55) and TNFR2 (p75),
both of which are essential for mediating anti-viral innate immunity in target cells (146).
TNF-α induces apoptosis in cells infected with viruses and intracellular bacteria. TNF-α
also establishes inflammation by inducing other pro-inflammatory cytokines such as IL-1,
IL-6 from monocytes/macrophages, and pro-inflammatory chemokines such as IL-8 from
fibroblasts at the site of infection (177). It also up regulates the adhesion molecules on the
surface of vascular endothelial cells to promote inflammatory cellular infiltration (177).
In T cells, TNF-α signaling through TNFR2 acts as a co-stimulatory signal that is
essential for T-cell activation and proliferation when antigen presentation is weak (80).
However, it also induces apoptosis in mature CD8+ T cells in TNFR2-dependent manner
(207).
8.2. Mechanism and Regulation of TNF-α induction
TNF-α production is tightly regulated virtually at nearly each step of its
biosynthesis. TNF-α can be induced by activation of toll-like receptors such as TLR4 and
TLR7 in response to microbial products. TLR activation leads to several intracellular
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pathways that ultimately up regulate production of membrane and soluble TNF-α. First, it
activates several distinct signaling pathways that lead to assembly of transcription factors
such as Sp1, NF-κB, CBP, Egr-1, Elk-1, ATF2-c-jun, AP-2 on TNF-α promoter to
activate transcription (52, 179). Second, TLR activation also stabilizes the mature TNF-α
mRNA through AU-rich element present in 3’untranslated region (15). The primary
product of TNF-α translation is a membrane form that is cleaved to produce soluble form
by TNF-α converting enzyme (TACE) (206).
8.3. Modulation of TNF-α by viruses
TNF-α has anti-viral effects towards DNA and RNA viruses (198). For example,
it controls replication of herpes simplex virus or murine cytomegalovirus in infected
macrophages (66). TNF-α also restricts respiratory syncytial virus replication in alveolar
macrophages (31). Several viruses encode proteins that inhibit TNF-α. In addition to
PRRSV, African swine fever virus (ASFV), and herpes simplex virus-1 (HSV-1)
suppress TNF-α production during infection (64, 117). Poxviruses, adenoviruses, and
hepatitis C virus employ different strategies to block TNF-α signaling pathway and
prevent apoptosis of infected cells (85). In contrast, Human immunodeficiency virus
(HIV) viral proteins activate TNF-α signaling in infected cells and bystander non-infected
cells to sustain the viral infection or induce apoptosis respectively (67).
9. IL-10 and its modulation by viruses (1)
9.1. Biological functions of IL-10
IL-10 is an anti-inflammatory cytokine secreted by monocytes, macrophages,
dendritic cells, T cells, B cells, and mast cells (118). It has anti-inflammatory and
immunosuppressive activities (139). IL-10 reduces pro-inflammatory cytokine responses
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and inhibits antigen-specific T cell activation (118). IL-10 antagonizes production and
function of several cytokines such as TNF-α, IL-1, GM-CSF, IFN-γ, IL-2, IL4 and IFN-γ
(118). It also down regulates MHC proteins and co-stimulatory molecules on the surface
of macrophages and dendritic cells (118). More importantly, IL-10 directly suppresses
the activity of T helper 1 cells thereby inhibiting CMI responses (118).
9.2. Modulation of IL-10 by viruses
Several intracellular pathogens that survive in macrophages, dendritic cells, or B
cells exploit IL-10 induction pathways to dampen immune responses against them (139).
Typically, persistent viral infections such as lymphocyte choriomeningitis virus (LCMV),
HIV, Hepatitis C virus (HCV), Epstein Barr virus (EBV), Human cytomegalovirus
(HCMV) are associated with high levels of IL-10 (16, 139, 157). HIV encodes several
proteins to induce IL-10 from macrophages and T cells (139), which may contribute to
immunosuppression during later stages of infection. LCMV induces IL-10 to suppress
antigen-specific CD8+ T cells which favors viral persistence (16). HCV induces IL-10 to
suppress Th1 responses in infected individuals (13). EBV and HCMV encode viral IL-10
homologs to dampen adaptive immune responses (157). Similarly, some PRRSV strains
induce IL-10 in infected pigs which antagonize IFN-γ specific T cell responses (44, 45).
10. PRRSV vaccine development
Currently, live attenuated and inactivated virus vaccines are commercially used to
control PRRSV in swine populations worldwide (83). Unfortunately, both types of
vaccines are not effective in protecting pigs from PRRSV field infections (91). Live
vaccines have additional problems such as reversion to virulence, and establishment of
viral persistence in vaccinated animals (79, 128). Availability of several reverse genetics
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systems for PRRSV (114, 126, 178) may facilitate the development of safe attenuated
live virus vaccines by rational introduction of mutations at multiple positions in viral
genome. To this end, chimeric viruses developed by swapping genes between virulent
and attenuated viruses enlighten the role of several viral proteins in virulence/attenuation
(89).
Interestingly, PRRSV virulence is regulated by both non-structural and structural
genes (89). Viral proteins such as Nsp3 to Nsp8, GP2 and GP5 contribute primarily to
virulence, while Nsp1, Nsp2, Nsp10-Nsp12 may have additional roles in virulence (89).
These studies collectively proved that non-structural proteins are important components
in PRRSV virulence. Dissecting multiple virulence determinants in non-structural and
structural proteins could lead to the development of attenuated live virus vaccines that
cannot revert back to virulence.
11. Objective
The ultimate objective of this dissertation is to generate PRRSV mutant viruses
that up regulates TNF-α but fail to induce IL-10 in infected pigs. It is expected that such
mutant viruses will be attenuated and activate optimal immune responses in swine.
Consequently, we evaluated TNF-α/IL-10 responses against a bona fide virulent
infectious clone-derived strain, vFL12 in vitro and/or in vivo. We confirmed the TNF-α
suppressing phenotype but not IL-10 inducing phenotype with vFL12 strain. Using
reporter assays and mutageneic studies, we characterized viral proteins important for
TNF-α suppression and their underlying mechanisms. Furthermore, we attempted to
generate PRRSV mutant viruses that are attenuated but up regulated TNF-α expression in
infected cells.
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CHAPTER II

Porcine reproductive and respiratory syndrome virus non-structural
protein 1 suppresses tumor necrosis factor-alpha promoter activation
by inhibiting NF-κB and Sp1

Virology, 406(2): 270-279, 2010
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ABSTRACT
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to
suppress tumor necrosis factor-alpha (TNF-α) in infected macrophages. The objective of
this study was to identify the PRRSV-encoded proteins that are responsible for the
inhibition of TNF-α expression and the mechanism(s) involved in this phenomenon.
Using a swine TNF-α promoter-specific luciferase reporter system, only the nonstructural protein 1 (Nsp1) was found, out of a total of 11 PRRSV-encoded proteins
screened, to strongly suppress the TNF-α promoter activity. Such inhibition takes place at
the promoter’s proximal region. Both Nsp1α and Nsp1β, the two proteolytic fragments of
Nsp1, were shown to be involved in TNF-α promoter suppression. Furthermore, using
reporter plasmids specific for transcription factors (TFs) that bind to the proximal region
of TNF-α promoter, Nsp1α and Nsp1β were found to inhibit the activity of the TFs that
bind CRE-κB3 and Sp1 elements respectively. Subsequent analyses showed that Nsp1α
moderately inhibits NF-κB activation and that Nsp1β completely abrogates the Sp1 transactivation through its B domain. These findings reveal one of the important mechanisms
underlying the innate immune-evasion by PRRSV during infection and provide avenues
to construct rationally designed attenuated PRRSVs for vaccine development.
Keywords: PRRSV, Tumor necrosis factor-α, promoter suppression, NF-κB, Sp1, Innate
immune evasion
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INTRODUCTION
Porcine reproductive and respiratory syndrome is an economically important
disease causing losses to swine industry worldwide. The disease is characterized by late
term reproductive failure in sows and respiratory distress in young growing pigs (192).
The severity of the disease in young pigs is related to the age and the multi-factorial
nature of the disease. The disease is caused by porcine reproductive and respiratory
syndrome virus (PRRSV), an arterivirus that belongs to the order, Nidovirales. The virus
is a single-stranded, positive-sense RNA virus having a genome of approximately 15 kb
in size (115). PRRSV predominantly replicates in differentiated cells of myeloid lineage
such as macrophages and dendritic cells (48, 190, 192). Since macrophages and dendritic
cells are major producers of innate defensive cytokines such as interferon-alpha (IFN-α)
and tumor necrosis factor-alpha (TNF-α) during viral infections, it is plausible that
PRRSV can actively suppress their induction in order to replicate in the host cells and
fulfill the pathogenic goal of establishing persistency in the host (3, 10, 102). In addition,
the defective induction of innate immune responses against PRRSV may contribute to the
delayed and weak development of antigen-specific adaptive immune responses later
during PRRSV infection (105, 110). PRRSV encodes 8 open reading frames that produce
14 non-structural proteins (Nsps) and 7 structural proteins. Recent studies from our
laboratory have shown that several proteins such as Nsp1, Nsp2, Nsp4, and Nsp11 are
able to suppress IFN-β promoter activation (10). These proteins suppress the induction of
Type I IFNs and their signaling by inhibiting transcription factors such as interferon
regulatory factor-3, nuclear factor-κB, CREB-binding protein (CBP) and signal
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transducers and activators of transcription-1 (STAT-1) (10, 26, 82). However, the
molecular mechanisms underlying the TNF-α suppression by PRRSV are unknown.
TNF-α is an immediate-early cytokine, which is secreted in response to various
viral infections by activated macrophages, dendritic cells and T cells (68, 108, 130).
TNF-α has two biological functions: First, it induces apoptosis in virus-infected cells.
This effect is synergistically augmented by the presence of IFN-γ (198). Second, TNF-α
promotes inflammation by inducing the production of other pro-inflammatory cytokines
at the vicinity of infection (177). TNF-α directly inhibits replication of both DNA and
RNA viruses in vitro (31, 66, 198). Viruses such as African swine fever virus (ASFV)
and herpes simplex virus-1 (HSV-1) directly inhibit induction of TNF-α during infection
(64, 117). Several studies have shown that PRRSV is also able to suppress TNF-α
production both in vitro and in vivo. (102, 173, 184, 185).
The objective of the present study was to identify the PRRSV proteins that inhibit
TNF-α expression, especially at the promoter level, and determine the underlying
mechanism(s). Among 11 PRRSV-encoded proteins screened, only Nsp1 was able to
strongly suppress the TNF-α promoter. Moreover, both Nsp1α and Nsp1β, products of
Nsp1 derived by auto-cleavage process, were involved in the TNF-α promoter
suppression. Further detailed analyses showed that Nsp1α and Nsp1β inhibit TNF-α
promoter by inhibiting NF-κB activation and Sp1 trans-activation, respectively. These
findings provide a mechanistic understanding of how PRRSV utilizes two of its nonstructural proteins to suppress the TNF-α promoter activation. This study also gives
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insights into how PRRSV evades the immune response by inhibiting innate immune
defenses during infection.
MATERIALS AND METHODS
Cell lines and viruses
RAW264.7, a murine macrophage cell line (obtained from ATCC) was
maintained in RPMI-1640 with 25mM HEPES (Mediatech) supplemented with 10% fetal
bovine serum (FBS). MARC-145 cells (obtained from Dr. Will Laegrid, USMARC, and
USDA/ARS) were maintained in DMEM supplemented with 10% FBS. PRRSV vFL12
virus, an infectious clone-derived highly virulent North American strain (88, 178), was
propagated and titrated in MARC-145 cells.
Preparation and phenotypic characterization of monocyte-derived macrophages
The procedure for the preparation of monocyte-derived macrophages was
followed as previously described with some modifications (106). Briefly, peripheral
blood mononuclear cells (PBMCs) were isolated from heparinized blood by densitygradient centrifugation using lymphocyte separation medium (Mediatech). Monocytes
were enriched from PBMCs by glass adherence overnight in DMEM supplemented with
10% FBS. Non-adherent lymphocyte populations were removed by rigorous washing
with PBS. Subsequently, the enriched adherent monocytes were incubated with RPMI1640 (Gibco) supplemented with 10% FBS, 25mM HEPES, 1mM sodium pyruvate, 1X
non-essential

aminoacids,

50µg/mL gentamicin

(Sigma)

and

5ng/mL murine

macrophage-colony stimulating factor (M-CSF) for 7 days. After 7 days, differentiated
macrophages were harvested using Hank’s salt solution (HSS)-based cell dissociation
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buffer (Invitrogen). The cells were phenotypically characterized by flow cytometry using
the following mouse primary antibodies namely anti-SWC3 mAb, anti-MHCII mAb
(VMRD), anti-CD163 mAb (Abserotec) and a goat anti-mouse IgG secondary antibody
conjugated with Alexafluor 488 (Invitrogen). Staining with secondary antibody only was
used as negative control.
Quantitative PCR and ELISA for swine TNF-α
Monocyte-derived macrophages were infected with PRRSV, vFL12 strain, at
MOI 10 or stimulated with lipopolysaccharide (LPS) (1µg/mL) for indicated time points.
Total RNA was isolated from cells using Trizol-LS reagent (Invitrogen). Total RNA (12µg) was reverse-transcribed using MMLV-RT (invitrogen) and oligo-dT as primer. The
complementary DNAs (cDNAs) synthesized were used as templates to quantify the
mRNA copy numbers for TNF-α and β-actin by quantitative PCR (qPCR) using
sequence-specific primers and Taqman probes (90):

TNF-α: forward primer

TCCAGTGGCAGAGTGGGTATG, reverse primer CCATCTGTCGGCACCACC, and
probe AATGCCCTCCTGGCCAACGGC. β-actin: forward primer CTCCTTCCTGGG
CATGGA, reverse primer CCACGTCGCACTTCATGATC, and probe TGCGG
CATCCACGAGACCACCT. All primers and probes were custom-synthesized from
Sigma-Genosys. The optimized concentrations were TNF-α: primer (300nM each); probe
(900 nM); β-actin: primer (250nM each); probe (900nM). qPCR was performed using
Fast start PCR master mix (Roche Applied sciences), the reactions were run in
Smartcycler (Cepheid) and the thermal profile included: 95○C for 10 min (hot start)
followed by 95○C for 15 sec (denaturation), 72○C for 60 sec (extension) for a total of 40
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cycles. The mRNA copy numbers were calculated based on a standard curve prepared
with known amount of PCR products. The TNF-α mRNA copy numbers were normalized
with β-actin mRNA copy numbers which served as internal control. The relative TNF-α
mRNA copy numbers (%) were calculated as previously described (163). TNF-α protein
levels in supernatant were measured by using a commercial swine TNF-α specific ELISA
as per manufacturer’s instructions (Pierce).
Plasmids construction
The plasmids, pGL3-Basic and pGL4.32NFkBRE-luc were purchased from
Promega. pswTNF-α-luc plasmid was constructed by cloning swine TNF-α promoter
sequences (-1348 to +58, position +1 refers to transcription start site of TNF-α gene,
NCBI accession No: NC_010449) into pGL3 basic vector (Promega). pswTNFa-194 luc
was constructed by cloning -194 to +58 region of TNF-α promoter into pGL3-basic
vector. All plasmids expressing non-structural proteins of PRRSV were described
previously (10). Plasmids expressing exact sequences of Nsp1α and Nsp1β were
constructed by cloning nucleotide (nt) 192-731 and nt 732-1340 sequences of vFL12
(Genbank accession no: AY545985) into CMV-based expression vector, pIHA-FLAG,
which was described previously (10). The expression of these constructs was confirmed
by western blot analysis using rabbit poly-clonal antibody custom-developed against
PRRSV-vFL12-Nsp1 (Open Biosystems). TF-specific reporter plasmids were constructed
by cloning sequences of 3X Sp1/Egr1RE or 3X CRE-kB3 RE or 5X Sp1RE fragments
(indicated in Fig 3A,whose sequences were derived from swine TNF-α promoter) into
pGL4.32 vector (Promega) by replacing 5X NF-κB RE fragment between Nhe I and Bgl
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II cloning sites. GAL4-Sp1TAD expressing plasmid was constructed by cloning the
trans-activation region (1-615 amino acids) of Sp1 (GenBank Accession No:
NM_013672.2) fused in frame with DNA binding domain (1-147 amino acids) of Gal4
(GenBank Accession No: NC_001148) in a mammalian expression vector, pCDNA3.1+
(Invitrogen). Gal4-Sp1-N, Gal4-Sp1B and Gal4-Sp1Bc were constructed by cloning 90615, 263-542, and 421-542 amino acid sequences of Sp1 respectively in frame with Gal4
DNA binding domain in pCDNA3.1+ vector. Sequences of all primers used for PCR
amplication were indicated in Table 1. The 5X Gal4RE-luc was constructed by cloning
five tandem repeats of Gal4 responsive element, using the following natural Gal10
promoter sequence ACGGAGGAGAGTCTTCCGTCGGAGGGCTGTCGCCCGCTCG
GCGGCTTCTAATCCGT (GenBank accession no: NC_001134, underlined sequences
correspond to Gal4 binding elements) into pGL4.32 vector by replacing NFκB-RE
element as described above.
RAW cell transfection and luciferase reporter assays
RAW 264.7 cells were transfected with all plasmids using DEAE-dextran
chemical transfection by a procedure that has been slightly modified from a previous
report (51). Briefly, 2.0x105 cells /mL were plated in a 12-well plate one day before
transfection. Just before transfection, cells were washed once with serum-free RPMI
medium. Then, cells were incubated for 2 h with 1 mL of transfection cocktail prepared
with serum-free RPMI medium that contains 50mM Tris-Cl, pH 7.4, 1.6mg of DEAEdextran (Sigma) and required amount of plasmid DNAs. After 2 h of incubation at 37◦C,
cells were washed twice with serum-free RPMI medium followed by treatment with 10%
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DMSO (prepared in PBS) for 1 min. Then, cells were washed again twice with serumfree RPMI medium before adding the growth medium. For western blotting analysis,
final growth medium was supplemented with 0.5µM 5-azacytidine to increase the
transfection efficiency as described previously (51). For luciferase reporter assays, cells
were transfected with PRRSV protein-expressing plasmids along with relevant firefly
reporter plasmid (200ng), pRL-TK (Promega) renilla vector (10ng) and further incubated
for 24 h at 37◦C to facilitate protein expression. After 24 h of incubation, transfected
RAW cells were stimulated with LPS (Sigma) (1µg/mL) for 6 h to stimulate the promoter.
Cells were then lysed and luciferase activities were measured in GloMax 20/20
luminometer (Promega) using dual luciferase assay kit as per manufacturer’s instructions
(Promega). Firefly luciferase activities in stimulated cells were expressed as luciferase
units relative to unstimulated cells after normalizing the transfection efficiency with
renilla luciferase values.
RESULTS
PRRSV reduced TNF-α production in infected swine macrophages
Previous studies have shown that PRRSV induces a weak TNF-α response during
in vitro and in vivo infections (102, 185). In order to reconfirm the defective TNF-α
response during PRRSV infection in our own experimental system, macrophages were
derived in vitro from peripheral blood mononuclear cells (PBMCs). The phenotype of
these macrophages was characterized by flow cytometry and it was found to be
SWC3+MHCII+CD163+. These cells were found to be permissive for PRRSV to a level
comparable to that exhibited by pulmonary alveolar macrophages, the natural host cells
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for PRRSV in vivo (data not shown). These PBMC-derived macrophages were infected
with a highly virulent PRRSV strain derived from an infectious clone, FL12 (88, 178) at
a multiplicity of infection of 10. LPS-stimulated cells and mock-infected cells were used
as positive and background controls for TNF-α response, respectively. When TNF-α
mRNA levels were measured by quantitative PCR, there were no signals during 2 and 6 h
post PRRSV infection (PI), when compared to LPS-stimulated cells (Fig 1A). However,
significant levels of TNF-α mRNA were observed at 12 and 24 h PI. Even though there
was a delayed TNF-α transcriptional response observed during PRRSV infection, there
were no detectable levels of secreted TNF-α protein in the supernatant of infected
macrophages as determined by ELISA (Fig 1B). The kinetics of PRRSV infection in the
infected macrophages was measured by titrating virus contained in the supernatant of
infected cells, which showed peak viral titers at 12 h PI (Fig 1C). Hence, PRRSV induces
a delayed TNF-α transcriptional response, which coincides with peak viral replication but
fails to elicit TNF-α protein secretion during in vitro infection in PBMC-derived
macrophages.
PRRSV Nsp1α and Nsp1β suppressed the activation of the proximal region of swine
TNF-α promoter
African Swine Fever Virus A238L protein inhibits TNF-α production by
modulating the activity of transcription factors at the promoter level (64). In the current
study with PRRSV, we examined which PRRSV proteins are involved in the downregulation of TNF-α expression at the promoter level. To this end, a swine TNF-α
promoter-based luciferase reporter plasmid was constructed and used to screen various
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PRRSV non-structural proteins and the N protein for suppression of the reporter activity
in transfected RAW 264.7 cells. We used LPS, a known inducer of TNF-α, to activate
swine TNF-α promoter. Upon LPS stimulation, of all the PRRSV proteins tested, only
Nsp 1 suppressed swine TNF-α promoter activation (Fig 2A). Previous reports suggested
that the proximal region of TNF-α promoter (-192) was sufficient for activation of TNF-α
promoter (65, 203). Hence, the effect of Nsp1 on the proximal region (-194) of TNF-α
promoter was next examined. As shown in Fig 2B, Nsp1 was able to suppress the
proximal region (-194) of swine TNF-α promoter in transfected cells suggesting that
Nsp1 suppression lies in the proximal region of the promoter.
PRRSV Nsp1 is auto-cleaved into two separate proteins, Nsp1α and Nsp1β in
infected cells (26, 42). Recently, the exact cleavage site between Nsp1α and Nsp1β has
been determined (26, 166). To determine their role, coding regions of Nsp1α and Nsp1β
were cloned separately in frame with an N-terminal flag tag under CMV promoter. As
shown in Fig 2C, both Nsp1α and Nsp1β equally suppressed the TNF-α promoter but not
to the levels of the full-length Nsp1 protein. In summary, both subunits of Nsp1 were
collaboratively involved in the TNF-α promoter suppression.
Effect of PRRSV Nsp1α and Nsp1β on different transcription factors that bind to
TNF-α promoter
Different transcription factors are known to bind TNF-α promoter especially at 192 proximal region of the promoter and form a specific transcriptional complex upon
activation by various stimuli (52, 179). The pair-wise sequence alignment comparison of
human and swine TNF-α proximal promoter sequences (Fig 3A) shows that the
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transcription factor binding sites (except Sp1/Egr1 binding site) seem to be well
conserved between humans and pigs. With the aim of finding the transcription factors
affected by Nsp1α and Nsp1β, luciferase reporter plasmids specific for different
functional transcription factors were constructed by utilizing specific sequences derived
from swine TNF-α promoter (Fig 3B). In addition, Gal4, a yeast transcription factorspecific reporter plasmid was also constructed as a negative control. As shown in Fig 3C,
Nsp1α significantly suppressed the activity of transcription factors at CRE-κB3. It was
also found to weakly suppress the activity of transcription factors that bind to the
Egr1/Sp1 element. However, Nsp1β but not Nsp1α suppressed the activation of Sp1 at
the proximal site of the TNF-α promoter including the distal Egr1/Sp1 element (Fig 3B).
In conclusion, Nsp1α partially inhibited the transcription factors that bind to CRE-κB3
while Nsp1β strongly inhibited the activity of Sp1 at both sites in the TNF-α promoter.
PRRSV Nsp1α partially inhibited NF-κB activation
Nsp1α was able to suppress the transcription factors that bind CRE-κB3 element
of TNF-α promoter (Fig 3C). ATF2/c-jun and p65/p50 complexes are known to directly
interact with CRE and κB3 sites respectively (179). Many viruses such as human
immunodeficiency virus and poxviruses are known to encode proteins that modulate
nuclear factor-κB (NF-κB) activation during infection (12, 125). Hence, the effect of
Nsp1α on NF-κB activation was next examined. To this end, using a reporter plasmid
specific for NF-κB activation, Nsp1α was found to partially suppress the NF-κB
activation in transfected cells upon LPS stimulation (Fig 4). Hence, the Nsp1α mediated
an inhibitory effect on NF-κB activation to suppress the activation of TNF-α promoter.
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PRRSV Nsp1β strongly inhibited the trans-activation of Sp1 especially through its B
domain
Nsp1β was found to inhibit the reporter activity specific to endogenous Sp1 upon
LPS stimulation (Fig 3C). Consistently, Sp1 is recruited to TNF-α promoter in an
inducible manner during virus infections in different cell types (52). Since Sp1 is a
transactivator at many inducible promoter activations (195), we examined whether Nsp1β
affects the trans-activation potential of Sp1. The N-terminal sequences (1-615 amino
acids position) of Sp1 were found to mainly contribute to the trans-activation potential of
Sp1 (195). It was fused in frame with DNA binding domain of Gal4, a yeast transcription
factor to construct Gal4-Sp1 fusion protein (Fig 5A). The Gal4-Sp1 fusion protein can
bind Gal4 responsive element containing promoter to stimulate the reporter activity in
transfected cells upon LPS stimulation. This reporter activity is then directly proportional
to the trans-activation potential of Sp1 N-terminal region fused to Gal4 DNA binding
domain. As shown in Fig 5B, Nsp1β was able to completely suppress the trans-activation
of Sp1 upon LPS stimulation.
The trans-activation potential of Sp1 is mainly carried out by A and B domains of
Sp1, each of which contains a glutamine-rich domain (195). In addition, Sp1 has a
negative inhibitory domain at its n-terminus which can repress the trans-activation
mediated through other domains, such as A and B domains, by recruiting transcriptional
repressors and co-repressors to Sp1 (99, 121). During activation, this negative inhibitory
domain is removed by ubiquitin-dependent proteasomal activity (160). Complete removal
of this negative regulatory domain from Sp1 trans-activation region did increase the
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trans-activation ability of Sp1 but did not have any effect on the ability of Nsp1β to
suppress the activity of Sp1 (Fig 5C). Hence, N-terminal negative inhibitory domain of
Sp1 was not necessary for Nsp1β-mediated inhibition of Sp1 trans-activation. LPS was
found to activate trans-activation of Sp1 mainly through its B domain rather than A
domain (14). Gal4 fusion protein with only B domain of Sp1 showed trans-activation
ability comparable to that of the whole trans-activation region without N domain (Fig 5C
and Fig 5D). Moreover, it was known that glutamine-rich C-terminal region of Sp1 B
domain (Sp1Bc) was found to be sufficient for activation of Sp1-dependent promoter (60).
Hence, we investigated whether Nsp1β was able to suppress the B domain especially
through its glutamine-rich C-terminal region. As shown in Fig 5D, Nsp1β strongly
suppressed the trans-activation of Sp1 B domain including its glutamine rich C-terminal
region. Overall, Nsp1β reduced the TNF-α promoter activity by suppressing the transactivation of Sp1 probably by modulating the interactions of glutamine-rich region of Sp1
B domain.
DISCUSSION
Porcine reproductive and respiratory syndrome virus replicates in macrophages
and dendritic cells and suppresses cytokines such as Type I interferons and TNF-α (10,
26, 82, 102). In this paper, we identified the PRRS viral protein-Nsp1 that mediated such
suppression at the level of the promoter of TNF-α. Moreover, we found that both
constitutive subunits of Nsp1 (Nsp1α and Nsp1β) suppressed the TNF-α promoter by
modulating activities of transcription factors NF-κB and Sp1, respectively. Our data also
suggested that by inhibiting transcription factors activated by two important pathways,
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NF-κB pathway and MAPK pathway, PRRSV effectively reduced the TNF-α promoter
activity to suppress TNF-α-mediated apoptosis of infected cells.
In our experiments, PRRSV induced negligible levels of TNF-α during in vitro
infection of PBMC-derived macrophages. Particularly, TNF-α mRNAs were not induced
at early time points after PRRSV infection, which would suggest that, at the MOI used,
the genomic RNAs of input virus may not activate TNF-α gene. However, there was an
up regulation of TNF-α mRNA levels observed at later time points of PRRSV infection.
Moreover, there may be an involvement of a post-transcriptional mechanism used by
PRRSV to suppress TNF-α production either at translation or at secretion levels. Even in
the presence of TNF-α mRNAs at later phases of infection, the secreted levels of TNF-α
were not detected. Our results were consistent with previous publications reporting that,
apart from inducing anti-apoptotic transcripts, PRRSV does not up regulate TNF-α
production during in vitro as well as in vivo infection (58, 173, 184, 185). Lopez-Fuertes
et al. reported that PRRSV elicits a defective TNF-α transcriptional response during early
hours of infection with no protein secreted at any time points after infection (102).
In order to find the proteins that may have inhibitory effect on TNF-α promoter,
several non-structural proteins and N protein of PRRSV were screened using a swine
TNF-α promoter based luciferase reporter assay. LPS was used as a stimulant for TNF-α
transcription in the luciferase assay to mimic TLR-mediated induction of TNF-α by virus
(172). Only Nsp1 was found to be actively suppressing the swine TNF-α promoter.
Hence, in addition to anti-IFN activities (10), Nsp1 also has an anti-TNF activity.
Moreover, regarding Nsp1-mediated suppression, there was no difference observed
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between a full-length TNF-α promoter and a region of TNF-α promoter involving 194
nucleotides proximal to transcriptional start site. This proximal region of TNF-α
promoter had been previously demonstrated to be sufficient for optimal stimulation of
TNF-α promoter (131, 203). In addition to reducing type I IFN activities, both of the
auto-cleaved subunits of Nsp1, Nsp1α and Nsp1β, were involved in the suppression of
the TNF-α production. Full-length Nsp1 suppressed TNF-α promoter stronger than
Nsp1α or Nsp1β do. Hence, it is conceivable that a synergistic functional interaction may
exist between two Nsp1 subunits. It may also be plausible that the two subunits of Nsp1
are synthesized at the early time points following PRRSV infection as they may have
been selected evolutionarily to inhibit innate cytokines such as TNF-α and type I
interferons. Hence, in addition to its role in replication, transcription and virion
biogenesis (10, 26, 82, 124, 175), the multi-functional protein Nsp1 has anti-innate
immunity roles that could facilitate viral replication in macrophages. This negative effect
on innate immunity may play a key role in dampening subsequent adaptive immune
responses during PRRSV infection.
Both Nsp1α and Nsp1β suppressed the functional activities of different regions of
the TNF-α promoter such as CRE-κB3 and Sp1 elements located in the proximal region of
the promoter respectively (Fig 6). Hence, both these proteins may target some
transcription factors that bind to these elements, which are strictly essential for TNF-α
transcription regardless of the type of stimuli or cell type (52, 179). In that regard, Nsp1α
was found to partially inhibit the activity of NF-κB in reporter assay which employs
tandem NF-κB binding sites. Therefore, it is speculated that the Nsp1α-mediated
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inhibition of NF-κB at κB3 may prevent the assembly of ATF2-c-jun-NF-κB complex at
CRE-κB3 site and further recruitment of CBP or p300 to TNF-α promoter (59, 76). A
previous study also shows that mutation in either CRE or κB3 element completely
abrogates the functionality of CRE-κB3 site in the context of TNF-α promoter (203).
In contrast to Nsp1α, Nsp1β suppressed a different transcription factor (Sp1) both
at proximal and distal Sp1 binding sites. Nsp1β inhibited the trans-activation of Sp1,
mediated through glutamine-rich region of its B domain that was demonstrated to be
primarily involved in the LPS-mediated Sp1 trans-activation (14). Consequently, Nsp1β
may prevent interactions of glutamine-rich Sp1 B domain with RNA polymerase initiator
complex (TFIID) at the TNF-α promoter. The glutamine rich C-terminal region of Sp1 B
domain (Sp1Bc) interacts with basal transcriptional machinery through direct interactions
with transcription initiation factor TFIID subunit 4 (Taf4) and TATA binding protein
(TBP) (50, 60). In addition to the suppression of Sp1 at proximal binding site, Nsp1β also
strongly suppresses the transcription factors that bind to distal Egr1/Sp1 element. This
may be explained by the fact that Egr1 and Sp1, both of which bind to this element,
would be reciprocally regulating the activity of each other (147). Consequently, by
inhibiting Sp1, Nsp1β would also control the activity of Egr-1 at this element.
Furthermore, based on our studies, Nsp1β of PRRSV would be one of the rare
examples of viral proteins of RNA viruses capable of modulating the inducible activity of
Sp1 and inhibiting a Sp1-dependent gene, TNF-α. Only one other viral protein, HIV tat
was shown to bind and modulate the activities of Sp1 (70). Interestingly, Sp1 is also
involved in the expression of several immuno-modulatory genes such as MHC Class I
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Chain-Related Protein A (MICA), interleukin-12 p35 subunit, etc. (4, 63). Therefore, the
possible role of Nsp1β in the regulation of other Sp1-dependent genes during PRRSV
infection would be of further interest.
The logical extension of this research is to fine map Nsp1 sequences that are
involved in TNF-α suppression. Using a reverse genetics approach, mutant viruses that
relieve TNF-α suppression could be generated by mutating the sequences that normally
suppress TNF-α in the context of PRRSV-FL12 full-length infectious clone. Such
enhanced TNF-α production could be anticipated to limit PRRS viral replication in
susceptible cells in vivo thereby reducing viremia and pathogenicity. In addition, the
virus-induced TNF-α is expected to improve anti-viral adaptive immune responses
especially by inducing other immuno-regulatory cytokines such as IL-8, IL-6, IL-1, thus
potentially making such mutant PRRSV interesting as a putative live-attenuated virus
vaccine candidate.
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Table 1. Primers used for PCR amplification.

a

Primer

Sequence (5′ to 3′)a

pTNF-α-F
pTNF-α-R
pTNF-α-194-F
Nsp1-F
Nsp1-R
Nsp1α-R
Nsp1β-F
Gal4DBD-F
Gal4DBD-R
Sp1TAD-F
Sp1TAD-R
Sp1-N-F
Sp1B-F
Sp1Bc-F
Sp1B-R

ATATATCCTAGGGCTCTTTTCTCTGAAATGCTGTCTGC
ATATATAAGCTTGGGTCCTGGAGATGGCTTGTCT
ATATATCCTAGGCTTCCAAACCGCCGCCCCCGCTAT
ATATATCTCGAGATGTCTGGGATACTTGATCGG
ATATATGCGGCCGCTTTACCGTACCATTTGTGACTGC
ATATATGCGGCCGCTTACATAGCACACTCAAAAGGGCA
ATATATCTCGAGGCTGACGTCTATGATATTGGTCATG
ATATATGCTAGCCACCATGAAGCTACTGTCTTCTATCGAACAAG
ATATATGGATCCCGATACAGTCAACTGTCTTTGAC
ATATATGAATTCTATGAGCGACCAAGATCACTCCA
ATATATGCGGCCGCTTATGAGGCTCTTCCCTCACTGTCTT
ATATATGAATTCTGGGGGCACAGGTGAACTTGAC
ATATATGAATTCTATCACCTTGCTACCTGTCAACAGC
ATATATGAATTCTTCCGGACAGACCTTCACAACTC
ATATATGCGGCCGCTTACTGGATCCCTGAAGTACCCAATGC

Primer sequences for TNF-α, Nsp1, Sp1, Gal4 were designed utilizing the sequences

with NCBI accession numbers, NC_010449, AY545985, NM_013672.2 and NC_001148
respectively.
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A

B

42

Tissue culture infectivity dose 50 /mL

C
10 7
10 6
10 5
10 4
10 3
2h

6h

12h

24h

Hours post infection

Figure 1. PRRSV down modulates TNF-α response during in vitro infection in
PBMC-derived

macrophages. (A) Quantitative PCR analysis. PBMC-derived

macrophages were either mock-infected or infected with PRRSV (vFL12 strain) at a
multiplicity of infection of 10. LPS-stimulated cells were used as positive control. Cells
were collected at indicated time points after infection. RNAs were isolated, cDNAs were
prepared and subjected to quantitative PCR. The TNF-α mRNA copy numbers were
normalized to β-actin mRNAs. Bars represent TNF-α mRNA copy numbers relative to
that of mock control (mean ± standard error, n=3). (B) Measurement of TNF-α protein
by ELISA. Supernatants were collected from the above cultures and the TNF-α protein
levels were measured by swine TNF-α-specific ELISA. Each bar represents mean ±
standard error value (pg/mL) (n=3). (C) Measurement of viral titers in the supernatants
obtained from above macrophage cultures infected with vFL12. Viral titers were
measured in MARC-145 cells and expressed as tissue culture infectious dose50/mL.
Mean ± standard error values are shown.
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Figure 2. PRRSV Nsp1α and Nsp1β down-modulate the activity of TNF-α promoter
at the proximal region. (A) Identification of PRRSV proteins that inhibit TNF-α
promoter activity. RAW264.7 cells were transfected with pswTNF-luc plasmid (0.2 µg)
along with plasmids expressing different PRRSV proteins (1µg) and a renilla luciferase
vector (10ng). Transfected cells were incubated for 24 h and stimulated with LPS
(1µg/mL) for 6 h. Firefly luciferase activities in cell lysates were measured and
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normalized with the renilla luciferase activities. (B) Effect of Nsp1 on proximal region of
TNF-α promoter. RAW 264.7 cells were transfected with a luciferase construct under the
control of proximal region (-194) of TNF-α promoter (0.2µg) along with Nsp1expressing plasmid (1µg) and a renilla luciferase vector (10ng). Cells were stimulated
and luciferase activities were measured as described above. (C) Role of Nsp1α and
Nsp1β in mediating TNF-α promoter suppression. TNF-α promoter-luciferase assays
were carried out as described above using plasmids that express Nsp1α and Nsp1β
separately. Each bar represents the mean of luciferase units relative to unstimulated cells
± standard error (n=3). P-values<0.05 were considered significant, CV means control
vector.
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A

B

Sp1
Egr1
.......T.C..........G.......A.....CG....................A...
-194 TTCCAAACCGCCGCCCCCGCTATGGAGATGAAACTAAGACAGAAGGTGCAGGGCCCGCTA

Human
Swine

CRE
κB3
...........................................................T
-137 CCGCTTCCTCCAGATGAGCTCATGGGTTTCTCCACCAAGGAAGTTTTCCGCTGGTTGAAA

Human
Swine

Sp1
TBP
..T—T..T............C....G...CAG.GA.A......G....T....G......
-77 GAGAGCCTCTCCCCGCCCTCTTCTCACCC--AGAGCGTATAAATGCAGCTGTTTGCACAC

Human
Swine

ts
..........G.C......TC..CA......G...A........T.A...G....G....
-19 CCAGCCAGCAGAAGCTCCCAGAGTGAGGACACCAGGGGACCAGCCAGGAGAGAGACAAGC
ts

Human
Swine

A.CTA.AGACC...
+42 CATCTCCAGGACCC +58

Human
Swine
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C

Figure 3. Transcription factors affected by Nsp1α and Nsp1β at the proximal region
(-194) of TNF-α promoter. (A) Pair-wise sequence alignment of swine TNF-α promoter
sequence (lower row) with that of human sequence (upper row). The nucleotides in the
human sequence that are conserved with that in swine sequence are denoted by dots.
Gaps in the sequences are denoted by dashes. Predicted functional elements that bind to
transcription factors are in bold and underlined. The names of the cis-acting functional
elements or binding transcription factors are indicated above the sequence. Number
represents the position of nucleotide relative to transcription start site of human sequence.
TBP means TATA binding protein. The transcription start sites of respective sequences
were denoted as ts (+1 position). The ts of human was considered for all cases in this
study.
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(B) Illustration that shows the sequences and the tandem repeats of cis-acting TF-specific
elements that were cloned upstream of a basal TATA promoter in a luciferase construct.
The sequences of functional elements are depicted above the schematic diagrams of the
constructs and are denoted in bold as well as underlined. (C) Effect of Nsp1 and its autocleaved products on the activity of different transcription cis-acting functional elements
of TNF-α promoter. RAW264.7 cells were transfected with each TF(s)-specific reporter
construct (0.2µg) along with plasmids expressing Nsp1 or its auto-cleaved products (1µg)
and renilla luciferase vector (10ng). After 24 h post-transfection, cells were stimulated
with LPS and luciferase activities were measured. For non-specific luciferase activities, a
Gal4-specific reporter construct was included. Mean ± standard error values (n=3) are
shown. P<0.05 was considered significant. CV means Control Vector.
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Figure 4. Nsp1α inhibits NF-κB activation. (A) RAW 264.7 cells were transfected with
pGL4.32NF-κBRE-luc (0.2µg) along with plasmids expressing either Nsp1 or Nsp1α
(1µg) and renilla luciferase vector (10ng). Cells were stimulated with LPS and luciferase
activities were measured from cell lysates as described in the methods section. Mean ±
standard error values (n=3) are shown. P<0.05 was considered significant. CV means
Control Vector.
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B

C

50

D

Figure 5. Nsp1β suppresses the trans-activation of Sp1. (A) Illustration that shows the
sequences of Sp1 (black box) cloned in frame with Gal4 DNA binding domain (DBD, 1147 amino acids position, grey box). The letters above Sp1 TAD (black box) indicate the
position of Sp1 domains in the trans-activation region. The bottom numbers indicate the
position of amino acids in Sp1 sequence. (B) RAW264.7 cells were transfected with
pGal4RE-luc (1µg), plasmids expressing Nsp1 or Nsp1β, pCDNA3.1 vector expressing
Gal4-Sp1TAD fusion protein (1µg) and renilla luciferase vector (10ng). Cells were
stimulated with LPS and luciferase activities were measured. (C and D) Effect of Nsp1β
on the activity of N-terminal negative inhibitory domain (N domain) or internal transactivating B domain of Sp1. Trans-activation assays were carried out as described in the
methods section. Briefly, pCDNA3.1 vector expressing Gal4 fusion proteins that lack 190 amino acids of Sp1 (N domain) , that have either full-length B domain (263-542
amino acids position) or C-terminal of B domain (421-542 amino acids position) of Sp1
were used to trans-activate Gal4RE promoter of luciferase construct. Mean ± standard
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error values (n=3) are shown. P<0.05 was considered significant. CV means Control
Vector.

diagram was adapted from (179) with modifications.

denotes the position of transcription factor binding elements relative to transcription start site (+1). The

Figure 6. Proposed mechanisms behind PRRSV-mediated suppression of TNF-α promoter. The number
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CHAPTER III

Identification of amino acids in non-structural proteins 1α and 1β of
porcine reproductive and respiratory syndrome virus that contribute to
tumor necrosis factor-alpha down regulation
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ABSTRACT
Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses tumor
necrosis factor-alpha (TNF-α) production in vitro and in vivo. This suppressive activity
occurs at both promoter and post-transcriptional levels. Specifically, PRRSV inhibits
TNF-α promoter activation through non-structural proteins 1α and 1β (Nsp1α and Nsp1β).
The objective of this study was focused on recovering mutant viruses that stimulate TNFα production in infected macrophages. First, Nsp1α and Nsp1β mutant constructs were
created by site-directed mutagenesis. Nsp1α amino acid residues, Gly90, Asn91, Arg97,
Arg100 and Arg124 were necessary for TNF-α promoter suppression in transient
transfection assays. Several amino acid regions in all domains of Nsp1β were important
for TNF-α promoter suppression. Subsequently, two mutant viruses, with mutations at
Nsp1α Gly90 or Nsp1β 70-74 positions, were recovered by reverse genetics. The mutant
viruses exhibited attenuated viral replication in vitro. Moreover, Nsp1α and Nsp1β
mutant viruses up regulated TNF-α in infected macrophages at protein and mRNA levels.
In addition, Nsp1α also reduced TNF-α protein expression post-transcriptionally in
transfected cells. In infected pigs, the Nsp1β mutant virus was attenuated in growth when
compared to infection with the wild type strain of PRRSV. These studies provide insights
into how PRRSV evades the effector mechanisms of innate immunity during infection.
Keywords: Porcine reproductive and respiratory syndrome virus, Tumor necrosis factoralpha, Reverse genetics, Promoter regulation, Immune evasion
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INTRODUCTION
Porcine reproductive and respiratory syndrome virus (PRRSV) causes late-term
abortion in sows and respiratory disease in young pigs (28, 29, 143). After infection,
PRRSV replicates in lungs and secondary lymphoid tissues in the host and establishes a
viremic period of about 3-4 weeks (49, 142, 143). The viremic period is followed by a
persistent period characterized by low levels of virus replication in secondary lymphoid
tissues (3). The host immune response usually takes several months to clear virus from
persistently infected swine (3).
Previous studies demonstrated that the adaptive immune responses against
PRRSV develop gradually, which prevents efficient clearing of the virus (3, 110). The
ineffective adaptive immune responses against PRRSV are the result of various immune
evasion strategies utilized by this virus to establish persistence in the host (5, 10, 34, 164,
187). One such strategy is inhibiting the key pro-inflammatory cytokine, tumor necrosis
factor-α (TNF-α) in infected cells (102, 164). Since TNF-α can inhibit PRRSV
replication in macrophages (102), PRRSV-mediated TNF-α suppression would enhance
virus production in the infected host.
Our laboratory previously showed that PRRSV suppresses TNF-α at the promoter
and perhaps post-transcriptionally during infection (164). Interestingly, PRRSV only
suppressed the TNF-α promoter at early times after infection (164). Even though TNF-α
transcripts were abundant at later time points after infection, secreted TNF-α was not
detected in the infected culture supernatant (164). These observations suggested that a
post-transcriptional mechanism suppresses TNF-α during PRRSV infection. PRRSV non-
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structural proteins, Nsp1α and Nsp1β inhibited TNF-α promoter activity by affecting two
different transcription factors, NF-κB and Sp1 that are important for activating the TNF-α
promoter (164).
Nsp1α and Nsp1β are non-structural proteins that participate in various aspects of
the PRRSV life cycle such as transcription, virion biogenesis and innate immune evasion
(10, 87, 175). Nsp1α contains 180 amino acid residues forming two domains, an Nterminal zinc finger domain (ZF domain) and a C-terminal cysteine protease (PCPα)
domain (166). Nsp1β contains 203 amino acid residues forming three domains, an Nterminal nuclease domain, a linker domain and a C-terminal cysteine protease (PCPβ)
domain (201). The PCPα and PCPβ domains auto-cleave Nsp1α and Nsp1β from ORF1a
polyprotein, respectively (87). Upon cleavage and activation, both of these proteins
homo-dimerize (166, 201). PCPα-mediated auto-cleavage of Nsp1α is essential for
transcription of viral sub-genomic RNAs (87). Likewise, PRRSV Nsp1α ZF domain may
also directly involve in viral transcription (53, 175). On the other hand, PCPβ-mediated
auto-cleavage of Nsp1β is essential for PRRSV replication (87). In addition, the Nsp1β
nuclease domain cleaves double-stranded DNA, and single-stranded RNA in vitro (201).
However, the Nsp1α and Nsp1β sequences necessary for reducing TNF-α promoter
activity are unknown.
In this study, I demonstrated that five Nsp1α amino acid residues, Gly90, Asn91,
Arg97, Arg100, and Arg124 are necessary for reducing TNF-α promoter activity. Several
amino acid sequences in Nsp1β are also necessary for reducing TNF-α promoter activity.
Nsp1α amino acid residue, Gly90 is required for the efficient reduction of TNF-α via
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post-transcriptional mechanism. The mutant viruses with mutations at Nsp1α Gly90
residue or Nsp1β 70-74 amino acid positions were recovered. These mutant viruses
enhanced TNF-α mRNA and protein levels in infected macrophages when compared to
the infection with wild type virus. In infected swine, the Nsp1β mutant virus is growthattenuated when compared to the wild type virus.
MATERIALS & METHODS
Cell lines, preparation of primary swine macrophages and viruses
RAW264.7 cells, a murine macrophage cell line (ATCC) was maintained in
RPMI-1640 supplemented with 25mM HEPES, and 10% fetal bovine serum (FBS).
MARC-145 cells, an African green monkey kidney epithelial cell line (obtained from Dr.
Will Laegreid, USMARC, USDA/ARS) was maintained in Dulbecco’s modified eagle
medium (DMEM)-low glucose supplemented with 0.7 g/L sodium bicarbonate, and 10%
FBS. BHK-21, baby hamster kidney epithelial cell line was maintained in DMEM-high
glucose supplemented with 3.4g/L sodium bicarbonate, and 10% FBS.
Primary swine macrophages were prepared from peripheral blood mononuclear
cells (PBMCs) as previously described (164). Briefly, PBMCs were isolated from blood
by density-gradient centrifugation. Monocytes were prepared by glass adherence of
PBMCs overnight. Adherent monocytes were differentiated into macrophages by
incubating the cells in RPMI-1640 supplemented with 25mM HEPES, 10% FBS, 1mM
sodium pyruvate, 1x non-essential amino acids, macrophage colony stimulating factor
(5µg/mL) for seven days. Differentiated macrophages were harvested using cell
dissociation buffer (0.06mM EDTA in PBS, pH 7.4).

58

PRRSV vFL12 strain and its mutant viruses were propagated and titrated in
MARC-145 cells. Viral titers were calculated using the Reed and Muench method (140).
Viral plaque assays were performed in MARC-145 cells. MARC-145 cells were
incubated with vFL12 strain and its mutant viruses in ten-fold serial dilutions. After 1 h,
cells were washed twice with PBS followed by overlay of growth agar medium. After 4
days, cells were fixed with 2% glutaraldehyde and stained with 0.01% crystal violet.
Luciferase Reporter Assays
Swine TNF-α promoter-luciferase reporter assay, Sp1 reporter assay, and Sp1
trans-activation assays were carried out as previously described (164). Briefly,
RAW264.7 cells were plated 24 h before transfection. Cells were incubated with plasmidtransfection cocktail mix (1.6mg/mL DEAE-dextran (Sigma), 50mM Tris HCl, pH 7.4,
RPMI-1640 medium) for 2 h. The reporter plasmids added in transfection cocktail mix
were pswTNF-luc (0.2µg) for TNF-α promoter reporter assay, 5XSp1RE-luc (0.2µg) for
Sp1 reporter assay, both pGal4RE-luc (0.2µg) and pCDNA3.1-Sp1TAD (1µg) for Sp1
trans-activation assay and renilla luciferase expressing vector (10ng) for all assays. In
addition to the reporter plasmids, wild type or mutant Nsp1α/Nsp1β-expressing plasmid
(1µg) was added to each mix. After 2 h of incubation, cells were exposed to 10% DMSO
(prepared in PBS, pH 7.4) for 1 min. Cells were then washed twice with RPMI medium
and incubated in growth medium for 24 h.
After 24 h, the reporter genes were stimulated with Lipopolysaccharide (LPS)
(1µg/mL) for 6 h. Cell lysates were prepared for measuring firefly and renilla luciferase
activities in GloMax 20/20 luminometer (Promega) using dual luciferase reporter assay
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system as per manufacturer’s instructions (Promega). Firefly luciferase units were
normalized with renilla luciferase units. Relative luciferase units were calculated by
dividing normalized firefly luciferase units measured from stimulated cells with those
measured from unstimulated cells.
Plasmids and site-directed mutagenesis
pIHA-Nsp1∆268-297 plasmid was constructed by deleting thirty amino acids
from 268 to 297 amino acid positions in the whole Nsp1 sequence (Gene Bank Accession
No. AY545985). Plasmids expressing authentic Nsp1α or Nsp1β (pIHA-Nsp1α and
pIHA-Nsp1β (164)) were used to introduce 3-6 amino acid alanine-scanning mutations.
pIHA-Nsp1∆268-297 plasmid was used to introduce point mutations in Nsp1α. Mutations
were introduced into Nsp1 genes by PCR mutagenesis following the mega primer method
(151). The primers used in PCR mutagenesis are listed in Table 1a. The plasmids,
pswTNFα-luc, 5XSp1RE-luc, pGal4RE-luc, pCDNA3.1+Gal4-Sp1TAD, were described
previously (164).
pCDNA3.1+TNFαIRESGFP plasmid was constructed by cloning swine TNF-α
cDNA (GenBank Accession No. NM_214022.1) in pCDNA3.1+ followed by
downstream cloning of IRES-eGFP sequences derived from pIRES2-eGFP (Clontech).
An internal hemagglutinin (HA) epitope tag was added in frame at amino acid position
183 in TNF-α coding sequence to facilitate its staining.
In vitro TNF-α translation assay
BHK-21 cells were grown on coverslip for 24 h before transfection. Cells were
transfected with pCDNA3.1+TNFαIRESGFP (1µg) plasmid along with either control
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vector or non-structural protein expressing plasmids (1µg) using lipofectamine 2000
(Invitrogen). After 18 h post-transfection, cells were subjected to confocal
immunofluorescence staining to detect the protein expression and intracellular
localization. A positive hit in this assay is a viral protein that down-modulated TNF-α
expression without affecting GFP expression.
Quantitative RT-PCR and ELISA
TNF-α-specific quantitative PCR (qPCR) was performed as previously described
(164). Briefly, total RNA fractions were prepared from mock-infected cells or cells
infected with either vFL12 or mutant viruses using Trizol-LS reagent (Invitrogen).
Complementary DNAs (cDNAs) were synthesized with 1-2µg total RNAs using oligodTs as reverse primer. cDNAs (1 µL) were used as template in qPCR reactions for TNFα or β-actin to measure respective mRNAs using sequence-specific primers and probes
(164).
PRRSV 3’untranslated region (UTR)-specific qRT-PCR was performed to detect
viral RNAs in serum of infected pigs. Briefly, viral RNAs were isolated from 140 µL of
serum using QIAamp viral RNA mini kit (Qiagen). Viral RNAs (4µL) were used as
template in quantitative reverse-transcription (RT)-PCR reaction using hot start-IT Probe
one step qRT-PCR kit (USB, 75772). The following primers and probe were used in the
reaction:

forward

primer

ATGTGTGGTGAATGGCACTG,

reverse

primer

GCATGGTTCTCGCCAATTAAA, Taqman probe 6-FAM-TCACCTATTCAATTAGG
GCGACCG-TAMRA. The cycling conditions employed were as follows: reverse
transcription at 50○C for 30 min, initial enzyme activation at 95○C for 2 min, denaturation
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at 95○C for 15 sec followed by annealing/extension at 60○C for 60 sec. Denaturation and
annealing/extension steps were repeated for total of 45 cycles.
To measure the TNF-α protein levels in the supernatant of mock-infected or virusinfected cells, a commercial swine TNF-α-specific ELISA was used (Pierce /Invitrogen).
Semi-quantitative reverse-transcription PCR
The mRNAs for CCL2, CXCL-10, TNF-α-IRES-GFP, Nsp1α, GAPDH, and
Cyclophilin were quantified by semi-quantitative RT-PCR. Total RNAs were prepared
from mock-infected, vFL12 wild type or mutant virus-infected cells using Trizol-LS
reagent (Invitrogen). cDNAs were prepared from 1-2µg total RNAs using oligo-dT as
reverse primers. The primers used in the PCR reactions were mentioned in Table 1b. The
contents of PCR reaction include: 1 µL of cDNA template, 2.5µL 10x Amplification
Buffer, 1.25µL of forward or reverse primers (12.5 pmoles each), 0.5µL of 10mM dNTPs,
0.25µL of Taq DNA polymerase (New England Biolabs), 19.5µL autoclaved distilled
water. The thermal set up was as follows: initial denaturation at 95○C for 45 sec,
annealing at 55○C for 30 sec, extension at 72○C for 1 min, for 25 cycles followed by final
extension at 72○C for 5 min. The PCR products for each gene were normalized with the
internal control, GAPDH or Cyclophilin before loading into 1% agarose gel
electrophoresis.
Confocal immunofluorescence
Transfected BHK-21 cells on coverslip were fixed with 4% paraformaldehyde for
15 min at room temperature (RT) and washed thrice with PBS. Cells were then blocked
with 3% bovine serum albumin (BSA) and 10% normal donkey serum (prepared in PBS
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Tween20 (0.05%)) for 1 h at RT. After incubating with anti-HA mouse monoclonal
antibody (1:100 dilutions, Covance) for 1 h at RT, cells were washed with PBS-Tween20
for 5 min thrice. Cells were then incubated with donkey Alexafluor 568-conjugated antimouse IgG (1:200 dilutions, Invitrogen) for 1 h at RT and washed thrice with PBSTween20.
After cell surface staining for TNF-α, intracellular staining for non-structural
proteins was performed. Cells were permeabilized with 0.15% saponin (prepared in
PBS) for 10 min at RT. Intracellular blocking was performed using 3% BSA and 10%
normal donkey serum (prepared in 0.15% saponin) for 1 h at RT. All subsequent washing
and antibody-incubation steps were performed using 0.15% saponin prepared in PBS.
After blocking, cells were incubated with anti-flag rabbit polyclonal antibody (1:100
dilutions, Sigma) for 1 h at RT. Cells were then washed thrice and incubated with donkey
Alexafluor 350-conjugated anti-rabbit IgG (1:200 dilutions, Invitrogen) for 1 h at RT.
After washing thrice, cells on cover slips were mounted on glass slides using aqueous gel
mounting medium (DAKO).
Intracellular TNF-α together with flag non-structural protein staining was carried
out as follows: cells were fixed with 4% paraformaldehyde for 15 min at RT, washed and
permeabilized with 0.15% saponin for 10 min at RT. After blocking, cells were incubated
with primary and secondary antibodies followed by mounting as described above.
For all cases, images were acquired using confocal laser scanning microscope
(CLSM) (Olympus IX 81, Inverted Confocal Microscope) at 405nm (for Alexafluor 350),
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488nm (for GFP) and 543nm (for Alexafluor 568) excitation laser filters. All images
were taken with 60X magnification with same settings in sequential mode.
Western blotting analysis
Cellular protein lysates were prepared in either radio-immuno-precipitation assay
buffer or cell-lysis buffer as described elsewhere (2, 10). The total protein content was
measured using Protein Assay Kit I (Biorad). Equal amounts of protein were resolved in
12% Sodium dodecyl Sulfate (SDS)-polyacrylamide gel electrophoresis and transferred
on Polyvinylidene fluoride (PVDF) membrane by semi-dry blotting. The membranes
were blotted with rabbit polyclonal antibodies specific for Nsp1 or mouse monoclonal
antibodies specific for β-actin (Santacruz) or HA (Sigma) or GFP (Santacruz) for
overnight at 4○C. The membranes were treated with Horse Radish Peroxidase (HRP)conjugated anti-rabbit or anti-mouse IgG antibodies (KPL) for 1 h at RT and signals were
obtained with chemiluminescence substrates (Thermo scientific).
Construction of mutant FL12 infectious clones and recovery of mutant viruses
In order to transfer Nsp1α and Nsp1β mutant sequences from pIHA constructs
into FL12 infectious clone, we constructed an intermediate transfer vector pIHA-2757.
The plasmid was constructed by cloning RsrII and SpeI restriction-digested fragment of
pFL12 infectious clone into pIHA empty vector (10). Nsp1α mutant sequences were
cloned into pIHA-2757 using AccI and StuI restriction sites present within Nsp1α. Nsp1β
mutant sequences were cloned into pIHA-2757 using AvrII and BsrGI restriction sites
present within Nsp1β. Finally, the RsrII and SpeI digested fragment was transferred from
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the pIHA-2757 mutant plasmid into pFL12 infectious clone. The corresponding mutation
in pFL12 plasmid was confirmed by sequencing.
For in vitro transcription, the mutant pFL12 was linearized using AclI enzyme and
gel purified. Capped in vitro transcripts (IVTs) were subsequently prepared from
linearized pFL12 template using mMessage mMachine T7 ultra kit (Ambion) and
purified by phenol-chloroform extraction method. Purified IVTs were checked in agarose
gel electrophoresis for integrity and quality. Finally, IVTs were electroporated into
MARC-145 or BHK-21 cells using Gene pulser Xcell electroporator (Biorad). Cells were
electroporated in DMEM containing 1.25% DMSO and immediately placed in recovery
medium (DMEM supplemented with 10% FBS and 1.25% DMSO). After 1-2 days postelectroporation, the replication of mutant virus was confirmed by immunofluorescence
using anti-N monoclonal antibodies (SDOW17, NVSL-USDA). The success of viral
recovery was assessed by spread of cytopathic effect in electroporated MARC-145 cells.
The supernatants from electroporated BHK-21 cells were transferred on to PBMCderived macrophages to propagate recovered viruses.
Multi-step growth kinetics of viruses
For multi-step growth kinetics, MARC-145 cells were cultured in 96-well plates
two days before infection. On the third day, cells were infected with vFL12 wild type or
mutant viruses at 0.1 multiplicity of infection (m.o.i.) in triplicates. At 6, 12, 24, 48, 72,
96 h post-infection, supernatants were collected and viruses were titrated in MARC-145
cells. The viral titers were calculated using Reed and Muench method (140).
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Viral infection studies in macrophages
For measuring TNF-α mRNA and protein responses, PBMC-derived macrophages
were infected with vFL12 wild type or mutant viruses at 0.1 m. o. i. At 12, 24, 36 and 48
h post-infection, cells were collected in Trizol-LS (Invitrogen) for mRNA quantification.
Supernatants were collected to measure TNF-α protein and viral titers.
Pig infection studies
PRRSV-negative pigs (n=3 each group) were infected with vFL12 wild type or
mutant strains at 105.1 TCID50/ 2 mL intra-muscularly. At 3, 7, 10, 14, 21 days postinfection (dpi), serum was collected to determine viremia and TNF-α protein levels by
viral titration and ELISA, respectively.
RESULTS
Cysteine protease activities of Nsp1α and Nsp1β are not necessary for TNF-α
promoter suppression
Nsp1α and Nsp1β cysteine protease activities are mediated by papain-like
cysteine protease domain α (PCPα) and papain-like cysteine protease domain β (PCPβ)
respectively (87). The histidine residue at amino acid position 146 in Nsp1α is part of
PCPα active site (87). Similarly, the cysteine residue at amino acid position 90 and the
histidine residue at amino acid position 159 are part of the PCPβ active site (87).
Mutating these residues in expression constructs did not affect their respective protein
levels (Fig 1a, 1b). Subsequently, transient reporter assays were carried out with a TNF-α
promoter-luciferase construct and LPS was used to stimulate the promoter. The PCPα and
PCPβ active site mutant proteins efficiently reduced the TNF-α promoter activity when
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compared to wild type protein (Fig 1a, 1b). The data suggested that Nsp1α and Nsp1β
reduced the TNF-α promoter activity independently of their cysteine protease activities.
Nsp1α cysteine protease domain is involved in TNF-α promoter suppression
Nsp1α has two distinct domains, zinger finger (ZF) domain (1-65 amino acids)
and PCPα domain (66-166 amino acids) (166). To identify which of these domains
necessary for reducing TNF-α promoter activity, I performed alanine scanning
mutagenesis in randomly selected blocks of 4-6 amino acid length spanning the Nsp1α
protein. In transient reporter assays, all PCPα domain mutants were unable to reduce
TNF-α promoter activity (Fig 2a). Certain PCPα domain mutants such as, Nsp1α122-6A,
Nsp1α139-5A, and Nsp1α155-5A had reduced protein levels when compared to the wild
type protein (Fig 2a). In contrast, three out of four ZF domain mutants reduced the TNF-α
promoter activity similar to the wild type protein (Fig 2a). The other ZF domain mutant
(Nsp1α41-5A) suppressed the TNF-α promoter less efficiently than the wild type protein,
which may be due to reduced protein expression (Fig 2a). Additional mutations of three
amino acid blocks in Nsp1α relieved TNF-α promoter suppression only if present in
PCPα domain but not in ZF domain (Fig 2b). In summary, the PCPα domain was
important for reducing TNF-α promoter activity.
Identification of amino acid residues of PCPα domain critical for TNF-α promoter
suppression
Additional studies were performed to identify individual amino acid residues in
PCPα domain necessary for reducing TNF-α promoter activity but not its own cysteine
protease activity. Point mutations were introduced at selected amino acid residues within
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positions 89-127 in an Nsp1Δ268-297 gene construct. Full-length Nsp1Δ268-297 is
expected to be auto-cleaved into wild type Nsp1α and deletion mutant Nsp1βΔ88-117 by
cis-acting PCPα protease activity. Nsp1α but not Nsp1βΔ88-117 reduced the TNF-α
promoter activity in cells transfected with Nsp1Δ268-297 gene construct (data not
shown). Therefore, PCPα mutations in this construct may affect two functions of Nsp1α:
TNF-α promoter suppression and/or PCPα protease activity in transient transfection
assays.
Mutation at Nsp1α amino acid residues, Gly90, Asn91, Arg97, Arg100, and
Arg124 reduced TNF-α promoter activity less efficiently when compared to the wild type
protein (Fig 2c, 2d, 2e). Mutations at these amino acid residues did not affect PCPα
protease activities as judged by migration of Flag-Nsp1α at approximately 22KDa size
(Fig 2c, 2d, 2e). Mutation at Nsp1α amino acid residues, Gln95 and Val99 reduced TNFα promoter activity more efficiently when compared to the wild type protein (Fig 2c, 2d).
Analysis of Nsp1α tertiary structure revealed that the amino acid residues, Gly90, Asn91,
Arg97, Arg100, and Arg124 are closely positioned on PCPα domain surface (Fig 2f). In
summary, five amino acid residues in PCPα domain, Gly90, Asn91, Arg97, Arg100, and
Arg124 are important for reducing the TNF-α promoter activity but not its protease
activity.
Mutations in all Nsp1β domains relieved TNF-α promoter suppression
Nsp1β has three domains, an N-terminal nuclease domain (1-48 amino acids), a
flexible linker domain (49-84 amino acids) and a C-terminal PCPβ domain (85-181
amino acids) (201). To identify the domains involved in reducing TNF-α promoter
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activity, alanine scanning mutations of 4-6 amino acids in all Nsp1β domains were
introduced. In transient reporter assays, most mutant proteins relieved TNF-α promoter
suppression activities approximately 50% relative to the wild type protein (Fig 3a). The
mutants, Nsp1β124-4A and Nsp1β136-5A, had reduced protein levels when compared to
the wild type protein (Fig 3a). The data suggested that all Nsp1β domains were necessary
for inhibiting TNF-α promoter activity.
Recovery of Nsp1α and Nsp1β mutant viruses by reverse genetics system
In the case of Nsp1α, attempts were made to recover viruses harboring 3-6 amino
acid block mutations by reverse genetics. Viruses with mutations at the Nsp1α positions,
89-93, 95-97, 97-100, and 122-127 were non-viable as judged by anti-N (PRRSV
nucleopcapsid) immunofluorescence (Table 2). However, viruses were recovered with
mutations at Nsp1α amino acid residue, Gly90 (Gly90Ala and Gly90Ser, respectively
designated as vFL12Nsp1αG90A and vFL12Nsp1αG90S) (Table 2). Viruses harboring
mutations at Nsp1α amino acid residues, Asn91, Arg97, Arg100, and Arg124 were not
viable (Table 2).
In the case of Nsp1β, attempts were made to generate viruses with mutations at
Nsp1β positions, 70-74 and 113-118. The infectious virus was successfully recovered
with mutations between positions 70-74 (named vFL12Nsp1β70-5A) but a viable virus
was not recovered with mutation between positions 113-118 (Table 2).
Repeated attempts to recover viruses harboring mutations in both Nsp1α Gly90
and Nsp1β 70-74 positions simultaneously led to failure. In summary, we recovered three
mutant PRRSVs, two having mutations in Nsp1α at Gly90 (Gly90Ala, Gly90Ser) and one
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having mutation in Nsp1β at position, 70-74. For further experiments, of the two Nsp1α
mutant viruses, we selected the one having maximum nucleotide substitutions (Gly90Ser).
The Nsp1β70-5A mutant protein did not disrupt Sp1 reporter activities in transient
transfection assays
My previous findings indicate that Nsp1β reduces TNF-α promoter activity, in
part by inhibiting Sp1 trans-activation (164). Since a virus was recovered carrying a
mutation in Nsp1β (Table 2), studies were carried out to determine whether the
corresponding mutant protein suppressed Sp1-dependent transcription. In transient
reporter assays that measure the activities of endogenous Sp1, the Nsp1β70-5A mutant
protein did not reduce Sp1-dependent reporter expression in transfected cells (Fig 4a).
Similarly, in trans-activation assays that measure the function of Sp1 transactivation
domain, the Nsp1β70-5A mutant protein did not suppress Sp1 trans-activation required
for reporter expression (Fig 4b). In conclusion, Nsp1β amino acids at position 70-74 were
necessary for inhibiting the Sp1-dependent transcription, including the TNF-α promoter.
Nsp1α reduces TNF-α protein levels in an in vitro translation assay
My previous findings suggest that PRRSV decreases TNF-α production by
reducing the promoter activity and by an unknown post-transcriptional mechanism (164).
Studies to identify viral protein(s) that inhibited TNF-α at the post-transcriptional level
were undertaken using an in vitro TNF-α translation reporter system (Fig 5a). Nonstructural proteins and N protein of PRRSV were tested for their ability to reduce TNF-α
protein levels in in vitro translation assays. Nsp1α only reduced TNF-α protein levels in a
specific manner that is without down modulating the bi-cistronic translation control, GFP
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(Fig 5b, 5c and 5d). Nsp1α up regulated Internal Ribosome Entry site (IRES)-dependent
GFP translation when compared to the control (Fig 5d). Moreover, Nsp1α did not affect
TNF-α-GFP bi-cistronic mRNA levels when compared to the control (Fig 5e). These
results suggested that in addition to its effect on the promoter, Nsp1α also suppressed
TNF-α expression by a post-transcriptional mechanism.
Gly90 residue was essential for efficient reduction of TNF-α protein levels by Nsp1α
Since viruses were recovered carrying mutations in Nsp1α (Table 2), studies were
performed to test whether corresponding mutant proteins can reduce TNF-α levels posttranscriptionally. The mutant proteins, Nsp1αG90A and Nsp1αG90S, reduced TNF-α
protein levels less efficiently when compared to the wild type protein (Fig 5d). Further,
the Nsp1αG90 mutant proteins did not affect TNF-α-GFP bi-cistronic mRNA levels
when compared to the wild type protein (Fig 5e). Therefore, Nsp1α Gly90 residue was
necessary for efficient suppression of the TNF-α production via a post-transcriptional
mechanism.
Growth characteristics and plaque morphology of PRRSV mutant viruses
Multi-step growth kinetic analysis revealed that both mutant viruses
(vFL12Nsp1αG90S and vFL12Nsp1β70-5A) exhibited moderate growth defect in
cultured MARC-145 cells when compared to the wild type vFL12. In particular, the
vFL12Nsp1β70-5A virus grew slower than vFL12 virus by a 1.0-1.5 log difference in
titers (Fig 6a). The vFL12Nsp1αG90S virus had a 0.5-1.0 log difference in titers when
compared to vFL12 (Fig 6a). Both mutant viruses also exhibited reduced plaque sizes
when compared to the wild type virus (Fig 6b). These results suggested that the Nsp1
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mutant viruses, vFL12Nsp1αG90S and vFL12Nsp1β70-5A, had reduced growth in
cultured MARC-145 cells.
Nsp1 mutant viruses induced TNF-α expression stronger than the wild type virus in
infected macrophages
Studies were then performed to examine TNF-α responses after infecting swine
macrophages with vFL12 wild type or the mutant viruses. Infections with Nsp1 mutant
viruses induced higher levels of TNF-α mRNAs only at 12 h post-infection when
compared to the infection with wild type virus (Fig 7a). However, there were no
differences observed in TNF-α mRNA levels between wild type and mutant virus
infected macrophage cultures at 24 h post-infection (Fig 7a). Noticeably, the cultures
infected with the mutant vFL12Nsp1β70-5A induced significant TNF-α mRNA levels as
early as 12 h post-infection (Fig 7a).
Both wild type vFL12 and mutant vFL12Nsp1β70-5A viruses induced negligible
levels of TNF-α protein in the supernatant of infected macrophage cultures (Fig 7b).
However, the mutant vFL12Nsp1αG90S virus induced higher levels of TNF-α in the
supernatant of infected macrophage cultures both at 12 and 24 h post-infection (Fig 7b).
Furthermore, the mutant viruses, vFL12Nsp1β70-5A and vFL12Nsp1αG90S replicated
with low viral titers in macrophage cultures after infection when compared to wild type
vFL12 (Fig 7c). In particular, the mutant vFL12Nsp1β70-5A showed two log10 reduced
viral titers in macrophage culture supernatants after infection when compared to vFL12
(Fig 7c).

72

Macrophages infected with both mutant viruses also induced higher levels of two
chemokines, CCL2 and CXCL10, at 24 and 36 h post-infection when compared to
macrophages infected with vFL12 (Fig 7d). This was expected because these two
chemokines are known to be induced by TNF-α (120, 138). In summary, the mutant
viruses, vFL12Nsp1αG90S and vFL12Nsp1β70-5A, stimulated the production of TNF-α
mRNA and protein stronger than the wild type vFL12 in infected macrophage cultures.
In vivo attenuation and TNF-α induction phenotype of PRRSV mutant viruses in
infected pigs
To examine the growth of the Nsp1 mutant viruses and TNF-α responses in swine,
pigs were infected with wild type vFL12 or the mutant viruses. At 14 days post-infection
(dpi), all infected pigs were positive for PRRSV-specific antibodies (Fig 8d).
Furthermore, all infected pigs exhibited peak viremia between 3-7 days post-infection
(Fig 8a, 8b). When compared to wild type vFL12, the mutant vFL12Nsp1β70-5A showed
two log10 reduced viral titers and viral RNA copies in serum at 3 dpi (Fig 8a, 8b). By 7
dpi, two out of three animals infected with the mutant vFL12Nsp1β70-5A had no
detectable infectious virus in serum (Fig 8a). However, viral RNAs were detected at
lower levels in pigs infected with the mutant vFL12Nsp1β70-5A when compared to pigs
infected with vFL12 for 14 days (Fig 8b). In contrast, pigs infected with the mutant
vFL12Nsp1αG90S had similar viral titers as well as viral RNA copies in serum when
compared to the pigs infected with vFL12 (Fig 8a, 8b).
Pigs infected with the mutant vFL12Nsp1αG90S showed increased TNF-α protein
levels in serum at 7 dpi when compared to pigs infected with wild type vFL12 (Fig 8c).
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However, at 10 dpi, both vFL12 and vFL12Nsp1αG90S groups had similar elevated
levels of TNF-α (Fig 8c). In contrast, TNF-α protein levels in serum did not increase in
pigs infected with vFL12Nsp1β70-5A virus at any time after infection (Fig 8c). These
results suggested that the mutant vFL12Nsp1β70-5A virus was attenuated in infected pigs.
DISCUSSION:
PRRSV decreases the production of TNF-α during infection in vitro and in vivo
(20, 92, 102, 164, 184). Nsp1α and Nsp1β are important viral mediators that reduce TNFα promoter activity in transient transfection assays (164). In this study, I identified critical
amino acid residues in Nsp1α and Nsp1β that are important for TNF-α suppression.
Subsequently, through reverse genetics, I generated two mutant PRRSV viruses that up
regulated TNF-α expression in macrophage cultures after infection. These two mutant
viruses replicated at lower levels in the cell culture and strongly stimulated TNF-αinduced chemokines. In infected pigs, one mutant virus with mutation in Nsp1β was
attenuated in growth. Moreover, Nsp1α reduced TNF-α protein levels by a posttranscriptional mechanism.
Several laboratories demonstrated that PRRSV infection leads to poor TNF-α
response in serum and broncho-alveolar lavage fluid from infected pigs (92, 173, 184).
Similarly, PRRSV infection actively inhibits TNF-α expression in macrophages and
dendritic cells in vitro (20, 102). Previous results from our laboratory indicated that
PRRSV cysteine proteases, Nsp1α and Nsp1β suppress TNF-α promoter by modulating
the activity of specific transcription factors (164). In this study, I sought to characterize
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the amino acid residues in Nsp1α and Nsp1β that reduce TNF-α and recover PRRSV
strains with mutations in those positions by reverse genetics.
Previous reports found that active site mutations in Nsp1 cysteine proteases lead
to failure of virus recovery by reverse genetics (87). My results showed that the Nsp1
cysteine protease activities were not necessary for reducing TNF-α promoter activity.
This observation is consistent with previous findings that the Nsp1 cysteine proteases
cleave only cis-substrates present at the end of respective proteins (166, 201). Therefore,
it is less likely that Nsp1 cysteine protease activities degrade signaling molecules
required for the TNF-α-induction pathway.
Further studies with domain-specific mutations showed that the PCPα domain, not
the ZF domain was important for inhibiting TNF-α promoter activity. Five amino acid
residues (Gly90, Asn91, Arg97, Arg100, and Arg124) on the surface of the PCPα domain
were important for inhibiting the TNF-α promoter. Many mutations in the ZF domain of
Nsp1α did not significantly relieve TNF-α suppression, which suggested the ZF domain
was not important.
Mutant viruses with mutation at Nsp1α Gly90 residue were only recovered. But,
viruses with mutation at residues, Asn91, Arg97, Arg100, and Arg124, apparently were
not viable. Since these mutations did not affect PCPα protease function, the amino acids
may be important for other functions, viral transcription and virion biogenesis (53). This
notion is further supported by my observation that Asn91, Arg97, Arg100 and Arg124
are well conserved across both PRRSV genotypes.
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Unlike Nsp1α, all three domains of Nsp1β were important for reducing TNF-α
promoter activity. One of Nsp1β mutants (70-5A) has protein levels equivalent to wild
type but did not reduce TNF-α promoter activity efficiently. The 70-5A mutation is
located in small linker domain of Nsp1β. The successful recovery of mutant virus in this
position suggests that the amino acids at 70-74 position are not required for Nsp1β
protease activity over Nsp1β-Nsp2 junction. The results also indicated that the Nsp1β705A mutant protein did not suppress Sp1 trans-activation activity, which is necessary for
activating the TNF-α promoter (52). It is plausible that the Nsp1β linker domain may
directly participate in the inhibition of Sp1 trans-activation or indirectly modulate the
functions of the other Nsp1β domains to inhibit Sp1-dependent TNF-α transcription.
Previous studies demonstrated that PRRSV possess an additional mechanism to
suppress TNF-α at post-transcriptional levels (164, 173). Hence, even if Nsp1 mutant
viruses could not inhibit TNF-α promoter activity, they might fail to induce TNF-α
protein levels during infection. Eventually, I was interested to find the proteins that
inhibit TNF-α at a post-transcriptional level. Using an in vitro translation assay, overexpression of Nsp1α suppressed intracellular and cell surface TNF-α levels. As expected,
Nsp1α did not affect GFP levels translated from same bi-cistronic mRNA in an IRESdependent manner. This suggested that Nsp1α directly inhibited cap-dependent TNF-α
translation or induced TNF-α degradation after translation.
Recently, a cellular protein kinase, Pak2 was shown to interfere with capdependent translation without affecting IRES-dependent translation (101). Pak2
phosphorylates ribosomal initiation factor, eIF4G to inhibit cap-dependent translation
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(101). If Nsp1α inhibits cap-dependent translation specifically, Pak2 may be an
interesting candidate for Nsp1α to target this pathway in infected cells. If this were true,
the cap-dependent translation of viral sub-genomic RNAs would also be affected during
PRRSV infection. Hence, it is likely that Nsp1α degraded TNF-α after translation.
When the growth characteristics of Nsp1 mutant viruses were examined, both
viruses were moderately attenuated in susceptible MARC-145 cells, which may be due to
attenuation of other Nsp1 functions such as transcription and replication. When we
examined the growth of these mutant viruses in macrophages in vitro and in infected pigs,
the growth of vFL12Nsp1β70-5A was severely compromised but the growth of
vFL12Nsp1αG90S was slightly reduced. Macrophages can strongly activate innate
immune pathways including TNF-α induction pathway during viral infection. It is
plausible that the attenuation of Nsp1 mutant viruses in macrophages in vitro and in
infected pigs was partially the result of stimulating immune responses, including TNF-α.
My previous finding concluded that PRRSV inhibited the TNF-α transcription
during early time points after infection in macrophages (164). I confirmed this finding in
the present study. Although both Nsp1 mutant virus infections showed enhanced TNF-α
transcriptional activity at early 12 h post-infection, only vFL12Nsp1αG90S mutant virus
infection produced detectable levels of TNF-α protein in macrophages. In agreement with
this finding, vFL12Nsp1αG90S mutant virus also induced TNF-α in serum of infected
pigs at 7 dpi when compared to wild type vFL12 infected pigs. Likewise, Nsp1α Gly90
mutant proteins did not efficiently reduce TNF-α protein levels in in vitro translation
assays. Thus, Nsp1α reduced TNF-α protein levels via a post-transcriptional mechanism,
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in addition to reducing the promoter activity. However, Nsp1β primarily involved in
reducing TNF-α promoter activity.
The overall conclusions of this study are as follows: 1) Nsp1α amino acid residue,
Gly90 is necessary for reducing TNF-α promoter activity and TNF-α protein levels via a
post-transcriptional mechanism during PRRSV infection. 2) Nsp1β amino acid residues
between positions, 70 and 74 are necessary for reducing TNF-α promoter activity, in part
by inhibiting the Sp1 transcription factor. 3) The above mentioned Nsp1α and Nsp1β
amino acid residues are also necessary for reducing the expression of TNF-α-inducible
chemokines. 4) The mutant virus with mutation at Nsp1β positions, 70-74 is greatly
attenuated in infected pigs, which may be a good candidate for the development of
attenuated live vaccines.
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Table 1a. Primers used in site-directed mutagenesis
Primer
Nsp1-F
Nsp1-R
Nsp1β-F
Nsp1α-R
nsp1Δ268-297-F
nsp1α-20-4A-R
nsp1α-41-5A-R
nsp1α-55-5A-R
nsp1α-63-5A-R
nsp1α-89-5A-F
nsp1α-97-4A-F
nsp1α-122-6A-F
nsp1α-139-5A-F
nsp1α-155-5A-F
nsp1α-32-3A-R
nsp1α-38-3A-R
nsp1α-52-3A-R
nsp1α-86-3A-R
nsp1α-93-3A-F
nsp1α-105-3A-F
nsp1α-117-3A-F
nsp1α-148-3A-F
nsp1αS89A-F
nsp1αG90A-F
nsp1αG90S-F
nsp1αN91A-F
nsp1αL92A-F
nsp1αN93A-F
nsp1αQ95A-R
nsp1αQ96A-R
nsp1αR97A-R
nsp1αV99A-F
nsp1αR100A-F
nsp1αY122A-F
nsp1αE123A-F
nsp1αR124A-F
nsp1αG125A-F
nsp1αC126A-F
nsp1αR127A-F
nsp1β-16-5A-F
nsp1β-48-6A-R
nsp1β-70-5A-R
nsp1β-101-5A-F
nsp1β-113-6A-F
nsp1β-124-4A-F
nsp1β-136-5A-F

Sequence (5’ to 3’)
ATATATCTCGAGATGTCTGGGATACTTGATCGG
ATATATGCGGCCGCTTAACCGTACCATTTGTGACTGC
ATATATCTCGAGGCTGACGTCTATGATATTGGTCATG
ATATATGCGGCCGCTTACATAGCACACTCAAAAGGGCA
GCTAATACTGTCCCTGAAAAGCATGGTGTCGCTGG
CTGAGACATCGTGTGCAGTAGGCTGCGGCGGCCGCCATAAACACCCTGGCAT
AAAATAGGCCCAGCACTGCAGCGGCAGCAGCTTGGAGATTCAGAGGAAG
GGGGAATGCACGTGGCAACGTGGCGGCGGCTGCGGCTTCGGGCCTGTAAAATAGGC
CGGGGGAGCACTCAACAGCGGCGGCTGCAGCTGGCAACGTCCACCGGAG
CCAATTGCACGAATGACCGCTGCAGCCGCCGCCTTTCAACAAAGAATGGTGCGG
TTCAACAAAGAGCAGCCGCAGCCGCAGCTGAGATTTA
GAAGGCTCTACAAGTTGCTGCAGCAGCTGCCGCCTGGTACCCTATAGTC
CCCTGGAGTGGCCGCTGCTGCCGCCGCCCTACATGTGAGTGA
TTCCCGGGAGCAGCTGCTGCAGCAGCCAACCTGCCACTC
CAGAGGAAGGGCAGCGGCTGCACTGA
CCAAGCTCAGGAACTGCGGCAGCCAGAGGAA
CCACCGGAGTGGCTCTGCGGCGGCGTAAAATAGGC
CAGGTTTCCACTGGCGGCTGCTGCAATTG
GGAAACCTGAACTTTGCAGCAGCAATGGTGCGGG
GCGGGTCGCAGCTGCCATTGCCGCAGCCGGCCA
GCAGTCTTGGCCGCTGCAGCAGTTTATGAAC
CCCTACATGTGGCTGCTGCACCTTTCCCGG
GCACGAATGACCGCTGGAAACCTGAA
GACCAGTGCAAACCTGAACTTTC
GCACGAATGACCAGTTCAAACCTGAACTTTC
GACCAGTGGAGCCCTGAACTTTCAAC
GACCAGTGGAAACGCGAACTTTCAAC
GGAAACCTGGCCTTTCAACAAAGAAT
CCCGCACCATTCTTTGTGCAAAGTTCAGGTTTCCACT
GCTGCGACCCGCACCATTCTTGCTTGAAAGTTCAGGTTTCC
GCTGCGACCCGCACCATTGCTTGTTGAAAGTTCAGGTT
CAACAAAGAATGGCGCGGGTCGCAGCTGAG
CAACAAAGAATGGTGGCGGTCGCAGCTGAG
CTACAAGTTGCTGAACGGGGTTGC
CTACAAGTTTATGCACGGGGTTGCCG
ACAAGTTTATGAAGCGGGTTGCCGCTG
TTATGAACGGGCTTGCCGCTGGTA
ATGAACGGGGTGCCCGCTGGTACCC
GAACGGGGTTGCGCCTGGTACCCTAT
CCGTCATGTATGTGGCCGCCGCTGCCGCCGCCTGGGCCCCTCGTGGC
AGACATGTCCACTGCGGCGGCGGCGGCGGCGGCGATGTGGAGTTGGTTC
CAGCCGTGTGGGCAGGCGGCGGCGGCAGCGACACCACTCCCAGG
ACTCGCTCCCACTGGCCGCTGCCGCCGCAGAAATTCGCCGTGCCA
TCGCCGTGCCAACCAAGCCGCCGCCGCAGCCGCCCATGGTGTCGCTGGC
TGGTGTCGCTGGCGCCGCCGCAGCACGGAGGCTGCAAGC
AAGCTAATGGTCTCGCAGCAGCCGCTGCTACAGATGGACCCATT
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Table 1b. Primers used in semi-quantitative RT-PCR
Primer
hTNFa-F
hTNFa-R
GAPDH(+)
GAPDH(-)
CCL2-F
CCL2-R
IP-10-F
IP-10-R
CYCROP-F
CYCROP-R

Sequence (5’ to 3’)
ATATATGCTAGCCACCATGAGCACTGAAAGCATG
ATATATGGATCCTCACAGGGCAATGATC
CCATGGAGAAGGCTGGGG
CAAAGTTGTCATGGATGACC
GCTTGAATCCTCATCCTCCA
AAGGCTTCGGAGTTTGGTTT
TTCGCTGTACCTGCATCAAG
AACAGCTCGGGATGATGAAC
TAACCCCACCGTCTTCTT
TGCCATCCAACCACTCAG

Table 2. Recovery of PRRSV mutant viruses by reverse genetics
Aminoacid position
Nsp1α (89-93)
Nsp1α (95-97)
Nsp1α (97-100)
Nsp1α (122-127)
Nsp1α Gly90Ala
Nsp1α Gly90Ser
Nsp1α Asn91Ala
Nsp1α Arg97Ala
Nsp1α Arg100Ala
Nsp1α Arg124Ala
Nsp1β (70-74)
Nsp1β (113-118)

Anti-N
Immunofluorescence
+
+
+
-

Virus recovery
+
+
+
-
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(a)

(b)

Figure 1. PRRSV Nsp1α and Nsp1β suppress TNF-α promoter activity independent
of their cysteine protease functions. RAW 264.7 cells were transfected with pswTNFluc plasmid (0.2µg) along with viral protein expressing plasmid (1µg) and a renilla
luciferase expressing vector (10ng). After 24 h, cells were stimulated with LPS (1µg) for
6 h. In cell lysates, firefly luciferase activities were measured and normalized with renilla
luciferase activities. 100% TNF-α promoter activity represents the activity in control
vector transfected cells and 0% promoter activity represents the activity in wild type
Nsp1α or Nsp1β transfected cells. Each bar represents mean ± standard error (n=3).
Bottom panels depict the amount of corresponding viral proteins in transfected cells.
RAW 264.7 cells were transfected with viral protein expressing plasmid (2µg). After 24 h
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post-transfection, the viral protein in cell lysates was detected by western blotting using
anti-Nsp1 antibodies. β-actin was used as loading control.
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(a)

(b)
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(c)

(d)

(e)

(f)

Figure 2. Characterization of Nsp1α amino acid residues necessary for reducing
TNF-α promoter activity. (a-e) RAW 264.7 cells were transfected with pswTNF-luc
(0.2µg) along with Nsp1α wild type or mutant protein expressing plasmid (1µg) and a
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renilla luciferase expressing vector (10ng). After 24 h, cells were stimulated with LPS
(1µg/mL) for 6 h. Firefly luciferase activities were measured in cell lysates and
normalized with renilla luciferase activities. 100% TNF-α promoter activity represents
the activity in control vector transfected cells and 0% promoter activity represents the
activity in wild type Nsp1α transfected cells. Each bar represents mean ± standard error
(n=3). The immunoblot panels depict the amount of corresponding viral proteins in
transfected cells. RAW 264.7 cells were transfected with Nsp1α wild type or mutant
protein expressing plasmid (2µg). After 24 h post-transfection, the viral protein in cell
lysates was detected by western blotting using anti-Nsp1 antibodies. β-actin was used as
loading control. (f) Tertiary structure of Nsp1α. Residues necessary for reducing TNF-α
promoter activity are highlighted: Three arginine residues (in green), the glycine residue
(in yellow) and the asparagine residue (in blue). The figure was adopted from NCBI
structure database (PDB ID: 3IFU) using Cn3D software.
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Figure 3. All domains of Nsp1β contribute to TNF-α promoter suppression. RAW
264.7 cells were transfected with pswTNF-luc (0.2µg) along with Nsp1β wild type or
mutant expressing plasmid (1µg) and a renilla luciferase vector (10ng). After 24 h, cells
were stimulated with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in
cell lysates and normalized with renilla luciferase activities. 100% TNF-α promoter
activity represents the activity in control vector transfected cells and 0% promoter
activity represents the activity in wild type Nsp1β transfected cells. Each bar represents
mean ± standard error (n=3). Bottom panels depict the amount of corresponding viral
proteins in transfected cells. RAW 264.7 cells were transfected with Nsp1β wild type or
mutant expressing plasmid (2µg). After 24 h post-transfection, the viral protein in cell
lysates was detected by western blotting using anti-Nsp1 antibodies. β-actin was used as
loading control.
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(a)

(b)

Figure 4. Nsp1β70-5A mutant protein is unable to suppress Sp1-dependent
transcription. (a) Sp1 reporter assay. RAW 264.7 cells were transfected with 5XSp1REluc (0.2µg) along with wild type Nsp1β or mutant Nsp1β70-5A expressing plasmid (1µg)
and a renilla luciferase expressing vector (10ng). After 24 h, Sp1 activity was stimulated
with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in cell lysates and
normalized with renilla luciferase activities. (b) Sp1 trans-activation assay. RAW 264.7
cells were transfected with pGal4RE-luc (0.2µg) along with pCDNA3.1 expressing Gal4Sp1TAD fusion protein (1µg), plasmid expressing Nsp1β wild type or Nsp1β70-5A
mutant (1µg) and renilla luciferase expression vector (10ng). After 24 h, cells were
stimulated with LPS (1µg/mL) for 6 h. Firefly luciferase activities were measured in cell
lysates and normalized with renilla luciferase activities. The values in y-axis represent the
firefly luciferase units obtained from stimulated cells relative to that obtained from
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unstimulated control vector transfected cells. Each bar represents the mean ± standard
error (n=3). In both panels, ‘control’ indicates cells transfected with empty expression
plasmid only. In panel (a), ‘control+’ indicates cells transfected with empty expression
plasmid along with 5XSp1RE-luc plasmid. In panel (b), ‘control+’ indicates cells
transfected with empty expression plasmid along with pGal4RE-luc plasmid.
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Nsp1αN93A

Nsp1αG90S

Nsp1αG90A

Nsp1Δ268-297

Nsp1α

Control vector

Cell control

(d)

TNF-α-HA
GFP
Nsp1α

Bactin

Nsp1αN93A

Nsp1αG90S

Nsp1αG90A

Nsp1Δ268-297

Nsp1α

Control vector

Cell control

(e)

TNF-α-HA-eGFP
Nsp1α
GAPDH

Figure 5. Nsp1α suppresses TNF-α protein expression and mutation at Gly90
position partially relieves the suppression.

(a) Schematic diagram of the TNF-α

translation reporter construct expressing under CMV promoter. The bi-cistronic gene
construct (pCDNA3.1+TNFαIRESGFP) has two genes, swine TNF-α gene and GFP
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under cap-dependent and IRES-dependent translation, respectively. A HA tag was
internally inserted at amino acid position 183 of TNF-α. pA means poly-adenylation
signal. (b, c) BHK-21 cells grown on cover slips were transfected with
pCDNA3.1+TNFαIRESGFP (1µg) along with plasmid expressing Nsp1α (1µg). After 18
h post-transfection, cells were fixed with 4% paraformaldehyde. For intracellular staining
(b), cells were further permeabilized with 0.15% saponin. For cell surface staining (c),
cells were stained first for cell surface before permeabilization for intracellular staining.
Prior to primary antibody staining, cells were blocked with bovine serum albumin and
normal donkey serum. TNF-α-HA was detected with mouse anti-HA antibody followed
by staining with Alexafluor 568-conjugated secondary antibody. Flag-Nsp1α was
detected with rabbit anti-flag antibody followed by staining with Alexafluor 350conjugated secondary antibody. All confocal images were captured with the same settings
in sequential mode. iTNF means intracellular TNF-α and mTNF means cell surface TNFα. (d) BHK-21 cells grown on coverslips were transfected with pCDNA3.1+TNFαIRES
GFP (1µg) along with plasmid expressing Nsp1α or mutant protein (1µg). After 24 h
post-transfection, cell lysates were prepared for immunoblotting to detect Nsp1α, TNF-αHA, and GFP using specific antibodies against Nsp1, HA probe and GFP, respectively.
β-actin was used as loading control. (e) BHK-21 cells were transfected with
pCDNA3.1+TNFαIRESGFP (1µg) along with plasmid expressing Nsp1α or mutant
protein (1µg). After 24 h post-transfection, total RNAs were prepared and cDNAs were
synthesized. cDNAs were used as templates in semi-quantitative RT-PCR reactions using
sequence-specific primers for TNF-α and Nsp1α. GAPDH was used as internal control.
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(a)

(b)
vFL12

vFL12Nsp1αG90S

vFL12Nsp1β70-5A

Figure 6. Nsp1 mutant viruses have reduced growth when compared to wild type
vFL12 virus. (a) Multi-step growth kinetics in MARC-145 cells after infection with 0.1
m. o. i. of indicated viruses. Supernatant of infected cells was collected at indicated time
points and viral titration was performed in MARC-145 cells. Viral titers are expressed as
tissue culture infectivity dose50 (TCID50). Viral titer values represent the mean ± standard
error (n=3). (b) Plaque morphology of viruses in MARC-145 cells. Cells were infected
with FL12 wild type or mutant viruses, covered with growth medium agar and incubated
for 4 days. Cells were fixed with glutaraldehyde followed by crystal violet staining.
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(a)

(b)
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(c)

(d)

Figure 7. Effect of mutations in Nsp1 proteins on TNF-α as well as TNF-α inducible
chemokines during PRRSV infection in vitro. (a) Quantitative PCR analysis. PBMCderived macrophages were mock-infected or infected with 0.1 m. o. i. of indicated viruses.
At different time points, total RNAs were prepared from infected cells and cDNAs were
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synthesized. Using cDNAs as template, the amount of TNF-α mRNAs was quantified by
qPCR. TNF-α copy numbers were calculated using standard curve prepared with known
amount of templates and normalized with β-actin copy numbers. Bars represent mean ±
standard error (n=3). A p-value less than 0.05 was considered as significant. (b) TNF-α
protein measurement by ELISA. PBMC-derived macrophages were infected with vFL12
wild type or indicated mutant viruses at 0.1 m. o. i. TNF-α protein levels in the
supernatant were measured by ELISA. Bars represent mean ± standard error (n=3).
Dotted line in y-axis represents the detection limit of assay. (c) Viral titers were measured
in MARC-145 cells and expressed as TCID50/mL. Mean ± standard error (n=3) values
were shown. (d) Semi-quantitative RT-PCR analysis of TNF-α induced chemokines.
PBMC-derived macrophages were infected with vFL12 wild type or mutant viruses.
Total RNAs were prepared from infected cells and cDNAs were synthesized. RT-PCR
reactions were performed using sequence-specific primers for CCL2 and CXCL10.
Cyclophilin was used as internal control.
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(a)

(b)

(c)
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Figure 8. Comparison of viremia, TNF-α serum levels, and antibody responses
between pigs infected with vFL12 wild type and pigs infected with mutant viruses.
Four-week old piglets (n=3 each group) were infected intra-muscularly with 105.1TCID50
of vFL12 wild type or indicated mutant viruses. (a) Viral titers were evaluated in serum
of infected pigs at indicated time points after infection. Viral titration was done in
MARC-145 cells. The viral titers were calculated by Reed and Muench method, and
expressed as tissue culture infectivity dose50 (TCID50/mL). Data indicate mean ± standard
error (n=3). (b) PRRSV-specific quantitative RT-PCR analysis. Viral RNAs were
isolated from serum of infected pigs at indicated time points after infection. They were
quantified by qRT-PCR specific to vFL12 3’UTR as described in materials and methods.
Viral RNA copies were calculated by using a standard curve prepared with known
amount of templates. Data indicate mean ± standard error (n=3). (c) TNF-α ELISA. TNFα protein levels in serum of infected pigs were measured by ELISA at indicated time
points after infection. Values are expressed as mean ± standard error (n=3). (d) PRRSVspecific antibody responses. The amount of anti-N specific antibodies in serum of
infected pigs was measured by IDEXX ELISA at 14 and 21 days post-infection. A signalto-positive (S/P) ratio ≥ 0.4 was considered as positive for PRRSV-specific antibodies.
Bars represent mean ± standard error values (n=3).
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CHAPTER IV

A virulent strain of porcine reproductive and respiratory syndrome
virus does not up-regulate interleukin-10 levels in vitro or in vivo

Virus Research, 155: 415-422, 2011
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ABSTRACT
Porcine reproductive and respiratory syndrome virus (PRRSV) causes
reproductive failure and respiratory illness in infected pigs. It has been postulated that the
ability of PRRSV to induce the anti-inflammatory cytokine interleukin-10 (IL-10) in
macrophages of infected pigs would be important for PRRSV immunopathogenesis.
However, several strains were reported to induce IL-10 in infected macrophages while
others would not. In this study, we analyzed the IL-10 expression during in vitro and in
vivo infections by a well characterized virulent strain of PRRSV, vFL12, which is derived
from an infectious clone. Our results showed that the vFL12 strain did not up-regulate IL10 at mRNA or protein levels in either macrophages or dendritic cells after infection in
vitro. Furthermore, immunofluorescence staining for IL-10 in tonsil sections of PRRSVinfected pigs did not produce any evidence of IL-10 induction in PRRSV-infected cells or
in bystander cells of the lymphoid tissues. We concluded that the induction of IL-10
release is not a part of the PRRSV virulence mechanisms.
Keywords: Interleukin-10, PRRSV, Virulence, Immunofluorescence, vFL12
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INTRODUCTION
Porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus
that causes syndrome characterized by a period of acute viremia followed by long-term
persistence in infected pigs (3). During the course of this disease, PRRSV causes
profound modulation of the homologous (PRRSV-specific) immune response which
includes: weak induction of innate immune responses (1), delayed and weak neutralizing
antibody responses (105) and weak cell-mediated immune responses, particularly IFN-γ
responses (110). One of the mechanisms exploited by PRRSV to actively suppress the
induction of immune response would be modulation of several key immuno-regulatory
cytokines such as type I interferons, interleukin-1 (IL-1), tumor necrosis factor-alpha
(TNF-α), interleukin-12 (IL-12), and interleukin-6 (IL-6) etc. in infected pigs (3, 102,
173). Many viruses actively suppress the innate and adaptive immune responses by either
up-regulating IL-10 or encoding viral homologs of IL-10 (139). Several viruses that
cause persistent/chronic infections up-regulate aberrant levels of IL-10 in the host to
dampen the antigen-specific adaptive responses, thus leading to failure of the subsequent
viral clearance (16). Since PRRSV is a persistent virus with immunosuppressive
properties in infected pigs, previous studies had speculated that IL-10 may have a key
role in the suppression of immune responses by PRRSV and subsequent establishment of
persistence in the host (72). Subsequently, several authors reported that PRRSV indeed
up-regulates IL-10 levels both at mRNA and at protein levels under in vitro conditions
and in vivo in infected pigs (22, 30, 55, 92, 171). In those studies, the temporal kinetics of
PRRSV-mediated induction of IL-10 was found to be strongly associated with the
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viremic period during the acute phase of infection but not throughout persistence. In
contrast to above findings, one study showed that some PRRSV European strains do not
up-regulate IL-10 levels in infected antigen presenting cells (Diaz et al., 2008). A most
recent study involving additional strains of PRRSV has also shown that several of them
do not up-regulate IL-10 levels in infected macrophages (154). Hence, there are
perceptions that the ability of PRRSV to induce IL-10 in infected cells would be straindependent. The correlation between the ability of a particular PRRSV strain to induce IL10 in infected pigs and its in vivo virulence is still not well understood. However, one
previous study showed that the IL-10 levels during PRRSV infection is not correlated
with the infection status of animals, and it may not be the cause of PRRS viral persistence
(84). It seems logical that an association between the virulent character of PRRSV strains
and their ability (or lack thereof) to induce IL-10 should be studied, using strains of bona
fide pathogenic profile.
Our laboratories have developed an infectious full-length cDNA (FL12) derived
from a highly pathogenic strain of type II PRRSV. By transcription from this infectious
clone, a PRRSV strain (vFL12) was obtained (78, 178, 204) The in vivo virulence of
vFL12 strain has also been well characterized in the highly reproducible pregnant female
model where vFL12 strain consistently causes reproductive failure in pregnant sows (88,
89) and produces respiratory illness and pathology in infected young pigs (unpublished
observations). Likewise the kinetics of immune response induced by vFL12 strain of
PRRSV in several other studies has been shown typically dysfunctional as described for
PRRSV: including delayed as well as poor neutralization antibody responses (5) and poor
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innate immune responses (10, 164). Hence, it can be concluded that vFL12 is one of the
prototypical pathogenic PRRSV strains inducing poor immune responses during disease
process.
We were interested in looking into whether vFL12 induces IL-10 levels in
infected cells as well as in infected tissues in a way that would correlate with in vivo
virulence. Unexpectedly, we found that vFL12 strain did not up-regulate IL-10 levels in
in vitro infected cells as well as in vivo, as evidenced by sequential immunofluorescence
staining of PRRSV (vFL12) infected tissues at different time points after infection. Hence,
this study would attempt to shed light on an important question: Whether PRRSV
virulent strains are really exploiting the IL-10 pathway to produce virulence in the
infected host. The possible mechanisms of IL-10 induction by certain strains of PRRSV
are discussed in this paper.
MATERIALS AND METHODS
Derivation of monocyte-derived macrophages and monocyte-derived dendritic cells
in vitro
Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient
centrifugation using lymphocyte separation medium (Mediatech, Inc). The isolated
PBMCs were incubated with Dulbecco’s modified eagle medium supplemented with 10%
fetal bovine serum (FBS) in a glass petri-dish overnight to allow adherence of monocytes.
The non-adherent lymphocytes were extensively washed away using sterile phosphate
buffered saline (PBS). The adherent monocytes were then incubated with RPMI-1640
supplemented with: 25mM HEPES, 1mM sodium pyruvate, 1X non-essential amino acids,
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10µg/mL gentamicin and the essential growth factor(s). For the differentiation of
macrophages, macrophage-colony stimulating factor (M-CSF) (5ng/mL) was added in the
RPMI-1640 growth medium and further incubated for seven days. For the differentiation
of dendritic cells, granulocyte-monocyte-colony stimulating factor (GM-CSF) (20ng/mL)
and interleukin-4 (IL-4) (20ng/mL) were added to RPMI-1640 growth medium and
incubated for five days. In dendritic cells culture, half of the medium was changed with
fresh medium supplemented with GM-CSF and IL-4. After appropriate incubation period,
the cells were harvested using Hank’s salt solution-based cell dissociation buffer
(Invitrogen).
Flow cytometry analysis of surface markers
Harvested macrophage/dendritic cell cultures were analyzed for surface markers
expression by flow cytometric analysis. Cells were washed with flow cytometry (FCM)
buffer (Phosphate buffered saline (Calcium and Magnesium Free) pH 7.4, 2% FBS, and
0.1% Sodium azide). Viable cells were counted after staining with trypan blue (0.4%).
Cells were resuspended in FCM buffer at a concentration of 5 x 107 cells/mL. Cells (100
µL) were then incubated with primary antibody (mouse anti-SWC3 or anti-MHC-II or
anti-CD163 or anti-CD1, VMRD, Inc) at a concentration of 15µg/mL for 45 min. Cells
were then washed twice with 1 mL of FCM buffer by centrifugation at 250 x g for 5 min
and incubated with goat anti-mouse IgG conjugated with Alexafluor 488 (Invitrogen) at a
dilution of 1:200 for 30 min in the dark. Subsequently, cells were washed twice with 0.5
mL of FCM buffer by centrifugation for 5 min. Finally, cells were resuspended in 1%
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paraformaldehyde in PBS and stored at 4○C until flow cytometry analysis with a
FACScan flow cytometer (BD Biosciences).
Viral infections, quantitative PCR, and ELISA
Both macrophages and dendritic cells were infected with PRRSV-vFL12 at an
m.o.i. of one. The cells were incubated with virus for 1 h at 37○C. Cell pellet and
supernatant samples were collected every 12 h post-infection. Total RNAs were isolated
using Trizol-LS reagent (Invitrogen). Approximately 1-2 µg of RNA was reversetranscribed using MMLV-RT (Invitrogen) to synthesize complementary DNAs (cDNAs).
cDNAs were used as templates for PCR amplication of IL-10 or β-actin transcripts in
each sample. The PCR primers and probes used in this study were as follows: IL-10
(GenBank Accession No. L20001): forward primer ACTTGTTGCTGACCGGGTCT,
reverse primer CGGCATTACGTCTTCCAGGT, Taqman probe ACCTGGGTTGCCAA
GCCTTGTCAG; -actin (GenBank Accession No. U07786): forward primer
CTCCTTCCTGGGCATGGA, reverse primer CCACGTCGCACTTCATGATC, Taqman
probe TGCGGCATCCACGAGACCACCT. The optimized concentrations for primers
and probes were as follows: 300nM each IL-10 primer, 900nM each -actin primer, and
250nM each probe (both IL-10 and -actin). Taqman probes were dually labeled with
FAM at 5’ end and TAMRA quencher at the 3’ end. The real time PCR was performed
using Fast start PCR master mix (Roche Applied Sciences) in 25µL volume. The thermal
set up consisted of initial denaturation at 95°C for 10 min; followed by denaturation at
95°C for 15 sec, and primer extension at 60°C for 1 min for a total of 40 cycles. The
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resulting ∆Ct values were used to interpolate the mRNA copy numbers using a standard
curve generated from specific PCR products as template. The relative mRNA copy
numbers were calculated as previously described (163). The secreted levels of IL-10 in
supernatants were measured using a commercially available ELISA kit for swine IL-10
(Biosource). Virus in the supernatant was titrated using MARC-145 cells and tissue
culture infectivity dose 50 (TCID50) was calculated using the Reed and Muench method
(140).
In vivo pig infections, fixation and indirect immunofluorescence of tissue sections
Six PRRSV-negative weaned pigs (approximately 4 weeks-old, white Yorkshire
crossbred) were assigned into two groups of three animals each. One group was infected
with PRRSV-vFL12 strain at a dose of 2 x 105.2 TCID50/2mL intra-nasal and intramuscular routes using half of dose at each route. One animal from each group was
euthanized at 4, 7 and 11 days post-infection (dpi). Lungs, tonsils and mandibular lymph
nodes were collected. The microtome-produced tissue sections were prepared on slides
following adaptations of previously published procedures (9, 57). Briefly, 2-3mm thick
tissue sections were fixed in B*5 fixative (0.6% ZnCl in 0.1% sodium acetate buffer,
American MasterTech) for approximately 24-48 h at room temperature (RT). Tissue
sections were gradually dehydrated at RT for 2 h each in 50% ethanol, 70% ethanol, 95%
ethanol and finally in 100% isopropanol. The sections were cleared in xylene for 1 h with
two changes, 30 min each at RT and infiltrated with paraffin at 58○C for three changes
with 10 min each. Tissues were embedded in paraffin immediately. 3-5µm sections were
cut sequentially by microtome and collected on microscopic slides.
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Paraffinized tissue sections on slides were deparaffinized in xylene three changes,
30 sec each. Subsequently, xylene was removed by washing twice with 100% ethanol, 30
sec each. The tissue sections were gradually rehydrated at RT in 90%, 80% and 70%
ethanol, 30 sec each. Finally, the sections were rehydrated completely with PBS and were
further incubated with 5% DMSO in PBS for 10 min at RT. Sections were incubated with
10% normal donkey serum and 3% bovine serum albumin in PBS-tween 20 (0.1%) to
block non-specific protein binding for 45 min at RT. They were further incubated with
goat anti-swine IL-10 polyclonal antibody (1:100 dilutions, R&D systems) and antiPRRSV murine monoclonal antibody (1:100 dilutions, USDA) for overnight at 4○C.
After washing with PBS-tween 20 (0.1%) for 5 min thrice, sections were then incubated
with donkey Alexafluor 568-conjugated anti-mouse IgG (1:100 dilutions) and donkey
Alexafluor 488-conjugated anti-goat IgG (1:200 dilutions) for 30 min at RT. Sections
were washed with PBS-tween 20 (0.1%) for 5 min thrice. After incubating with DAPI
(final concentration, 250ng/mL) for 5 min, the sections were washed with PBS for 5 min
twice. Sections were mounted using aqueous gel permanent mounting medium (DAKO)
and examined under confocal laser scanning microscope (CLSM) (Olympus IX 81,
Inverted Confocal Microscope) at 405nm (for DAPI), 488nm (for Alexafluor 488) and
543nm (for Alexafluor 568) excitation laser filters. All images were taken with 60X
magnification with the same settings in sequential mode. The pigs used in this experiment
were confirmed negative for PCV2 viremia by PCV2-specific PCR in serum samples.
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RESULTS
Phenotypic characterization of swine macrophages and dendritic cells
In order to study the IL-10 induction by PRRSV, macrophages and dendritic cells
were established in vitro from glass adherent PBMC-derived monocytes. The
differentiated macrophages and dendritic cells have typical morphology of respective
cells as indicated by features such as pseudopodia, lamellipodia for macrophages and
dendritic appearance for dendritic cells (data not shown). The surface expression of
various markers specific for these myeloid cells was analyzed by flow cytometric
analysis. Both cell populations expressed myeloid marker, SWC3 in approximately 97%
of cells (Fig 1). Differentiation of myeloid cells from monocytes up-regulates surface
MHC-II expression. Monocyte-derived macrophages consisted of two sub-populations
based on the amount of surface MHC-II expression, corresponding to low and medium
levels (Fig 1). However, as previously reported (190), monocyte-derived dendritic cells
expressed high levels of MHC-II on the surface (Fig 1). Moreover, approximately 80% of
cells among macrophage population expressed high levels of CD163 (Fig 1), which is
highly expressed in differentiated macrophages but weakly on monocytes (149). On the
other hand, approximately 70% of monocyte-derived dendritic cells expressed dendritic
cell marker, CD1 (Fig 1).
PRRSV-vFL12 strain did not up-regulate IL-10 levels in infected macrophages and
dendritic cells in vitro
Several (contrasting) previous reports have concluded that IL-10 expression is
PRRSV strain-dependent. As it had been suggested that IL-10 induction might imply an
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evasion role in PRRSV pathogenesis, we were interested in assessing the levels of IL-10
in response to a virulent strain of PRRSV (our infectious clone-derived, vFL12) (178). To
determine the levels of IL-10 mRNA and secreted IL-10 during vFL12 infection,
monocyte-derived macrophages were infected with PRRSV vFL12 at an m. o. i. of 1. At
various time points after infection, IL-10 transcripts were quantified by quantitative PCR.
Simultaneously, IL-10 protein levels and viral titer were measured in the supernatants. As
shown in Fig 2, there was no significant up-regulation of IL-10 mRNA levels (Fig 2a) or
protein levels (Fig 2b) in vFL12 infected macrophages at any of the time points observed
after infection. However, LPS-stimulated cells induced a stronger IL-10 response which
showed a peak at 12 h after infection. The kinetics of viral replication in these cells
showed a peak viral titer at 36 h after infection (Fig 2c). Even though these macrophages
are capable of inducing IL-10 in response to LPS, they fail to up-regulate IL-10 at mRNA
and protein levels during vFL12 infection.
In order to confirm these results, we also repeated the experiments in monocytederived dendritic cells. In contrast to PRRSV-infected macrophages, monocyte-derived
dendritic cells induced IL-10 transcripts (about 10 fold), when infected with PRRSV,
which peaked at 24 h post-infection (Fig 3a). However, there were barely detectable
levels of IL-10 protein released in supernatants of infected dendritic cells (Fig.3b). LPSstimulated dendritic cells showed stronger IL-10 response than LPS-stimulated
macrophages (Fig 2a, 2b, 3a, and 3b). From these experiments, we concluded that
PRRSV strain vFL12 did not stimulate secretion of IL-10 in infected macrophages and
dendritic cells grown under in vitro conditions.
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PRRSV-vFL12 strain did not up-regulate IL-10 in infected or bystander cells in vivo
IL-10 levels can also be up-regulated in bystander immune cells such as T-cells
and B-cells of swine during in vivo infection by porcine circovirus (47). Even though
PRRSV vFL12 strain did not up-regulate IL-10 in infected macrophages, it might still
possibly up-regulate IL-10 in bystander immune cells such as T cells or B cells in
infected tissues during in vivo infection. This was examined by immunofluorescence
staining of PRRSV-infected tissues using swine IL-10-specific antibody. The IL-10
staining was detected only in tonsils but not in lungs or mandibular lymph nodes after
B*5 fixation. In both control and infected tissue sections, IL-10 positive cells were
sporadically detected throughout the sections (shown in inset, Fig 4) suggestive of
cytoplasmic localization of IL-10 signals (Fig 4). PRRSV-specific signals were localized
mostly in cytoplasm of cells in all PRRSV-infected tonsils (Fig 4). They were observed
in the area between tonsillar cryptae and T cell-rich area. Mock-infected control slides at
all time points were scored negative for PRRSV staining. The differences in the intensity
of PRRSV-specific staining between different time points after infection may be
attributed to the differences in the level of fixation. The PRRSV-specific signals did not
co-localize with IL-10 staining at cellular level in tonsils of infected animals at 7 and 10
dpi. However, PRRSV-infected cells showed a very weak positive IL-10 staining only at
4 dpi (Fig 4). Overall, the data suggested that PRRSV did not induce IL-10 response in
infected cells or bystander cells in tonsils of infected animals.

109

DISCUSSION
In this study, we report that a well characterized virulent strain of PRRSV, vFL12,
failed to up-regulate IL-10 levels in infected cells or in bystander cells both in vitro and
in vivo. These findings suggested that IL-10 does not appear to contribute to the virulence
of PRRSV. Our findings were congruent with a previous report that showed IL-10 levels
in pigs are not associated with virulent or avirulent PRRSV infections (Klinge et al.,
2009). PRRSV vFL12 strain was previously shown to actively suppress immune
responses during infection (10). We propose that the ability of PRRSV strains to induce
IL-10 may be indirectly mediated through the induction of one or more pro-inflammatory
(PI) cytokines such as TNF-α, IL-1, and IL-12 during the acute phase of infection, since
all these PI cytokines would lead to the induction of IL-10 (35, 56). Several studies have
shown that many PRRSV strains induce IL-10 transcripts and protein levels in infected
tissues, specifically in association with the acute phase of disease (22, 30, 45, 92, 171).
This suggests that PRRSV has an ability to induce IL-10 during active replication in
viremic phase in vivo. However, in our study, a virulent strain of PRRSV-vFL12 was
unable to induce any detectable level of IL-10 in the supernatant of infected macrophages
and dendritic cells. This clearly suggests that pathogenic vFL12 strain would not exploit
the IL-10 induction pathway in infected myeloid cells to suppress active innate and
adaptive immune responses. There were differences in DC populations in their ability to
induce IL-10 in response to PRRSV infection (Hernandez et al., 2006). It is possible that
PRRSV-vFL12 may differentially regulate IL-10 expression in different DC populations.
However, our in vivo results showed that there were no IL-10 positive cells observed in
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infected tonsil tissues, where mixed DC populations are present (Polak et al., 2008).
Hence, it is more likely that PRRSV-vFL12 may not induce IL-10 in a cell type specific
manner.
Temporarily induced IL-10, along with many PI cytokines, is generally seen as
beneficial to the host as it would help to suppress or mitigate the immunopathogenesis
caused by PI cytokines (54). Previous studies have shown the occurrence of up-regulation
of PI cytokines such as IL-12 (30, 61), IL-1 (92) and TNF-α (71) in PRRSV-infected
animals. Such effect could potentially explain the up-regulated IL-10 levels that were
observed in those studies. In support of our observation, recent studies also reported that
several European and a few North American PRRSV strains lack the capacity of upregulating IL-10 in infected macrophages or dendritic cells (71, 154, 190). While vFL12
strain poorly induces TNF-α and IFN-α (10, 164), its ability to induce other PI cytokines
such as IL-1 and IL-12 remains to be studied. It is plausible that the failure of induction
of IL-10 in vFL12-infected macrophages or dendritic cells may be associated with the
poor induction of PI cytokines by vFL12 in those cells.
A strong IL-10 staining in tissues should be expected in case of viral infections
that would exploit IL-10-induction pathway (47). During in vivo infection with vFL12,
strong PRRSV-positive cells were observed at all time points after infection in tonsils,
which were located between the tonsillar cryptae and T cell area. These PRRSV-positive
cells did not co-localize with IL-10 positive cells observed in the infected tissues. There
were no differences in the number and distribution of sporadically-present IL-10-positive
cells between control and infected tissues indicate that vFL12 does not induce IL-10 in
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bystander cells such as T cells or non-infected macrophages. It will be interesting to see
whether the same infected tissues would show positive signals for any PI cytokines which
we have not explained in our studies.
Overall, it may be concluded that a highly pathogenic PRRSV strain such as
vFL12 does not need to exploit IL-10 induction to evade surveillance in the infected host.
It may further be suggested that the induction of IL-10 by other PRRSV strains in several
studies from other laboratories may be associated with their ability to induce PI cytokines
during the acute phase of infection. In future studies, it may be appropriate to check the
levels of different PI cytokines simultaneously with IL-10 during infection with various
PRRSV strains.
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Figure 1. Phenotypic characterization of monocyte-derived macrophages and
monocyte-derived dendritic cells. Harvested cells were stained with respective primary
antibodies (15µg/mL) followed by Alexafluor 488-conjugated anti-mouse secondary
antibodies (10µg/mL). Staining with secondary antibody only was used as background
control. Filled histograms: Surface marker-stained cells. Empty histograms: control cells.
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a

MFI indicates mean fluorescence intensity ± standard deviation and b% of positive cells

among gated cells ± standard deviation.
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Figure 2. PRRSV-vFL12 strain does not up-regulate IL-10 during in vitro infection
of monocyte-derived macrophages. (a) Measurement of IL-10 mRNAs in cells mockinfected or infected with vFL12 or stimulated with LPS by quantitative PCR. Monocytederived macrophages were infected with vFL12 strain at one m.o.i. Cells in growth
medium were used as control cells. Cells stimulated with LPS were used as positive
control. At various time points after infection, total RNA was isolated from cells and
cDNAs were prepared. The copy number of IL-10 mRNA was quantified by quantitative
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PCR using cDNAs as template and normalized with the copy number of β-actin mRNA.
Each bar indicates the amount of IL-10 mRNA copies relative to every hundred IL-10
mRNA copies in mock-infected cells. Mean ± standard error values are shown (n=3). (b)
IL-10 ELISA. IL-10 was measured in the supernatants of above cultures using swine IL10-specific ELISA. Each bar indicates mean ± standard error value (n=3) (c) Viral titers
in the supernatant of above cultures infected with vFL12 were measured in MARC-145
cells and expressed as TCID50/mL. Mean ± standard error values are shown (n=3).
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Figure 3. PRRSV-vFL12 up-regulates IL-10 mRNAs but does not induce IL-10
protein secretion in infected monocyte-derived dendritic cells. (a) Measurement of IL10 mRNA levels in mock-infected, vFL12-infected and LPS-stimulated cells. Total RNA
was isolated, cDNAs were prepared to quantify by quantitative PCR. Each bar indicates
the average number of IL-10 mRNA copies relative to every hundred IL-10 mRNA
copies in mock-infected cells. Mean ± standard error values (n=3) are shown. (b)
Measurement of secreted levels of IL-10 in the supernatant of vFL12-infected dendritic
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cells or LPS-stimulated cells or mock-infected cells. Mean ± standard error values (n=3)
are shown. (c) Viral titers in supernatants of vFL12-infected cultures were measured in
MARC-145 cells and expressed as TCID50/mL. Mean ± standard error values (n=3) are
shown.
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Figure 4. Confocal immunofluorecence staining of PRRSV-vFL12-infected and
mock-infected control tonsils for swine IL-10 and PRRSV nucleocapsid antigen. Pigs
were either mock-infected or infected with vFL12 and tonsils were collected at 4, 7 and
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11 days post-infection. Tissue sections of tonsils were prepared and stained for IL-10
(green) and PRRSV (red) using specific antibodies. The insets of confocal images
representing tonsil section from 11 days post-infection were enlarged for cellular details
of staining. DAPI staining was performed to mark nucleated cells (blue).
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CONCLUSIONS
Porcine reproductive and respiratory syndrome virus (PRRSV) causes
reproductive failure and respiratory illness in late-term gestational sows and growing pigs
respectively. PRRSV primarily replicates in resident macrophages in lungs and lymphoid
tissues. After acute replication in these tissues, PRRSV perpetuates in a persistent phase
in lymphoid tissues. The immune response to PRRSV infection is characterized by a
weak innate-immune response, followed by retarded and inefficient neutralizing antibody
and cell-mediated responses. The abnormal immune responses caused by PRRSV
infection are the consequences of multiple immune-evasion mechanisms including
cytokine dysregulation. Particularly, PRRSV infection reduces the levels of an important
pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α) while increasing the levels
of the anti-inflammatory cytokine, interleukin-10 (IL-10). It seems plausible that by
inhibiting TNF-α, PRRSV could facilitate its replication in macrophages whereas by
inducing IL-10, it could suppress the IFN-γ-specific T cell responses. In this dissertation,
studies were undertaken to elucidate the mechanisms by which PRRSV regulates the
production of TNF-α and IL-10.
Macrophages induce TNF-α in response to viral infections.

However, after

PRRSV infection, macrophages induce negligible levels of TNF-α. In our studies, an
infectious clone-derived PRRSV strain, vFL12 did not induce TNF-α after infection of
monocyte-derived macrophages. In macrophage cultures, vFL12 infection reduced TNFα mRNA levels at early times after infection but increased the mRNA levels at later
stages of infection. Macrophage cultures infected with vFL12 did not contain detectable
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levels of TNF-α protein in the supernatants. Therefore, vFL12 modulated TNF-α
production in infected macrophages via two independent mechanisms: reduction of TNFα mRNAs and reduction of TNF-α protein.
TNF-α mRNA levels are regulated at the promoter in the nucleus while TNF-α
protein levels are regulated via post-transcriptional mechanisms in the cytoplasm. To
identify viral proteins that reduce TNF-α promoter activity, we performed TNF-α
promoter-specific luciferase assays in cells transfected with PRRSV non-structural
proteins (Nsps) or N protein. Nsp1α and Nsp1β reduced the activation of TNF-α
promoter at its proximal region (from nt -194 to +58). Multiple transcription factors bind
the proximal region of TNF-α promoter. Transcription factors ATF2-c-jun and p65/p50
(NF-κB) bind CRE-κB3 sequence while the transcription factor Sp1 binds to proximal
and distal Sp1-binding sequences. In transcription factor-specific luciferase assays,
Nsp1α and Nsp1β reduced the functional activities of transcription elements, CRE-κB3
and Sp1 respectively. Additionally, in NF-κB-specific luciferase assays, Nsp1α reduced
NF-κB activation. On the other hand, Nsp1β reduced the trans-activation function of Sp1
in transient Sp1-specific reporter assays. Together, Nsp1α and Nsp1β reduced the
activities of two different transcription factors to achieve maximal decrease in TNF-α
promoter activation. We designed an in vitro TNF-α translation assay to identify PRRSV
proteins that regulate TNF-α protein levels via a post-transcriptional mechanism. Nsp1α
reduced TNF-α protein levels via the post-transcriptional mechanism. Therefore, Nsp1α
may prevent the accumulation of TNF-α protein synthesized from pre-existing mRNAs
after PRRSV infection.
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Nsp1α and Nsp1β are multi-domain proteins that participate in viral transcription,
replication and virion biogenesis. Nsp1α has 180 amino acid residues that fold into two
domains, zinc finger domain and protease domain. Nsp1β has 203 amino acid residues
that fold into three domains, nuclease domain, linker domain and protease domain.
Protease domains of both proteins cleave the respective proteins from viral polyprotein,
pp1a. However, their enzymatic activities were not necessary for reducing TNF-α
promoter activity in transient TNF-α promoter-luciferase assays. Nevertheless, protease
domains of Nsp1α and Nsp1β reduced the TNF-α promoter activity. In addition, the other
two domains of Nsp1β were also important for reducing TNF-α promoter activity. At
amino acid level, five residues (Gly90, Asn91, Arg97, Arg100, and Arg124) of Nsp1α
protease domain were necessary for reducing TNF-α promoter activity. In contrast,
multiple amino acid stretches in all Nsp1β domains were important for reducing TNF-α
promoter activity.
Mutant vFL12 strains were generated by reverse genetics with mutations in
Nsp1α at Gly90 residue and Nsp1β at 70-74 amino acid positions. Both mutant strains
grew with slightly slower kinetics in African green monkey kidney cells, MARC-145.
However, under in vivo conditions, the Nsp1β mutant strain replicated in pigs with
reduced viral titers in serum. In macrophage cultures, both mutant strains increased TNFα mRNA levels at early times after infection. However, only Nsp1α mutant strain
increased TNF-α protein levels in the supernatants of the cultures. Both mutant strains
also increased TNF-α inducible chemokines such as CCL2 and CXCL10. Moreover,
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Nsp1α mutant virus induced higher TNF-α protein in serum of pigs after 7 days postinfection.
Several strains of PRRSV induced IL-10 after infection but others did not. The
correlation between PRRSV virulence and the IL-10 levels in infected pigs was unknown.
In this study, the virulent PRRSV-vFL12 strain did not increase IL-10 mRNAs and
protein in macrophages after infection. However, it increased IL-10 mRNAs but not the
protein in dendritic cells after infection. In addition, vFL12 failed to increase IL-10
expression in tissues after infecting swine.
The general conclusions of this dissertation can be summarized as follows: 1)
PRRSV Nsp1α and Nsp1β reduce the TNF-α expression at mRNA and protein levels. 2)
Nsp1α Gly90 residue and Nsp1β amino acid residues at 70-74 positions are necessary for
reducing TNF-α expression. 3) The highly virulent PRRSV strain, vFL12 fails to increase
IL-10 levels in cultured cells or in pigs after infection, casting doubts about the
significance of IL-10 modulation for PRRSV virulence.
The findings of this dissertation may be helpful to design novel prophylactic and
therapeutic strategies for PRRSV.

124

BIBILIOGRAPHY
1.

Albina, E., C. Carrat, and B. Charley. 1998. Interferon-alpha response to swine
arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. J
Interferon Cytokine Res 18:485-90.

2.

Alcaraz, C., M. De Diego, M. J. Pastor, and J. M. Escribano. 1990.
Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA
for detection of antibody to African swine fever virus. J Vet Diagn Invest 2:191-6.

3.

Allende, R., W. W. Laegreid, G. F. Kutish, J. A. Galeota, R. W. Wills, and F.
A. Osorio. 2000. Porcine reproductive and respiratory syndrome virus:
description of persistence in individual pigs upon experimental infection. J Virol
74:10834-7.

4.

Andresen, L., H. Jensen, M. T. Pedersen, K. A. Hansen, and S. Skov. 2007.
Molecular regulation of MHC class I chain-related protein A expression after
HDAC-inhibitor treatment of Jurkat T cells. J Immunol 179:8235-42.

5.

Ansari, I. H., B. Kwon, F. A. Osorio, and A. K. Pattnaik. 2006. Influence of Nlinked glycosylation of porcine reproductive and respiratory syndrome virus GP5
on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J
Virol 80:3994-4004.

6.

Batista, L., C. Pijoan, S. Dee, M. Olin, T. Molitor, H. S. Joo, Z. Xiao, and M.
Murtaugh. 2004. Virological and immunological responses to porcine
reproductive and respiratory syndrome virus in a large population of gilts. Can J
Vet Res 68:267-73.

7.

Bautista, E. M., and T. W. Molitor. 1997. Cell-mediated immunity to porcine
reproductive and respiratory syndrome virus in swine. Viral Immunol 10:83-94.

8.

Bautista, E. M., and T. W. Molitor. 1999. IFN gamma inhibits porcine
reproductive and respiratory syndrome virus replication in macrophages. Arch
Virol 144:1191-200.

9.

Beckstead, J. H. 1994. A simple technique for preservation of fixation-sensitive
antigens in paraffin-embedded tissues. J Histochem Cytochem 42:1127-34.

10.

Beura, L. K., S. N. Sarkar, B. Kwon, S. Subramaniam, C. Jones, A. K.
Pattnaik, and F. A. Osorio. 2009. Porcine reproductive and respiratory
syndrome virus nonstructural protein 1beta modulates host innate immune
response by antagonizing IRF3 activation. J Virol 84:1574-84.

125

11.

Bierk, M. D., S. A. Dee, K. D. Rossow, S. Otake, J. E. Collins, and T. W.
Molitor. 2001. Transmission of porcine reproductive and respiratory syndrome
virus from persistently infected sows to contact controls. Can J Vet Res 65:261-6.

12.

Bour, S., C. Perrin, H. Akari, and K. Strebel. 2001. The human
immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by
interfering with beta TrCP-mediated degradation of Ikappa B. J Biol Chem
276:15920-8.

13.

Brady, M. T., A. J. MacDonald, A. G. Rowan, and K. H. Mills. 2003. Hepatitis
C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10
production from monocytes. Eur J Immunol 33:3448-57.

14.

Brightbill, H. D., S. E. Plevy, R. L. Modlin, and S. T. Smale. 2000. A
prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10
promoter in macrophages. J Immunol 164:1940-51.

15.

Brook, M., G. Sully, A. R. Clark, and J. Saklatvala. 2000. Regulation of
tumour necrosis factor alpha mRNA stability by the mitogen-activated protein
kinase p38 signalling cascade. FEBS Lett 483:57-61.

16.

Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern,
and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or
persistence in vivo. Nat Med 12:1301-9.

17.

Buddaert, W., K. Van Reeth, and M. Pensaert. 1998. In vivo and in vitro
interferon (IFN) studies with the porcine reproductive and respiratory syndrome
virus (PRRSV). Adv Exp Med Biol 440:461-7.

18.

Cafruny, W. A., R. G. Duman, G. H. Wong, S. Said, P. Ward-Demo, R. R.
Rowland, and E. A. Nelson. 2006. Porcine reproductive and respiratory
syndrome virus (PRRSV) infection spreads by cell-to-cell transfer in cultured
MARC-145 cells, is dependent on an intact cytoskeleton, and is suppressed by
drug-targeting of cell permissiveness to virus infection. Virol J 3:90.

19.

Calzada-Nova, G., W. Schnitzlein, R. Husmann, and F. A. Zuckermann. 2010.
Characterization of the cytokine and maturation responses of pure populations of
porcine plasmacytoid dendritic cells to porcine viruses and toll-like receptor
agonists. Vet Immunol Immunopathol 135:20-33.

20.

Calzada-Nova, G., W. M. Schnitzlein, R. J. Husmann, and F. A. Zuckermann.
2011. North American porcine reproductive and respiratory syndrome viruses

126

inhibit type I interferon production by plasmacytoid dendritic cells. J Virol
85:2703-13.
21.

Carter, Q. L., and R. E. Curiel. 2005. Interleukin-12 (IL-12) ameliorates the
effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection.
Vet Immunol Immunopathol 107:105-18.

22.

Chang, H. C., Y. T. Peng, H. L. Chang, H. C. Chaung, and W. B. Chung.
2008. Phenotypic and functional modulation of bone marrow-derived dendritic
cells by porcine reproductive and respiratory syndrome virus. Vet Microbiol
129:281-93.

23.

Charerntantanakul, W., R. Platt, and J. A. Roth. 2006. Effects of porcine
reproductive and respiratory syndrome virus-infected antigen-presenting cells on
T cell activation and antiviral cytokine production. Viral Immunol 19:646-61.

24.

Chaung, H. C., C. W. Chen, B. L. Hsieh, and W. B. Chung. Toll-Like
Receptor expressions in porcine alveolar macrophages and Dendritic Cells in
responding to poly IC stimulation and porcine reproductive and respiratory
syndrome virus (PRRSV) infection. Comp Immunol Microbiol Infect Dis 33:197213.

25.

Chen, H. Y., L. L. Zheng, X. S. Li, Z. Y. Wei, B. A. Cui, X. K. Li, J. P. Liu, H.
Z. Yin, J. T. Meng, Y. Zhang, and S. M. Li. 2009. Cloning, in vitro expression,
and bioactivity of interleukin-18 isolated from a domestic porcine breed found in
Henan. FEMS Immunol Med Microbiol 57:129-35.

26.

Chen, Z., S. Lawson, Z. Sun, X. Zhou, X. Guan, J. Christopher-Hennings, E.
A. Nelson, and Y. Fang. 2009. Identification of two auto-cleavage products of
nonstructural protein 1 (nsp1) in porcine reproductive and respiratory syndrome
virus infected cells: nsp1 function as interferon antagonist. Virology 398:87-97.

27.

Chen, Z., X. Zhou, J. K. Lunney, S. Lawson, Z. Sun, E. Brown, J.
Christopher-Hennings, D. Knudsen, E. Nelson, and Y. Fang. 2010.
Immunodominant epitopes in nsp2 of porcine reproductive and respiratory
syndrome virus are dispensable for replication, but play an important role in
modulation of the host immune response. J Gen Virol 91:1047-57.

28.

Christianson, W. T., C. S. Choi, J. E. Collins, T. W. Molitor, R. B. Morrison,
and H. S. Joo. 1993. Pathogenesis of porcine reproductive and respiratory
syndrome virus infection in mid-gestation sows and fetuses. Can J Vet Res
57:262-8.

127

29.

Christianson, W. T., J. E. Collins, D. A. Benfield, L. Harris, D. E. Gorcyca, D.
W. Chladek, R. B. Morrison, and H. S. Joo. 1992. Experimental reproduction
of swine infertility and respiratory syndrome in pregnant sows. Am J Vet Res
53:485-8.

30.

Chung, H. K., and C. Chae. 2003. Expression of interleukin-10 and interleukin12 in piglets experimentally infected with porcine reproductive and respiratory
syndrome virus (PRRSV). J Comp Pathol 129:205-12.

31.

Cirino, N. M., J. R. Panuska, A. Villani, H. Taraf, N. A. Rebert, R. Merolla,
P. Tsivitse, and I. A. Gilbert. 1993. Restricted replication of respiratory
syncytial virus in human alveolar macrophages. J Gen Virol 74 ( Pt 8):1527-37.

32.

Collins, J. E., D. A. Benfield, W. T. Christianson, L. Harris, J. C. Hennings,
D. P. Shaw, S. M. Goyal, S. McCullough, R. B. Morrison, H. S. Joo, and et al.
1992. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC
VR-2332) in North America and experimental reproduction of the disease in
gnotobiotic pigs. J Vet Diagn Invest 4:117-26.

33.

Costers, S., D. J. Lefebvre, P. L. Delputte, and H. J. Nauwynck. 2008. Porcine
reproductive and respiratory syndrome virus modulates apoptosis during
replication in alveolar macrophages. Arch Virol 153:1453-65.

34.

Costers, S., D. J. Lefebvre, B. Goddeeris, P. L. Delputte, and H. J. Nauwynck.
2009. Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.
Vet Res 40:46.

35.

Daftarian, P. M., A. Kumar, M. Kryworuchko, and F. Diaz-Mitoma. 1996.
IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in
monocytes by tumor necrosis factor-alpha. J Immunol 157:12-20.

36.

Das, P. B., P. X. Dinh, I. H. Ansari, M. de Lima, F. A. Osorio, and A. K.
Pattnaik. The minor envelope glycoproteins GP2a and GP4 of porcine
reproductive and respiratory syndrome virus interact with the receptor CD163. J
Virol 84:1731-40.

37.

Das, P. B., H. L. Vu, P. X. Dinh, J. L. Cooney, B. Kwon, F. A. Osorio, and A.
K. Pattnaik. Glycosylation of minor envelope glycoproteins of porcine
reproductive and respiratory syndrome virus in infectious virus recovery, receptor
interaction, and immune response. Virology 410:385-94.

38.

Dea, S., C. A. Gagnon, H. Mardassi, B. Pirzadeh, and D. Rogan. 2000.
Current knowledge on the structural proteins of porcine reproductive and

128

respiratory syndrome (PRRS) virus: comparison of the North American and
European isolates. Arch Virol 145:659-88.
39.

Delputte, P. L., S. Costers, and H. J. Nauwynck. 2005. Analysis of porcine
reproductive and respiratory syndrome virus attachment and internalization:
distinctive roles for heparan sulphate and sialoadhesin. J Gen Virol 86:1441-5.

40.

Delputte, P. L., and H. J. Nauwynck. 2004. Porcine arterivirus infection of
alveolar macrophages is mediated by sialic acid on the virus. J Virol 78:8094-101.

41.

Delputte, P. L., N. Vanderheijden, H. J. Nauwynck, and M. B. Pensaert. 2002.
Involvement of the matrix protein in attachment of porcine reproductive and
respiratory syndrome virus to a heparinlike receptor on porcine alveolar
macrophages. J Virol 76:4312-20.

42.

Den Boon, J. A., K. S. Faaberg, J. J. Meulenberg, A. L. Wassenaar, P. G.
Plagemann, A. E. Gorbalenya, and E. J. Snijder. 1995. Processing and
evolution of the N-terminal region of the arterivirus replicase ORF1a protein:
identification of two papainlike cysteine proteases. J Virol 69:4500-5.

43.

Den Boon, J. A., M. F. Kleijnen, W. J. Spaan, and E. J. Snijder. 1996. Equine
arteritis virus subgenomic mRNA synthesis: analysis of leader-body junctions and
replicative-form RNAs. J Virol 70:4291-8.

44.

Diaz, I., L. Darwich, G. Pappaterra, J. Pujols, and E. Mateu. 2006. Different
European-type vaccines against porcine reproductive and respiratory syndrome
virus have different immunological properties and confer different protection to
pigs. Virology 351:249-59.

45.

Diaz, I., L. Darwich, G. Pappaterra, J. Pujols, and E. Mateu. 2005. Immune
responses of pigs after experimental infection with a European strain of Porcine
reproductive and respiratory syndrome virus. J Gen Virol 86:1943-51.

46.

Done, S. H., and D. J. Paton. 1995. Porcine reproductive and respiratory
syndrome: clinical disease, pathology and immunosuppression. Vet Rec 136:32-5.

47.

Doster, A. R., Subramaniam, S., Yhee, J., Kwon, B., Yu, C., Kwon, S., Osorio,
F.A., Sur, J.H. 2010. Distribution and characterization of IL-10-secreting cells in
lymphoid tissues of PCV2-infected pigs. J.Vet.Sci. 11(3): 177-83.

48.

Duan, X., H. J. Nauwynck, and M. B. Pensaert. 1997. Effects of origin and
state of differentiation and activation of monocytes/macrophages on their

129

susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV).
Arch Virol 142:2483-97.
49.

Duan, X., H. J. Nauwynck, and M. B. Pensaert. 1997. Virus quantification and
identification of cellular targets in the lungs and lymphoid tissues of pigs at
different time intervals after inoculation with porcine reproductive and respiratory
syndrome virus (PRRSV). Vet Microbiol 56:9-19.

50.

Emili, A., J. Greenblatt, and C. J. Ingles. 1994. Species-specific interaction of
the glutamine-rich activation domains of Sp1 with the TATA box-binding protein.
Mol Cell Biol 14:1582-93.

51.

Escher, G., A. Hoang, S. Georges, U. Tchoua, A. El-Osta, Z. Krozowski, and
D. Sviridov. 2005. Demethylation using the epigenetic modifier, 5-azacytidine,
increases the efficiency of transient transfection of macrophages. J Lipid Res
46:356-65.

52.

Falvo, J. V., A. M. Uglialoro, B. M. Brinkman, M. Merika, B. S. Parekh, E. Y.
Tsai, H. C. King, A. D. Morielli, E. G. Peralta, T. Maniatis, D. Thanos, and A.
E. Goldfeld. 2000. Stimulus-specific assembly of enhancer complexes on the
tumor necrosis factor alpha gene promoter. Mol Cell Biol 20:2239-47.

53.

Fang, Y., and E. J. Snijder. 2010. The PRRSV replicase: exploring the
multifunctionality of an intriguing set of nonstructural proteins. Virus Res
154:61-76.

54.

Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra.
1991. IL-10 inhibits cytokine production by activated macrophages. J Immunol
147:3815-22.

55.

Flores-Mendoza, L., E. Silva-Campa, M. Resendiz, F. A. Osorio, and J.
Hernandez. 2008. Porcine reproductive and respiratory syndrome virus infects
mature porcine dendritic cells and up-regulates interleukin-10 production. Clin
Vaccine Immunol 15:720-5.

56.

Foey, A. D., S. L. Parry, L. M. Williams, M. Feldmann, B. M. Foxwell, and F.
M. Brennan. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1
and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J
Immunol 160:920-8.

57.

Frangogiannis, N. G., L. H. Mendoza, M. L. Lindsey, C. M. Ballantyne, L. H.
Michael, C. W. Smith, and M. L. Entman. 2000. IL-10 is induced in the

130

reperfused myocardium and may modulate the reaction to injury. J Immunol
165:2798-808.
58.

Genini, S., P. L. Delputte, R. Malinverni, M. Cecere, A. Stella, H. J.
Nauwynck, and E. Giuffra. 2008. Genome-wide transcriptional response of
primary alveolar macrophages following infection with porcine reproductive and
respiratory syndrome virus. J Gen Virol 89:2550-64.

59.

Gerritsen, M. E., A. J. Williams, A. S. Neish, S. Moore, Y. Shi, and T. Collins.
1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc
Natl Acad Sci U S A 94:2927-32.

60.

Gill, G., E. Pascal, Z. H. Tseng, and R. Tjian. 1994. A glutamine-rich
hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component
of the Drosophila TFIID complex and mediates transcriptional activation. Proc
Natl Acad Sci U S A 91:192-6.

61.

Gomez-Laguna, J., F. J. Salguero, I. Barranco, F. J. Pallares, I. M.
Rodriguez-Gomez, A. Bernabe, and L. Carrasco. 2010. Cytokine expression
by macrophages in the lung of pigs infected with the porcine reproductive and
respiratory syndrome virus. J Comp Pathol 142:51-60.

62.

Gomez-Laguna, J., F. J. Salguero, M. F. De Marco, F. J. Pallares, A. Bernabe,
and L. Carrasco. 2009. Changes in lymphocyte subsets and cytokines during
European porcine reproductive and respiratory syndrome: increased expression of
IL-12 and IL-10 and proliferation of CD4(-)CD8(high). Viral Immunol 22:261-71.

63.

Goriely, S., D. Demonte, S. Nizet, D. De Wit, F. Willems, M. Goldman, and C.
Van Lint. 2003. Human IL-12(p35) gene activation involves selective
remodeling of a single nucleosome within a region of the promoter containing
critical Sp1-binding sites. Blood 101:4894-902.

64.

Granja, A. G., M. L. Nogal, C. Hurtado, C. Del Aguila, A. L. Carrascosa, M.
L. Salas, M. Fresno, and Y. Revilla. 2006. The viral protein A238L inhibits
TNF-alpha expression through a CBP/p300 transcriptional coactivators pathway.
J Immunol 176:451-62.

65.

Haudek, S. B., B. E. Natmessnig, H. Redl, G. Schlag, and B. P. Giroir. 1998.
Genetic sequences and transcriptional regulation of the TNFA promoter:
comparison of human and baboon. Immunogenetics 48:202-7.

131

66.

Heise, M. T., and H. W. t. Virgin. 1995. The T-cell-independent role of gamma
interferon and tumor necrosis factor alpha in macrophage activation during
murine cytomegalovirus and herpes simplex virus infections. J Virol 69:904-9.

67.

Herbein, G., and K. A. Khan. 2008. Is HIV infection a TNF receptor signallingdriven disease? Trends Immunol 29:61-7.

68.

Higuchi, M., K. Nagasawa, T. Horiuchi, M. Oike, Y. Ito, M. Yasukawa, and
Y. Niho. 1997. Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on
HTLV-I-infected T cells mediates a costimulatory signal for B cell activation-characterization of membrane TNF-alpha. Clin Immunol Immunopathol 82:13340.

69.

Hopper, S. A., M. E. White, and N. Twiddy. 1992. An outbreak of blue-eared
pig disease (porcine reproductive and respiratory syndrome) in four pig herds in
Great Britain. Vet Rec 131:140-4.

70.

Howcroft, T. K., L. A. Palmer, J. Brown, B. Rellahan, F. Kashanchi, J. N.
Brady, and D. S. Singer. 1995. HIV Tat represses transcription through Sp1-like
elements in the basal promoter. Immunity 3:127-38.

71.

I.Diaz, M. G., N.Navarrol, E.Cano,M.Montoya,J.Pujols,E.Mateu. 2008.
Clustering of European-type PRRSV strains based on IL-10/TNF-A induction and
their correlation with IFN-secreting cell levels induced in pigs. International
PRRS symphosium.

72.

Johnsen, C. K., A. Botner, S. Kamstrup, P. Lind, and J. Nielsen. 2002.
Cytokine mRNA profiles in bronchoalveolar cells of piglets experimentally
infected in utero with porcine reproductive and respiratory syndrome virus:
association of sustained expression of IFN-gamma and IL-10 after viral clearance.
Viral Immunol 15:549-56.

73.

Johnson, C. R., T. F. Griggs, J. Gnanandarajah, and M. P. Murtaugh. 2011.
Novel structural protein in porcine reproductive and respiratory syndrome virus
encoded by an alternative ORF5 present in all arteriviruses. J Gen Virol 92:110716.

74.

Jung, K., G. J. Renukaradhya, K. P. Alekseev, Y. Fang, Y. Tang, and L. J.
Saif. 2009. Porcine reproductive and respiratory syndrome virus modifies innate
immunity and alters disease outcome in pigs subsequently infected with porcine
respiratory coronavirus: implications for respiratory viral co-infections. J Gen
Virol 90:2713-23.

132

75.

Karniychuk, U. U., D. Saha, M. Geldhof, M. Vanhee, P. Cornillie, W. Van
den Broeck, and H. J. Nauwynck. 2011. Porcine reproductive and respiratory
syndrome virus (PRRSV) causes apoptosis during its replication in fetal
implantation sites. Microb Pathog.51(3):194-202.

76.

Kawasaki, H., J. Song, R. Eckner, H. Ugai, R. Chiu, K. Taira, Y. Shi, N.
Jones, and K. K. Yokoyama. 1998. p300 and ATF-2 are components of the DRF
complex, which regulates retinoic acid- and E1A-mediated transcription of the cjun gene in F9 cells. Genes Dev 12:233-45.

77.

Keffaber. 1989. Reproductive failure of unknown etiology. Am Assoc Swine
Pract Newsletter:48-39.

78.

Key, K. F., J. DiCristina, J. Gillespie, D. K. Guenette, and X. J. Meng. 2007.
Direct inoculation of RNA transcripts from an infectious cDNA clone of porcine
reproductive and respiratory syndrome virus (PRRSV) into the lymph nodes and
tonsils of pigs initiates PRRSV infection in vivo. Arch Virol 152:1383-7.

79.

Key, K. F., G. Haqshenas, D. K. Guenette, S. L. Swenson, T. E. Toth, and X.
J. Meng. 2001. Genetic variation and phylogenetic analyses of the ORF5 gene of
acute porcine reproductive and respiratory syndrome virus isolates. Vet Microbiol
83:249-63.

80.

Kim, E. Y., and H. S. Teh. 2001. TNF type 2 receptor (p75) lowers the threshold
of T cell activation. J Immunol 167:6812-20.

81.

Kim, J. K., A. M. Fahad, K. Shanmukhappa, and S. Kapil. 2006. Defining the
cellular target(s) of porcine reproductive and respiratory syndrome virus blocking
monoclonal antibody 7G10. J Virol 80:689-96.

82.

Kim, O., Y. Sun, F. W. Lai, C. Song, and D. Yoo. 2010. Modulation of type I
interferon induction by porcine reproductive and respiratory syndrome virus and
degradation of CREB-binding protein by non-structural protein 1 in MARC-145
and HeLa cells. Virology. 402(2): 315-26.

83.

Kimman, T. G., L. A. Cornelissen, R. J. Moormann, J. M. Rebel, and N.
Stockhofe-Zurwieden. 2009. Challenges for porcine reproductive and respiratory
syndrome virus (PRRSV) vaccinology. Vaccine 27:3704-18.

84.

Klinge, K. L., E. M. Vaughn, M. B. Roof, E. M. Bautista, and M. P.
Murtaugh. 2009. Age-dependent resistance to Porcine reproductive and
respiratory syndrome virus replication in swine. Virol J 6:177.

133

85.

Krajcsi, P., and W. S. Wold. 1998. Inhibition of tumor necrosis factor and
interferon triggered responses by DNA viruses. Semin Cell Dev Biol 9:351-8.

86.

Kreutz, L. C., and M. R. Ackermann. 1996. Porcine reproductive and
respiratory syndrome virus enters cells through a low pH-dependent endocytic
pathway. Virus Res 42:137-47.

87.

Kroese, M. V., J. C. Zevenhoven-Dobbe, J. N. Bos-de Ruijter, B. P. Peeters, J.
J. Meulenberg, L. A. Cornelissen, and E. J. Snijder. 2008. The nsp1alpha and
nsp1 papain-like autoproteinases are essential for porcine reproductive and
respiratory syndrome virus RNA synthesis. J Gen Virol 89:494-9.

88.

Kwon, B., I. H. Ansari, F. A. Osorio, and A. K. Pattnaik. 2006. Infectious
clone-derived viruses from virulent and vaccine strains of porcine reproductive
and respiratory syndrome virus mimic biological properties of their parental
viruses in a pregnant sow model. Vaccine 24:7071-80.

89.

Kwon, B., I. H. Ansari, A. K. Pattnaik, and F. A. Osorio. 2008. Identification
of virulence determinants of porcine reproductive and respiratory syndrome virus
through construction of chimeric clones. Virology 380:371-8.

90.

Kwon, B., A. R. Doster, and F. A. Osorio. 2006. Immunopathology of porcine
reproductive and respiratory syndrome virus infection and quantification of
porcine cytokine mRNA expression using real-time PCR. Ph.D. Dissertation,
University of Nebraska-Lincoln:142-180.

91.

Labarque, G., K. V. Reeth, H. Nauwynck, C. Drexler, S. Van Gucht, and M.
Pensaert. 2004. Impact of genetic diversity of European-type porcine
reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine
22:4183-90.

92.

Labarque, G., S. Van Gucht, H. Nauwynck, K. Van Reeth, and M. Pensaert.
2003. Apoptosis in the lungs of pigs infected with porcine reproductive and
respiratory syndrome virus and associations with the production of apoptogenic
cytokines. Vet Res 34:249-60.

93.

Lager, K. M., W. L. Mengeling, and S. L. Brockmeier. 1997. Duration of
homologous porcine reproductive and respiratory syndrome virus immunity in
pregnant swine. Vet Microbiol 58:127-33.

94.

Lager, K. M., W. L. Mengeling, and S. L. Brockmeier. 1999. Evaluation of
protective immunity in gilts inoculated with the NADC-8 isolate of porcine

134

reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed
with an antigenically distinct PRRSV isolate. Am J Vet Res 60:1022-7.
95.

Lamontagne, L., C. Page, R. Larochelle, D. Longtin, and R. Magar. 2001.
Polyclonal activation of B cells occurs in lymphoid organs from porcine
reproductive and respiratory syndrome virus (PRRSV)-infected pigs. Vet
Immunol Immunopathol 82:165-82.

96.

Lamontagne, L., C. Page, R. Larochelle, and R. Magar. 2003. Porcine
reproductive and respiratory syndrome virus persistence in blood, spleen, lymph
nodes, and tonsils of experimentally infected pigs depends on the level of
CD8high T cells. Viral Immunol 16:395-406.

97.

Lawson, S. R., K. D. Rossow, J. E. Collins, D. A. Benfield, and R. R. Rowland.
1997. Porcine reproductive and respiratory syndrome virus infection of
gnotobiotic pigs: sites of virus replication and co-localization with MAC-387
staining at 21 days post-infection. Virus Res 51:105-13.

98.

Lee, C., and D. Yoo. 2006. The small envelope protein of porcine reproductive
and respiratory syndrome virus possesses ion channel protein-like properties.
Virology 355:30-43.

99.

Lee, J. A., D. C. Suh, J. E. Kang, M. H. Kim, H. Park, M. N. Lee, J. M. Kim,
B. N. Jeon, H. E. Roh, M. Y. Yu, K. Y. Choi, K. Y. Kim, and M. W. Hur.
2005. Transcriptional activity of Sp1 is regulated by molecular interactions
between the zinc finger DNA binding domain and the inhibitory domain with
corepressors, and this interaction is modulated by MEK. J Biol Chem 280:2806171.

100.

Lee, S. M., S. K. Schommer, and S. B. Kleiboeker. 2004. Porcine reproductive
and respiratory syndrome virus field isolates differ in in vitro interferon
phenotypes. Vet Immunol Immunopathol 102:217-31.

101.

Ling, J., S. J. Morley, and J. A. Traugh. 2005. Inhibition of cap-dependent
translation via phosphorylation of eIF4G by protein kinase Pak2. EMBO J
24:4094-105.

102.

Lopez-Fuertes, L., E. Campos, N. Domenech, A. Ezquerra, J. M. Castro, J.
Dominguez, and F. Alonso. 2000. Porcine reproductive and respiratory
syndrome (PRRS) virus down-modulates TNF-alpha production in infected
macrophages. Virus Res 69:41-6.

135

103.

Lopez Fuertes, L., N. Domenech, B. Alvarez, A. Ezquerra, J. Dominguez, J.
M. Castro, and F. Alonso. 1999. Analysis of cellular immune response in pigs
recovered from porcine respiratory and reproductive syndrome infection. Virus
Res 64:33-42.

104.

Lopez, O. J., M. F. Oliveira, E. A. Garcia, B. J. Kwon, A. Doster, and F. A.
Osorio. 2007. Protection against porcine reproductive and respiratory syndrome
virus (PRRSV) infection through passive transfer of PRRSV-neutralizing
antibodies is dose dependent. Clin Vaccine Immunol 14:269-75.

105.

Lopez, O. J., and F. A. Osorio. 2004. Role of neutralizing antibodies in PRRSV
protective immunity. Vet Immunol Immunopathol 102:155-63.

106.

Loving, C. L., S. L. Brockmeier, and R. E. Sacco. 2007. Differential type I
interferon activation and susceptibility of dendritic cell populations to porcine
arterivirus. Immunology 120:217-29.

107.

Lunney, J. K., E. R. Fritz, J. M. Reecy, D. Kuhar, E. Prucnal, R. Molina, J.
Christopher-Hennings, J. Zimmerman, and R. R. Rowland. 2010. Interleukin8, interleukin-1beta, and interferon-gamma levels are linked to PRRS virus
clearance. Viral Immunol 23:127-34.

108.

Majumder, B., N. J. Venkatachari, E. A. Schafer, M. L. Janket, and V.
Ayyavoo. 2007. Dendritic cells infected with vpr-positive human
immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of
tumor necrosis factor alpha. J Virol 81:7388-99.

109.

Mardassi, H., B. Massie, and S. Dea. 1996. Intracellular synthesis, processing,
and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and
respiratory syndrome virus. Virology 221:98-112.

110.

Meier, W. A., J. Galeota, F. A. Osorio, R. J. Husmann, W. M. Schnitzlein,
and F. A. Zuckermann. 2003. Gradual development of the interferon-gamma
response of swine to porcine reproductive and respiratory syndrome virus
infection or vaccination. Virology 309:18-31.

111.

Meng, X. J., P. S. Paul, P. G. Halbur, and M. A. Lum. 1995. Phylogenetic
analyses of the putative M (ORF 6) and N (ORF 7) genes of porcine reproductive
and respiratory syndrome virus (PRRSV): implication for the existence of two
genotypes of PRRSV in the U.S.A. and Europe. Arch Virol 140:745-55.

112.

Meulenberg, J. J. 2000. PRRS, the virus. Vet. Res. 31:11-21.

136

113.

Meulenberg, J. J., J. N. Bos-de Ruijter, R. van de Graaf, G. Wensvoort, and
R. J. Moormann. 1998. Infectious transcripts from cloned genome-length cDNA
of porcine reproductive and respiratory syndrome virus. J Virol 72:380-7.

114.

Meulenberg, J. J., J. N. Bos-de Ruijter, G. Wensvoort, and R. J. Moormann.
1998. An infectious cDNA clone of porcine reproductive and respiratory
syndrome virus. Adv Exp Med Biol 440:199-206.

115.

Meulenberg, J. J., M. M. Hulst, E. J. de Meijer, P. L. Moonen, A. den Besten,
E. P. de Kluyver, G. Wensvoort, and R. J. Moormann. 1993. Lelystad virus,
the causative agent of porcine epidemic abortion and respiratory syndrome
(PEARS), is related to LDV and EAV. Virology 192:62-72.

116.

Meulenberg, J. J., A. P. van Nieuwstadt, A. van Essen-Zandbergen, and J. P.
Langeveld. 1997. Posttranslational processing and identification of a
neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus. J
Virol 71:6061-7.

117.

Mogensen, T. H., J. Melchjorsen, L. Malmgaard, A. Casola, and S. R.
Paludan. 2004. Suppression of proinflammatory cytokine expression by herpes
simplex virus type 1. J Virol 78:5883-90.

118.

Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R.
Mosmann. 1993. Interleukin-10. Annu Rev Immunol 11:165-90.

119.

Mulupuri, P., J. J. Zimmerman, J. Hermann, C. R. Johnson, J. P. Cano, W.
Yu, S. A. Dee, and M. P. Murtaugh. 2008. Antigen-specific B-cell responses to
porcine reproductive and respiratory syndrome virus infection. J Virol 82:358-70.

120.

Murao, K., T. Ohyama, H. Imachi, T. Ishida, W. M. Cao, H. Namihira, M.
Sato, N. C. Wong, and J. Takahara. 2000. TNF-alpha stimulation of MCP-1
expression is mediated by the Akt/PKB signal transduction pathway in vascular
endothelial cells. Biochem Biophys Res Commun 276:791-6.

121.

Murata, Y., H. G. Kim, K. T. Rogers, A. J. Udvadia, and J. M. Horowitz.
1994. Negative regulation of Sp1 trans-activation is correlated with the binding of
cellular proteins to the amino terminus of the Sp1 trans-activation domain. J Biol
Chem 269:20674-81.

122.

Murtaugh, M. P., T. Stadejek, J. E. Abrahante, T. T. Lam, and F. C. Leung.
2010. The ever-expanding diversity of porcine reproductive and respiratory
syndrome virus. Virus Res 154:18-30.

137

123.

Murtaugh, M. P., Z. Xiao, and F. Zuckermann. 2002. Immunological
responses of swine to porcine reproductive and respiratory syndrome virus
infection. Viral Immunol 15:533-47.

124.

Nedialkova, D. D., A. E. Gorbalenya, and E. J. Snijder. 2010. Arterivirus Nsp1
modulates the accumulation of minus-strand templates to control the relative
abundance of viral mRNAs. PLoS Pathog 6:e1000772.

125.

Nichols, D. B., and J. L. Shisler. 2009. Poxvirus MC160 protein utilizes multiple
mechanisms to inhibit NF-kappaB activation mediated via components of the
tumor necrosis factor receptor 1 signal transduction pathway. J Virol 83:3162-74.

126.

Nielsen, H. S., G. Liu, J. Nielsen, M. B. Oleksiewicz, A. Botner, T. Storgaard,
and K. S. Faaberg. 2003. Generation of an infectious clone of VR-2332, a highly
virulent North American-type isolate of porcine reproductive and respiratory
syndrome virus. J Virol 77:3702-11.

127.

Olin, M. R., L. Batista, Z. Xiao, S. A. Dee, M. P. Murtaugh, C. C. Pijoan, and
T. W. Molitor. 2005. Gammadelta lymphocyte response to porcine reproductive
and respiratory syndrome virus. Viral Immunol 18:490-9.

128.

Opriessnig, T., P. G. Halbur, K. J. Yoon, R. M. Pogranichniy, K. M. Harmon,
R. Evans, K. F. Key, F. J. Pallares, P. Thomas, and X. J. Meng. 2002.
Comparison of molecular and biological characteristics of a modified live porcine
reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS
MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and
two recent field isolates of PRRSV. J Virol 76:11837-44.

129.

Ostrowski, M., J. A. Galeota, A. M. Jar, K. B. Platt, F. A. Osorio, and O. J.
Lopez. 2002. Identification of neutralizing and nonneutralizing epitopes in the
porcine reproductive and respiratory syndrome virus GP5 ectodomain. J Virol
76:4241-50.

130.

Paludan, S. R., S. Ellermann-Eriksen, V. Kruys, and S. C. Mogensen. 2001.
Expression of TNF-alpha by herpes simplex virus-infected macrophages is
regulated by a dual mechanism: transcriptional regulation by NF-kappa B and
activating transcription factor 2/Jun and translational regulation through the AUrich region of the 3' untranslated region. J Immunol 167:2202-8.

131.

Panne, D., T. Maniatis, and S. C. Harrison. 2007. An atomic model of the
interferon-beta enhanceosome. Cell 129:1111-23.

138

132.

Park, J. Y., H. S. Kim, and S. H. Seo. 2008. Characterization of interaction
between porcine reproductive and respiratory syndrome virus and porcine
dendritic cells. J Microbiol Biotechnol 18:1709-16.

133.

Patel, D., Y. Nan, M. Shen, K. Ritthipichai, X. Zhu, and Y. J. Zhang. Porcine
reproductive and respiratory syndrome virus inhibits type I interferon signaling by
blocking STAT1/STAT2 nuclear translocation. J Virol 84:11045-55.

134.

Patton, J. B., R. R. Rowland, D. Yoo, and K. O. Chang. 2009. Modulation of
CD163 receptor expression and replication of porcine reproductive and
respiratory syndrome virus in porcine macrophages. Virus Res 140:161-71.

135.

Pedersen, K. W., Y. van der Meer, N. Roos, and E. J. Snijder. 1999. Open
reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic
reticulum-derived double-membrane vesicles which carry the viral replication
complex. J Virol 73:2016-26.

136.

Plagemann, P. G., R. R. Rowland, and K. S. Faaberg. 2002. The primary
neutralization epitope of porcine respiratory and reproductive syndrome virus
strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol
147:2327-47.

137.

Prieto, C., P. Suarez, I. Simarro, C. Garcia, A. Fernandez, and J. M. Castro.
1997. Transplacental infection following exposure of gilts to porcine reproductive
and respiratory syndrome virus at the onset of gestation. Vet Microbiol 57:301-11.

138.

Qi, X. F., D. H. Kim, Y. S. Yoon, D. Jin, X. Z. Huang, J. H. Li, Y. K. Deung,
and K. J. Lee. 2009. Essential involvement of cross-talk between IFN-gamma
and TNF-alpha in CXCL10 production in human THP-1 monocytes. J Cell
Physiol 220:690-7.

139.

Redpath, S., P. Ghazal, and N. R. Gascoigne. 2001. Hijacking and exploitation
of IL-10 by intracellular pathogens. Trends Microbiol 9:86-92.

140.

Reed, L. J., Muench, H. 1938. A simple method of estimating fifty percent
endpoints. Am J Hygiene 27:493-497.

141.

Rossow, K. D. 1998. Porcine reproductive and respiratory syndrome. Vet Pathol
35:1-20.

142.

Rossow, K. D., E. M. Bautista, S. M. Goyal, T. W. Molitor, M. P. Murtaugh,
R. B. Morrison, D. A. Benfield, and J. E. Collins. 1994. Experimental porcine

139

reproductive and respiratory syndrome virus infection in one-, four-, and 10week-old pigs. J Vet Diagn Invest 6:3-12.
143.

Rossow, K. D., J. E. Collins, S. M. Goyal, E. A. Nelson, J. ChristopherHennings, and D. A. Benfield. 1995. Pathogenesis of porcine reproductive and
respiratory syndrome virus infection in gnotobiotic pigs. Vet Pathol 32:361-73.

144.

Rowland, R. R. 2010. The interaction between PRRSV and the late gestation pig
fetus. Virus Res 154:114-22.

145.

Rowland, R. R., B. Robinson, J. Stefanick, T. S. Kim, L. Guanghua, S. R.
Lawson, and D. A. Benfield. 2001. Inhibition of porcine reproductive and
respiratory syndrome virus by interferon-gamma and recovery of virus replication
with 2-aminopurine. Arch Virol 146:539-55.

146.

Ruby, J., H. Bluethmann, and J. J. Peschon. 1997. Antiviral activity of tumor
necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med
186:1591-6.

147.

Ruo-Pan Huang, Y. F., Zhengyu Ni, Dan Mercola, and Eileen D. Adamson.
1997. Reciprocal Modulation Between Sp1 and Egr-1. Journal of Cellular
Biochemistry 66:489-499.

148.

Samsom, J. N., T. G. de Bruin, J. J. Voermans, J. J. Meulenberg, J. M. Pol,
and A. T. Bianchi. 2000. Changes of leukocyte phenotype and function in the
broncho-alveolar lavage fluid of pigs infected with porcine reproductive and
respiratory syndrome virus: a role for CD8(+) cells. J Gen Virol 81:497-505.

149.

Sanchez, C., N. Domenech, J. Vazquez, F. Alonso, A. Ezquerra, and J.
Dominguez. 1999. The porcine 2A10 antigen is homologous to human CD163
and related to macrophage differentiation. J Immunol 162:5230-7.

150.

Sang, Y., R. R. Rowland, R. A. Hesse, and F. Blecha. 2010. Differential
expression and activity of the porcine type I interferon family. Physiol Genomics
42:248-58.

151.

Sarkar, G., and S. S. Sommer. 1990. The "megaprimer" method of site-directed
mutagenesis. Biotechniques 8:404-7.

152.

Shanmukhappa, K., J. K. Kim, and S. Kapil. 2007. Role of CD151, A
tetraspanin, in porcine reproductive and respiratory syndrome virus infection.
Virol J 4:62.

140

153.

Shi, M., T. T. Lam, C. C. Hon, M. P. Murtaugh, P. R. Davies, R. K. Hui, J. Li,
L. T. Wong, C. W. Yip, J. W. Jiang, and F. C. Leung. 2010. Phylogeny-based
evolutionary, demographical, and geographical dissection of North American type
2 porcine reproductive and respiratory syndrome viruses. J Virol 84:8700-11.

154.

Silva-Campa, E., L. Cordoba, L. Fraile, L. Flores-Mendoza, M. Montoya,
and J. Hernandez. 2010. European genotype of porcine reproductive and
respiratory syndrome (PRRSV) infects monocyte-derived dendritic cells but does
not induce Treg cells. Virology 396:264-71.

155.

Silva-Campa, E., L. Flores-Mendoza, M. Resendiz, A. Pinelli-Saavedra, V.
Mata-Haro, W. Mwangi, and J. Hernandez. 2009. Induction of T helper 3
regulatory cells by dendritic cells infected with porcine reproductive and
respiratory syndrome virus. Virology 387:373-9.

156.

Sirinarumitr, T., Y. Zhang, J. P. Kluge, P. G. Halbur, and P. S. Paul. 1998. A
pneumo-virulent United States isolate of porcine reproductive and respiratory
syndrome virus induces apoptosis in bystander cells both in vitro and in vivo. J
Gen Virol 79 ( Pt 12):2989-95.

157.

Slobedman, B., P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth. 2009.
Virus-encoded homologs of cellular interleukin-10 and their control of host
immune function. J Virol 83:9618-29.

158.

Solano, G. I., E. Bautista, T. W. Molitor, J. Segales, and C. Pijoan. 1998.
Effect of porcine reproductive and respiratory syndrome virus infection on the
clearance of Haemophilus parasuis by porcine alveolar macrophages. Can J Vet
Res 62:251-6.

159.

Song, C., P. Krell, and D. Yoo. 2010. Nonstructural protein 1alpha subunitbased inhibition of NF-kappaB activation and suppression of interferon-beta
production by porcine reproductive and respiratory syndrome virus. Virology
407:268-80.

160.

Spengler, M. L., and M. G. Brattain. 2006. Sumoylation inhibits cleavage of
Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent
transcription. J Biol Chem 281:5567-74.

161.

Spilman, M. S., C. Welbon, E. Nelson, and T. Dokland. 2009. Cryo-electron
tomography of porcine reproductive and respiratory syndrome virus: organization
of the nucleocapsid. J Gen Virol 90:527-35.

141

162.

Stadejek, T., M. B. Oleksiewicz, A. V. Scherbakov, A. M. Timina, J. S.
Krabbe, K. Chabros, and D. Potapchuk. 2008. Definition of subtypes in the
European genotype of porcine reproductive and respiratory syndrome virus:
nucleocapsid characteristics and geographical distribution in Europe. Arch Virol
153:1479-88.

163.

Stordeur, P., L. F. Poulin, L. Craciun, L. Zhou, L. Schandene, A. de
Lavareille, S. Goriely, and M. Goldman. 2002. Cytokine mRNA quantification
by real-time PCR. J Immunol Methods 259:55-64.

164.

Subramaniam, S., B. Kwon, L. K. Beura, C. A. Kuszynski, A. K. Pattnaik,
and F. A. Osorio. 2010. Porcine reproductive and respiratory syndrome virus
non-structural protein 1 suppresses tumor necrosis factor-alpha promoter
activation by inhibiting NF-kappaB and Sp1. Virology 406:270-9.

165.

Subramaniam, S., J. H. Sur, B. Kwon, A. K. Pattnaik, and F. A. Osorio. 2010.
A virulent strain of porcine reproductive and respiratory syndrome virus does not
up-regulate interleukin-10 levels in vitro or in vivo. Virus Res 155:415-22.

166.

Sun, Y., F. Xue, Y. Guo, M. Ma, N. Hao, X. C. Zhang, Z. Lou, X. Li, and Z.
Rao. 2009. Crystal structure of porcine reproductive and respiratory syndrome
virus leader protease Nsp1alpha. J Virol 83:10931-40.

167.

Sun, Z., Z. Chen, S. R. Lawson, and Y. Fang. 2010. The cysteine protease
domain of porcine reproductive and respiratory syndrome virus nonstructural
protein 2 possesses deubiquitinating and interferon antagonism functions. J Virol
84:7832-46.

168.

Sur, J. H., A. R. Doster, J. S. Christian, J. A. Galeota, R. W. Wills, J. J.
Zimmerman, and F. A. Osorio. 1997. Porcine reproductive and respiratory
syndrome virus replicates in testicular germ cells, alters spermatogenesis, and
induces germ cell death by apoptosis. J Virol 71:9170-9.

169.

Sur, J. H., A. R. Doster, J. A. Galeota, and F. A. Osorio. 2001. Evidence for
the localization of porcine reproductive and respiratory syndrome virus (PRRSV)
antigen and RNA in ovarian follicles in gilts. Vet Pathol 38:58-66.

170.

Suradhat, S., and R. Thanawongnuwech. 2003. Upregulation of interleukin-10
gene expression in the leukocytes of pigs infected with porcine reproductive and
respiratory syndrome virus. J Gen Virol 84:2755-60.

142

171.

Suradhat, S., R. Thanawongnuwech, and Y. Poovorawan. 2003. Upregulation
of IL-10 gene expression in porcine peripheral blood mononuclear cells by
porcine reproductive and respiratory syndrome virus. J Gen Virol 84:453-9.

172.

Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int
Immunol 17:1-14.

173.

Thanawongnuwech, R., B. Thacker, P. Halbur, and E. L. Thacker. 2004.
Increased production of proinflammatory cytokines following infection with
porcine reproductive and respiratory syndrome virus and Mycoplasma
hyopneumoniae. Clin Diagn Lab Immunol 11:901-8.

174.

Thanawongnuwech, R., E. L. Thacker, and P. G. Halbur. 1997. Effect of
porcine reproductive and respiratory syndrome virus (PRRSV) (isolate ATCC
VR-2385) infection on bactericidal activity of porcine pulmonary intravascular
macrophages (PIMs): in vitro comparisons with pulmonary alveolar macrophages
(PAMs). Vet Immunol Immunopathol 59:323-35.

175.

Tijms, M. A., D. D. Nedialkova, J. C. Zevenhoven-Dobbe, A. E. Gorbalenya,
and E. J. Snijder. 2007. Arterivirus subgenomic mRNA synthesis and virion
biogenesis depend on the multifunctional nsp1 autoprotease. J Virol 81:10496505.

176.

Tingstedt, J. E., and J. Nielsen. 2004. Cellular immune responses in the lungs of
pigs infected in utero with PRRSV: an immunohistochemical study. Viral
Immunol 17:558-64.

177.

Toews, G. B. 2001. Cytokines and the lung. Eur Respir J Suppl 34:3s-17s.

178.

Truong, H. M., Z. Lu, G. F. Kutish, J. Galeota, F. A. Osorio, and A. K.
Pattnaik. 2004. A highly pathogenic porcine reproductive and respiratory
syndrome virus generated from an infectious cDNA clone retains the in vivo
virulence and transmissibility properties of the parental virus. Virology 325:30819.

179.

Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L.
H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld.
2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1,
and CREB binding protein and p300 is recruited to the tumor necrosis factor
alpha promoter in vivo. Mol Cell Biol 20:6084-94.

180.

van Aken, D., J. Zevenhoven-Dobbe, A. E. Gorbalenya, and E. J. Snijder.
2006. Proteolytic maturation of replicase polyprotein pp1a by the nsp4 main

143

proteinase is essential for equine arteritis virus replication and includes internal
cleavage of nsp7. J Gen Virol 87:3473-82.
181.

van der Meer, Y., H. van Tol, J. K. Locker, and E. J. Snijder. 1998. ORF1aencoded replicase subunits are involved in the membrane association of the
arterivirus replication complex. J Virol 72:6689-98.

182.

Van Gorp, H., W. Van Breedam, P. L. Delputte, and H. J. Nauwynck. 2009.
The porcine reproductive and respiratory syndrome virus requires trafficking
through CD163-positive early endosomes, but not late endosomes, for productive
infection. Arch Virol 154:1939-43.

183.

Van Gucht, S., K. Van Reeth, H. Nauwynck, and M. Pensaert. 2005. Porcine
reproductive and respiratory syndrome virus infection increases CD14 expression
and lipopolysaccharide-binding protein in the lungs of pigs. Viral Immunol
18:116-26.

184.

van Gucht, S., K. van Reeth, and M. Pensaert. 2003. Interaction between
porcine reproductive-respiratory syndrome virus and bacterial endotoxin in the
lungs of pigs: potentiation of cytokine production and respiratory disease. J Clin
Microbiol 41:960-6.

185.

Van Reeth, K., G. Labarque, H. Nauwynck, and M. Pensaert. 1999.
Differential production of proinflammatory cytokines in the pig lung during
different respiratory virus infections: correlations with pathogenicity. Res Vet Sci
67:47-52.

186.

Vanhee, M., W. Van Breedam, S. Costers, M. Geldhof, Y. Noppe, and H.
Nauwynck. 2011. Characterization of antigenic regions in the porcine
reproductive and respiratory syndrome virus by the use of peptide-specific serum
antibodies. Vaccine. 29(29-30):4794-804.

187.

Vu, H. L., B. Kwon, K. J. Yoon, W. W. Laegreid, A. K. Pattnaik, and F. A.
Osorio. 2011. Immune Evasion of Porcine Reproductive and Respiratory
Syndrome Virus through Glycan Shielding Involves both Glycoprotein 5 as Well
as Glycoprotein 3. J Virol 85:5555-64.

188.

Vu., H. L. X. 2009. Sub-typing of PRRSV isolates by means of measurement of
cross-neutralization reactions. Master's Thesis:1-74.

189.

Wang, D., L. Fang, F. Zhao, R. Luo, H. Chen, and S. Xiao. 2011. Molecular
cloning, expression and antiviral activity of porcine interleukin-29 (poIL-29). Dev
Comp Immunol 35:378-84.

144

190.

Wang, X., M. Eaton, M. Mayer, H. Li, D. He, E. Nelson, and J. ChristopherHennings. 2007. Porcine reproductive and respiratory syndrome virus
productively infects monocyte-derived dendritic cells and compromises their
antigen-presenting ability. Arch Virol 152:289-303.

191.

Wang, Y., R. Luo, L. Fang, D. Wang, J. Bi, H. Chen, and S. Xiao. 2011.
Porcine reproductive and respiratory syndrome virus (PRRSV) infection activates
chemokine RANTES in MARC-145 cells. Mol Immunol 48:586-91.

192.

Wensvoort, G. 1993. Lelystad virus and the porcine epidemic abortion and
respiratory syndrome. Vet Res 24:117-24.

193.

Wensvoort, G., C. Terpstra, J. M. Pol, E. A. ter Laak, M. Bloemraad, E. P.
de Kluyver, C. Kragten, L. van Buiten, A. den Besten, F. Wagenaar, and et al.
1991. Mystery swine disease in The Netherlands: the isolation of Lelystad virus.
Vet Q 13:121-30.

194.

Wesley, R. D., K. M. Lager, and M. E. Kehrli, Jr. 2006. Infection with Porcine
reproductive and respiratory syndrome virus stimulates an early gamma interferon
response in the serum of pigs. Can J Vet Res 70:176-82.

195.

Wierstra, I. 2008. Sp1: emerging roles--beyond constitutive activation of TATAless housekeeping genes. Biochem Biophys Res Commun 372:1-13.

196.

Wills, R. W., J. J. Zimmerman, K. J. Yoon, S. L. Swenson, M. J. McGinley,
H. T. Hill, K. B. Platt, J. Christopher-Hennings, and E. A. Nelson. 1997.
Porcine reproductive and respiratory syndrome virus: a persistent infection. Vet
Microbiol 55:231-40.

197.

Wissink, E. H., M. V. Kroese, H. A. van Wijk, F. A. Rijsewijk, J. J.
Meulenberg, and P. J. Rottier. 2005. Envelope protein requirements for the
assembly of infectious virions of porcine reproductive and respiratory syndrome
virus. J Virol 79:12495-506.

198.

Wong, G. H., and D. V. Goeddel. 1986. Tumour necrosis factors alpha and beta
inhibit virus replication and synergize with interferons. Nature 323:819-22.

199.

Wu, W. H., Y. Fang, R. Farwell, M. Steffen-Bien, R. R. Rowland, J.
Christopher-Hennings, and E. A. Nelson. 2001. A 10-kDa structural protein of
porcine reproductive and respiratory syndrome virus encoded by ORF2b.
Virology 287:183-91.

145

200.

Xiao, S., D. Mo, Q. Wang, J. Jia, L. Qin, X. Yu, Y. Niu, X. Zhao, X. Liu, and
Y. Chen. 2010. Aberrant host immune response induced by highly virulent
PRRSV identified by digital gene expression tag profiling. BMC Genomics
11:544.

201.

Xue, F., Y. Sun, L. Yan, C. Zhao, J. Chen, M. Bartlam, X. Li, Z. Lou, and Z.
Rao. 2010. The crystal structure of porcine reproductive and respiratory
syndrome virus nonstructural protein Nsp1beta reveals a novel metal-dependent
nuclease. J Virol 84:6461-71.

202.

Yang, L., M. L. Frey, K. J. Yoon, J. J. Zimmerman, and K. B. Platt. 2000.
Categorization of North American porcine reproductive and respiratory syndrome
viruses: epitopic profiles of the N, M, GP5 and GP3 proteins and susceptibility to
neutralization. Arch Virol 145:1599-619.

203.

Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997.
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in
human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription
factors. J Biol Chem 272:17795-801.

204.

Yoo, D., A. Pattnaik, and O. Kim. 2007. Mutational analysis of PRRSV nonstructural protein 11 endoribonuclease Nendou and the virus replication. In page
30: Proceedings 2007 International Symphosium, December 7-8, 2007, Chicago,
Available from: http://www.prrssymphosium.org/Documents/Proceedings/
PrrsSymposiumProceedings2007.PDF.

205.

Yoon, K. J., J. J. Zimmerman, S. L. Swenson, M. J. McGinley, K. A. Eernisse,
A. Brevik, L. L. Rhinehart, M. L. Frey, H. T. Hill, and K. B. Platt. 1995.
Characterization of the humoral immune response to porcine reproductive and
respiratory syndrome (PRRS) virus infection. J Vet Diagn Invest 7:305-12.

206.

Zhang, Z., J. K. Kolls, P. Oliver, D. Good, P. O. Schwarzenberger, M. S.
Joshi, J. L. Ponthier, and J. R. Lancaster, Jr. 2000. Activation of tumor
necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric
oxide. J Biol Chem 275:15839-44.

207.

Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J.
Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis
factor. Nature 377:348-51.

208.

Zuckermann, F. A., and R. J. Husmann. 1996. Functional and phenotypic
analysis of porcine peripheral blood CD4/CD8 double-positive T cells.
Immunology 87:500-12.

